FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Manning, M
   MacFarlane, A
   Hickey, A
   Franklin, S
AF Manning, Molly
   MacFarlane, Anne
   Hickey, Anne
   Franklin, Sue
TI Perspectives of people with aphasia post-stroke towards personal
   recovery and living successfully: A systematic review and thematic
   synthesis
SO PLOS ONE
LA English
DT Review
ID QUALITY-OF-LIFE; SOCIAL-PARTICIPATION; COMMUNITY REINTEGRATION; INSIDER
   PERSPECTIVE; CHRONIC ILLNESS; FAMILY-MEMBERS; OLDER-PEOPLE; 1ST YEAR;
   STROKE; NEEDS
AB Background
   There is increased focus on supporting people with chronic conditions to live well via person- centred, integrated care. There is a growing body of qualitative literature examining the insider perspectives of people with post-stroke aphasia (PWA) on topics relating to personal recovery and living successfully (PR-LS). To date no synthesis has been conducted examining both internal and external, structural influences on living well. In this study, we aimed to advance theoretical understanding of how best to promote and support PR-LS by integrating the perspectives of PWA on a wide range of topics relating to PR-LS. This is essential for planning and delivering quality care.
   Methods and findings
   We conducted a systematic review, following PRISMA guidelines, and thematic synthesis. Following a search of 7 electronic databases, 31 articles were included and critically appraised using predetermined criteria. Inductive and iterative analysis generated 5 analytical themes about promoting PR-LS. Aphasia occurs in the context of a wider social network that provides valued support and social companionship and has its own need for formal support. PWA want to make a positive contribution to society. The participation of PWA is facilitated by enabling environments and opportunities. PWA benefit from access to a flexible, responsive, life-relevant range of services in the long-term post-stroke. Accessible information and collaborative interactions with aphasia-aware healthcare professionals empower PWA to take charge of their condition and to navigate the health system.
   Conclusion
   The findings highlight the need to consider wider attitudinal and structural influences on living well. PR-LS are promoted via responsive, long-term support for PWA, friends and family, and opportunities to participate autonomously and contribute to the community. Shortcomings in the quality of the existing evidence base must be addressed in future studies to ensure that PWA are meaningfully included in research and service development initiatives.
C1 [Manning, Molly; Franklin, Sue] Univ Limerick, Sch Allied Hlth, Fac Educ & Hlth Sci, Limerick, Ireland.
   [MacFarlane, Anne] Univ Limerick, Fac Educ & Hlth Sci, GEMS, Limerick, Ireland.
   [MacFarlane, Anne] Univ Limerick, Hlth Res Inst, Limerick, Ireland.
   [Hickey, Anne] Royal Coll Surgeons Ireland, Dept Psychol, Dublin, Ireland.
RP Manning, M (reprint author), Univ Limerick, Sch Allied Hlth, Fac Educ & Hlth Sci, Limerick, Ireland.
EM molly.manning@ul.ie
FU Health Research Board [SPHeRE/2013/1]
FX MM is a PhD scholar funded by the Health Research Board (SPHeRE/2013/1).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abu Dabrh AM, 2015, J ROY COLL PHYS EDIN, V45, P114, DOI 10.4997/JRCPE.2015.205
   [Anonymous], 2008, CLOS GAP GEN HLTH EQ
   Anthony W. A., 1993, PSYCHOSOC REHABIL, V16, P11, DOI DOI 10.1037/H0095655
   Armstrong E, 2015, DISABIL REHABIL, V37, P1462, DOI 10.3109/09638288.2014.972581
   Armstrong E, 2012, INT J SPEECH-LANG PA, V14, P271, DOI 10.3109/17549507.2011.663790
   Ayerbe L, 2013, BR J PSYCHIAT, V202
   Baker C, 2018, DISABIL REHABIL, V40, P1870, DOI 10.1080/09638288.2017.1315181
   Bank World, 2017, WORLD DEV IND 2017
   Barry CA, 1999, QUAL HEALTH RES, V9, P26, DOI 10.1177/104973299129121677
   Berg K, 2016, DISABIL REHABIL, V39, P1
   BLACKSCHAFFER RM, 1990, ARCH PHYS MED REHAB, V71, P285
   Boles L, 2006, TOP STROKE REHABIL, V13, P37, DOI 10.1310/29WX-32LE-A21H-3JQJ
   Brady MC, 2013, INT J STROKE, V8, P193, DOI 10.1111/j.1747-4949.2012.00900.x
   Bramer W, 2015, EUR ASS HLTH INF LIB
   Brannigan C, 2017, DISABIL REHABIL, V39, P211, DOI 10.3109/09638288.2016.1141242
   Bright FAS, 2013, APHASIOLOGY, V27, P41, DOI 10.1080/02687038.2012.718069
   Brown K, 2013, INT J SPEECH-LANG PA, V15, P165, DOI 10.3109/17549507.2012.692814
   Brown K, 2012, INT J SPEECH-LANG PA, V14, P141, DOI 10.3109/17549507.2011.632026
   Brown K, 2010, APHASIOLOGY, V24, P1267, DOI 10.1080/02687031003755429
   BURY M, 1991, SOCIOL HEALTH ILL, V13, P451, DOI 10.1111/j.1467-9566.1991.tb00522.x
   Byng S, 2005, APHASIOLOGY, V19, P906, DOI 10.1080/02687030544000128
   Campbell R, 2011, HEALTH TECHNOL ASSES, V15, pIII, DOI 10.3310/hta15430
   Carroll C, 2017, BMJ, V356
   Chapey R., 2001, LANGUAGE INTERVENTIO, P235
   Clinical Centre for Research Excellence in Aphasia Rehabilitation, 2014, APH REH BEST PRACT S
   Cooke A, 2012, QUAL HEALTH RES, V22, P1435, DOI 10.1177/1049732312452938
   Cruice M, 2006, TOP STROKE REHABIL, V13, P14, DOI 10.1310/4JW5-7VG8-G6X3-1QVJ
   Cruice M, 2010, APHASIOLOGY, V24, P327, DOI 10.1080/02687030802565849
   Dalemans RJP, 2008, APHASIOLOGY, V22, P1071, DOI 10.1080/02687030701632179
   Dalemans RJP, 2010, INT J LANG COMM DIS, V45, P537, DOI 10.3109/13682820903223633
   Davidson B, 2008, TOP STROKE REHABIL, V15, P325, DOI 10.1310/tsr1504-325
   Denman A, 1998, DISABIL REHABIL, V20, P411, DOI 10.3109/09638289809166103
   Dietz A, 2013, APHASIOLOGY, V27, P309, DOI 10.1080/02687038.2012.725241
   Duke SAS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005268.pub2
   Engelter ST, 2006, STROKE, V37, P1379, DOI 10.1161/01.STR.0000221815.64093.8c
   Feigin VL, 2015, STROKE, V46, P1740, DOI 10.1161/STROKEAHA.115.008222
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Flowers HL, 2016, ARCH PHYS MED REHABI
   Fryer CE, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010442.pub2
   Gallacher K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001473
   Gallacher K, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-10
   Grohn B, 2014, APHASIOLOGY, V28, P1405, DOI 10.1080/02687038.2014.935118
   Grohn B, 2012, INT J SPEECH-LANG PA, V14, P390, DOI 10.3109/17549507.2012.692813
   Halle M, 2013, STROKE, V44, pE195
   Halle MC, 2014, DISABIL REHABIL, V36, P1774, DOI 10.3109/09638288.2013.870608
   Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534
   Harlow A, 2001, Top Stroke Rehabil, V7, P46
   Hemsley B, 2013, APHASIOLOGY, V27, P706, DOI 10.1080/02687038.2012.748181
   Hersh D, 2015, TOP LANG DISORD, V35, P219, DOI 10.1097/TLD.0000000000000060
   Hersh D, 2009, APHASIOLOGY, V23, P331, DOI 10.1080/02687030701764220
   Hilari K, 2011, DISABIL REHABIL, V33, P211, DOI 10.3109/09638288.2010.508829
   Hilton R, 2014, APHASIOLOGY, V28, P797, DOI 10.1080/02687038.2014.906562
   Hinckley JJ, 2006, TOP STROKE REHABIL, V13, P25, DOI 10.1310/FLJ3-04DQ-MG8W-89EU
   Hjelmblink F., 2007, INT J QUALITATIVE ST, V2, P93, DOI DOI 10.1080/17482620701296358
   Holland AL, 2006, TOP STROKE REHABIL, V13, P44, DOI 10.1310/13D7-R31R-8A0D-Y74G
   Horn EAD, 2016, J COUNS DEV, V94, P225, DOI 10.1002/jcad.12078
   Houghton C, 2017, J CLIN NURS, V26, P873, DOI 10.1111/jocn.13443
   Howe T, 2012, INT J LANG COMM DIS, V47, P511, DOI 10.1111/j.1460-6984.2012.00159.x
   Howe TJ, 2008, APHASIOLOGY, V22, P1, DOI 10.1080/02687030701640941
   Jeste DV, 2010, WORLD PSYCHIATRY, V9, P78
   Jones F, 2008, DISABIL REHABIL, V30, P507, DOI 10.1080/09638280701355561
   Jones MC, 2011, J NURS HLTH CHRONIC, V3, P174
   Kelly C, 2018, COCHRANE DB SYST REV
   Kerr J, 2010, APHASIOLOGY, V24, P1170, DOI 10.1080/02687030903383738
   Langlois EV, 2018, B WORLD HEALTH ORGAN, V96, P79
   Laska AC, 2001, J INTERN MED, V249, P413, DOI 10.1046/j.1365-2796.2001.00812.x
   Le Dorze G, 2014, APHASIOLOGY, V28, P421, DOI 10.1080/02687038.2013.869305
   LEDORZE G, 1995, APHASIOLOGY, V9, P239
   Lenferink A, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011682.pub2
   Lewin S, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-017-0688-3
   Lewin S, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001895
   Lorig K R, 2001, Eff Clin Pract, V4, P256
   Mackenzie C, 2011, DISABIL REHABIL, V33, P187, DOI 10.3109/09638288.2010.508555
   Manning M, 2017, PROSPERO
   Martin P, 2015, GERONTOLOGIST, V55, P14, DOI 10.1093/geront/gnu044
   Mc Menamin R, 2015, APHASIOLOGY, V29, P889, DOI 10.1080/02687038.2015.1004155
   McDaid S, 2013, RECOVERY WHAT YOU SH
   McKevitt C, 2010, UK STROKE SURVIVOR N
   McKevitt C, 2011, STROKE
   McLellan KM, 2014, APHASIOLOGY, V28, P453, DOI 10.1080/02687038.2013.845740
   Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8
   Mental Health Commission, 1998, BLUEPR MENT HLTH SER
   Michallet B, 2003, APHASIOLOGY, V17, P835, DOI 10.1080/02687030344000238
   Michallet B, 2001, APHASIOLOGY, V15, P731, DOI 10.1080/02687040143000087
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Morris J, 2011, APHASIOLOGY, V25, P890, DOI 10.1080/02687038.2010.549568
   Morris K, 2014, INT J SPEECH-LANG PA, V16, P541, DOI 10.3109/17549507.2013.855260
   Mumby K, 2013, APHASIOLOGY, V27, P462, DOI 10.1080/02687038.2013.772559
   Niemi T, 2013, DISABIL REHABIL, V35, P1828, DOI 10.3109/09638288.2012.759628
   Northcott S, 2016, J SPEECH LANG HEAR R, V59, P772, DOI 10.1044/2016_JSLHR-L-15-0201
   Northcott S, 2011, INT J LANG COMM DIS, V46, P524, DOI 10.1111/j.1460-6984.2011.00079.x
   Organization WH, 2001, INT CLASS FUNCT DIS
   Pal K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008776.pub2
   Parr S, 2001, FOLIA PHONIATR LOGO, V53, P266, DOI 10.1159/000052681
   PARR S, 1994, APHASIOLOGY, V8, P457, DOI 10.1080/02687039408248670
   Parr S, 2007, APHASIOLOGY, V21, P98, DOI 10.1080/02687030600798337
   Pearl G, 2011, DISABIL REHABIL, V33, P1805, DOI 10.3109/09638288.2010.549285
   Peytremann-Bridevaux I, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007988.pub2
   Potter CM, 2017, SOCIOL HLTH ILLN
   Rees R, 2009, CHILDRENS VIEWS OBES
   Rohde A, 2013, J EVAL CLIN PRACT, V19, P994, DOI 10.1111/jep.12023
   Rubinstein RL, 2015, GERONTOLOGIST, V55, P34, DOI 10.1093/geront/gnu080
   Shepherd G, 2008, MAKING RECOVERY REAL
   Shrubsole K, 2017, APHASIOLOGY, V31, P1, DOI 10.1080/02687038.2016.1143083
   Simmons-Mackie N, 2017, APHASIOLOGY, V31, P131, DOI 10.1080/02687038.2016.1180662
   Simmons-Mackie N, 2013, APHASIOLOGY, V27, P1281, DOI 10.1080/02687038.2013.818098
   Simmons-Mackie NN, 2007, APHASIOLOGY, V21, P81, DOI 10.1080/02687030600798311
   Simmons-Mackie NN, 2007, APHASIOLOGY, V21, P39, DOI 10.1080/02687030600798287
   Slade M., 2009, PERSONAL RECOVERY ME
   Squire S., 2006, CLIN GOVERNANCE INT, V11, P17
   Tanner D, 1988, APHASIOLOGY, V2, P79, DOI DOI 10.1080/02687038808248889
   Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45
   Thrift AG, 2017, INT J STROKE, V12, P13, DOI 10.1177/1747493016676285
   Tomkins B, 2013, APHASIOLOGY, V27, P972, DOI 10.1080/02687038.2013.811211
   Tong A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-181
   Vassilev I, 2011, CHRONIC ILLN, V7, P60, DOI 10.1177/1742395310383338
   Walsh ME, 2015, DISABIL REHABIL, V37, P1599, DOI 10.3109/09638288.2014.974834
   Wood JP, 2010, CLIN REHABIL, V24, P1045, DOI 10.1177/0269215510375901
   World Health Organization, 2016, FRAM INT PEOPL CTR H
   World Health Organization, 2002, INN CAR CHRON COND B
   Worrall L, 2011, APHASIOLOGY, V25, P309, DOI 10.1080/02687038.2010.508530
   Wray F, 2017, DISABIL REHABIL, P1
   Wray F, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017944
NR 123
TC 0
Z9 0
U1 5
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 22
PY 2019
VL 14
IS 3
AR e0214200
DI 10.1371/journal.pone.0214200
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HP9GF
UT WOS:000462000400041
PM 30901359
DA 2019-06-18
ER

PT J
AU Dantas, LF
   Marchesi, JF
   Peres, IT
   Hamacher, S
   Bozza, FA
   Neira, RAQ
AF Dantas, Leila F.
   Marchesi, Janaina F.
   Peres, Igor T.
   Hamacher, Silvio
   Bozza, Fernando A.
   Quintano Neira, Ricardo A.
TI Public hospitalizations for stroke in Brazil from 2009 to 2016
SO PLOS ONE
LA English
DT Article
ID CASE-FATALITY RATES; MORTALITY; TRENDS; EPIDEMIOLOGY; OUTCOMES; DISEASE
AB Background
   Stroke is the third major cause of death in the world and the second in Brazil. The purpose of this work was to assess the stroke-related hospitalization, in-hospital mortality, and case fatality rates under the Brazilian Unified Health System (SUS) from 2009 to 2016.
   Methods
   We evaluated the hospital admissions for stroke and their associated outcomes using data from the Hospital Information available at the Informatics Department of SUS. We selected hospitalization registries according to stroke diagnosis codes from the International Statistical Classification of Diseases and Related Health Problems (ICD-10). We identified the association of age and sex with patient death through multiple logistic regression and calculated the rates of hospitalization, mortality and case-fatality per 100,000 inhabitants using age-adjustment methodology.
   Results
   We analyzed 1,113,599 stroke hospitalizations. From 2009 to 2016, the number of admissions increased from 131,122 to 146,950 and the absolute number of in-hospital deaths increased from 28,731 to 31,937. Younger age and male sex were significantly associated with patient survival. Our results showed that the annual age-adjusted hospitalization and in-hospital mortality rates decreased by 11.8% and 12.6%, respectively, but the case fatality rate increased for patients older than 70 years.
   Conclusions
   Although the age-adjusted hospitalization and in-hospital mortality rates declined, the total number of hospitalization and deaths have increased. It is expected a continuous increase over the next years of stroke admissions with the rapid aging of the Brazilian population. Efforts should be renewed targeting risk factors, access to hospital and rehabilitation in particular for the elderly population.
C1 [Dantas, Leila F.; Marchesi, Janaina F.; Peres, Igor T.; Hamacher, Silvio; Quintano Neira, Ricardo A.] Pontifical Catolic Univ Rio De Janeiro, Dept Ind Engn, Rio De Janeiro, RJ, Brazil.
   [Bozza, Fernando A.] Oswaldo Cruz Fdn FIOCRUZ, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, RJ, Brazil.
   [Bozza, Fernando A.] DOr Inst Res & Educ, IDOR, Rio De Janeiro, RJ, Brazil.
RP Bozza, FA (reprint author), Oswaldo Cruz Fdn FIOCRUZ, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, RJ, Brazil.; Bozza, FA (reprint author), DOr Inst Res & Educ, IDOR, Rio De Janeiro, RJ, Brazil.
EM bozza.fernando@gmail.com
FU National Council for Scientific and Technological Development (CNPq)
   [306802/2015-5, 403863/2016-3, 140511/2018-0, 169049/2017-5]; Carlos
   Chagas Filho Foundation (FAPERJ) [E-26/201.959/2017]; Coordination for
   theImprovement of Higher Education Personnel (CAPES); Pontifical
   Catholic University of Rio de Janeiro; Philips Research; Brazilian
   National Council for Scientific and Technological Development (CNPq)
FX This work was supported by the National Council for Scientific and
   Technological Development (CNPq) http://cnpq.br/[grant numbers
   306802/2015-5 and 403863/2016-3 to SH; 140511/2018-0 to RAQN;
   169049/2017-5 to LED]; Carlos Chagas Filho Foundation (FAPERJ)
   http://www.faperj.br/. [grant number E-26/201.959/2017 to JFM]; the
   Coordination for theImprovement of Higher Education Personnel (CAPES)
   http://www.capes.gov.br/; and the Pontifical Catholic University of Rio
   de Janeiro http://www.puc-rio.br/english/.The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.; The authors would like to thank
   Coordination for the Improvement of Higher Education Personnel (CAPES),
   the Pontifical Catholic University of Rio de Janeiro, Philips Research
   and the Brazilian National Council for Scientific and Technological
   Development (CNPq) for their financial support.
CR Adami F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152739
   Ahmad O. B., 2001, GPE DISCUSS PAP SER, P1
   Bejot Y, 2016, REV NEUROL-FRANCE, V172, P59, DOI 10.1016/j.neurol.2015.07.013
   Bejot Y, 2016, PRESSE MED, V45, pE391, DOI 10.1016/j.lpm.2016.10.003
   Cabral NL, 2009, J NEUROL NEUROSUR PS, V80, P749, DOI 10.1136/jnnp.2008.164475
   CSIS, BRAZ SIST UN SAUD SU
   de Santana Nathalia Matos, 2018, BMC Res Notes, V11, P735, DOI 10.1186/s13104-018-3842-3
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   de Carvalho JJF, 2011, STROKE, V42, P3341, DOI 10.1161/STROKEAHA.111.626523
   Garritano CR, 2012, ARQ BRAS CARDIOL, V98, P519, DOI 10.1590/S0066-782X2012005000041
   Global Burden of Disease 2016 Lifetime Risk of Stroke Collaborators, 2018, NEW ENGL J MED, V379, P2429, DOI DOI 10.1056/NEJMOA1804492
   Goulart AC, 2010, INT J STROKE, V5, P284, DOI 10.1111/j.1747-4949.2010.00441.x
   Hankey GJ, 2017, LANCET, V389, P641, DOI 10.1016/S0140-6736(16)30962-X
   Iser BPM, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0185-x
   Kamal N, 2015, CAN J NEUROL SCI, V42, P168, DOI 10.1017/cjn.2015.20
   Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf
   Lotufo PA, 2007, ARQ NEURO-PSIQUIAT, V65, P752, DOI 10.1590/S0004-282X2007000500004
   Lotufo PA, 2015, SAO PAULO MED J, V133, P457, DOI 10.1590/1516-3180.2015.13360510
   Malachias MVB, 2016, 7A DIRETRIZ BRASELLE
   Malta DC, 2015, SCIELO PUBLIC HLTH, V20, P631
   Mansur AD, 2016, ARQ BRAS CARDIOL, V107, P137, DOI 10.5935/abc.20160102
   Marinho F, 2018, LANCET, V392, P760, DOI 10.1016/S0140-6736(18)31221-2
   Massuda A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000829
   Minelli C, 2007, STROKE, V38, P2906, DOI 10.1161/STROKEAHA.107.484139
   Monteiro CA, 2017, VIGITEL BRASIL 2006
   O'Donnell MJ, 2016, LANCET, V388, P761, DOI 10.1016/S0140-6736(16)30506-2
   Passos VMA, 2016, ARQ NEURO-PSIQUIAT, V74, P376, DOI 10.1590/0004-282X20160055
   Picon RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048255
   Rolim CLRC, 2011, CAD SAUDE PUBLICA, V27, P2105
   Sarfo FS, 2015, J NEUROL SCI, V357, P240, DOI 10.1016/j.jns.2015.07.043
   Team RStudio, 2015, INT DEV R
   Thrift AG, 2014, INT J STROKE, V9, P6, DOI 10.1111/ijs.12245
   *WHO, 2007, INT CLASS DIS
NR 33
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 19
PY 2019
VL 14
IS 3
AR e0213837
DI 10.1371/journal.pone.0213837
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HP3JN
UT WOS:000461573000034
PM 30889198
OA Other Gold
DA 2019-06-18
ER

PT J
AU Sanuade, OA
   Dodoo, FNA
   Koram, K
   Aikins, AD
AF Sanuade, Olutobi Adekunle
   Dodoo, Francis Nii-Amoo
   Koram, Kwadwo
   Aikins, Ama de-Graft
TI Prevalence and correlates of stroke among older adults in Ghana:
   Evidence from the Study on Global AGEing and adult health (SAGE)
SO PLOS ONE
LA English
DT Article
ID ISCHEMIC-STROKE; RISK-FACTORS; CARDIOVASCULAR-DISEASE;
   SOCIOECONOMIC-STATUS; ALCOHOL-CONSUMPTION; SELF-REPORTS; BURDEN;
   VALIDITY; SMOKING; HYPERTENSION
AB This study examines the prevalence and correlates of stroke among older adults in Ghana. This cross-sectional study retrieved data from Wave 1 of the World Health Organization (WHO) Survey on Global Ageing and Adult Health (SAGE) conducted between 2007 and 2008. The sample, comprising 4,279 respondents aged 50 years and above, was analysed using descriptive statistics, cross tabulations and Chi-Square tests, and a multivariable binary logistic regression. Respondents ranged in age from 50 to 114 years, with a median age of 62 years. Stroke prevalence was 2.6%, with the correlates being marital status, level of education, employment status, and living with hypertension or diabetes. The results showed that being separated/divorced, having primary and secondary education, being unemployed and living with hypertension and diabetes, significantly increased the odds of stroke prevalence in this population. The results suggest that interventions to reduce stroke prevalence and impact must be developed alongside interventions for hypertension, diabetes and sociodemographic/economic factors such as marital status, level of education, and employment status.
C1 [Sanuade, Olutobi Adekunle] UCL, Inst Adv Studies, London, England.
   [Dodoo, Francis Nii-Amoo; Aikins, Ama de-Graft] Univ Ghana, Reg Inst Populat Studies, Accra, Ghana.
   [Koram, Kwadwo] Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana.
RP Sanuade, OA (reprint author), UCL, Inst Adv Studies, London, England.
EM o.sanuade@ucl.ac.uk
OI Sanuade, Olutobi/0000-0003-4972-1098
CR Addo J, 2012, Ghana Med J, V46, P4
   Agyemang C, 2012, Ghana Med J, V46, P12
   American Heart Association, 2015, HEART DIS STROK STAT
   Avendano M, 2006, STROKE, V37, P1368, DOI 10.1161/01.STR.0000221702.75002.66
   Bergmann MM, 1998, AM J EPIDEMIOL, V147, P969
   Birabi Bridget N, 2012, Glob J Health Sci, V4, P17, DOI 10.5539/gjhs.v4n6p17
   Biritwum RB, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20096
   Bots ML, 1996, STROKE, V27, P1499, DOI 10.1161/01.STR.27.9.1499
   Connor MD, 2007, LANCET NEUROL, V6, P269, DOI 10.1016/S1474-4422(07)70002-9
   Cox AM, 2006, LANCET NEUROL, V5, P181, DOI 10.1016/S1474-4422(06)70351-9
   Damasceno A, 2010, STROKE, V41, P2463, DOI 10.1161/STROKEAHA.110.594275
   Danesi MA, 2013, J NEUROL SCI, V331, P43, DOI 10.1016/j.jns.2013.04.026
   de-Graft Aikins Ama, 2007, Ghana Med J, V41, P154
   Donkor ES, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-196
   Emberson JR, 2006, VASC HEALTH RISK MAN, V2, P239, DOI 10.2147/vhrm.2006.2.3.239
   Engels T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089271
   Engstad T, 2000, STROKE, V31, P1602, DOI 10.1161/01.STR.31.7.1602
   Eze C. O., 2013, Journal of Biology, Agriculture and Healthcare, V3, P141
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Ghana Health Service, HLTH SECT GHAN FACTS
   Ghana Statistical Service, 2013, 2010 POP HOUS CENS E
   Ghana Statistical Service, 2014, GHAN LIV STAND SURV
   GORELICK PB, 1989, NEUROLOGY, V39, P339, DOI 10.1212/WNL.39.3.339
   Help Age International, 2015, GLOB AGEWATCH IND 20
   Hillbom M, 1999, STROKE, V30, P2307, DOI 10.1161/01.STR.30.11.2307
   Jamrozik E, 2014, CEREBROVASC DIS, V37, P256, DOI 10.1159/000358583
   Jin YP, 2010, NEUROEPIDEMIOLOGY, V35, P215, DOI 10.1159/000315484
   Kadlecova P, 2015, STROKE, V46, P627, DOI 10.1161/STROKEAHA.114.006724
   KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973
   Kengne AP, 2006, INT J STROKE, V1, P180, DOI 10.1111/j.1747-4949.2006.00064.x
   Kurth T, 2002, ARCH INTERN MED, V162, P2557, DOI 10.1001/archinte.162.22.2557
   Lai SM, 2002, STROKE, V33, P1840, DOI 10.1161/01.STR.0000019289.15440.F2
   Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8
   Lee CD, 2003, STROKE, V34, P2475, DOI 10.1161/01.STR.0000091843.02517.9D
   Medical and Dental Council Ghana, 2018, PERM REG
   Minicuci N, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.21292
   Nakayama T, 2000, NEUROEPIDEMIOLOGY, V19, P217, DOI 10.1159/000026259
   O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3
   Obiako OR, 2011, NIGER J CLIN PRACT, V14, P359, DOI 10.4103/1119-3077.86784
   Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005
   Owolabi MO, 2018, LANCET GLOB HEALTH, V6, pE436, DOI 10.1016/S2214-109X(18)30002-0
   Owusu-Dabo E, 2009, TOB CONTROL, V18, P365, DOI 10.1136/tc.2009.030635
   Petrea RE, 2009, STROKE, V40, P1032, DOI 10.1161/STROKEAHA.108.542894
   Phaswana-Mafuya N, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121523
   Rost NS, 2001, STROKE, V32, P2575, DOI 10.1161/hs1101.098151
   Sanuade O. A., 2016, THESIS
   Sanuade OA, 2013, CHRONIC NONCOMMUNICA, P29
   Sanuade OA, 2018, PLOS ONE, V13, DOI [10.1371/journal.pone.0205985, 10.1371/journal.pone.0]
   Sanuade Olutobi Adekunle, 2018, Ethn Health, P1, DOI 10.1080/13557858.2018.1439898
   Shah RS, 2010, EXPERT REV CARDIOVAS, V8, P917, DOI [10.1586/erc.10.56, 10.1586/ERC.10.56]
   Sriram K, 2002, NEUROSCIENCE, V115, P1335, DOI 10.1016/S0306-4522(02)00306-8
   Teh R, 2013, J CLIN EPIDEMIOL, V66, P1135, DOI 10.1016/j.jclinepi.2013.05.001
   Toure K, 2008, Dakar Med, V53, P105
   United Nations, 2015, WORLD POP PROSP 2015
   Venketasubramanian N, 2005, STROKE, V36, P551, DOI 10.1161/01.STR.0000155687.18818.13
   Wahab KW, 2008, JCPSP-J COLL PHYSICI, V18, P755, DOI 12.2008/JCPSP.755758
   WHO, 2006, STUD GLOB AG AD HLTH
   Wong CW, 2018, HEART, V104, P1937, DOI 10.1136/heartjnl-2018-313005
   World Health Organization, 2015, SOCIAL DETERMINANTS
   World Health Organization, 2004, WHO LONG TERM STRAT
   World Health Organization, 2016, HLTH STAT
   World Heart Federation, 2014, GLOB BURD STORK
   Wu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074176
   Xu F, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-170
NR 64
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 13
PY 2019
VL 14
IS 3
AR e0212623
DI 10.1371/journal.pone.0212623
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HO6OH
UT WOS:000461048900029
PM 30865654
OA Other Gold
DA 2019-06-18
ER

PT J
AU Chen, ZQ
   Xue, T
   Huang, HC
   Xu, JY
   Shankar, S
   Yu, H
   Wang, Z
AF Chen, Zhouqing
   Xue, Tao
   Huang, Huachen
   Xu, Jiayi
   Shankar, Sandhya
   Yu, Hao
   Wang, Zhong
TI Efficacy and safety of sonothombolysis versus non-sonothombolysis in
   patients with acute ischemic stroke: A meta-analysis of randomized
   controlled trials
SO PLOS ONE
LA English
DT Article
ID ULTRASOUND-ENHANCED THROMBOLYSIS; SONOTHROMBOLYSIS
AB Recent studies have shown that inconsistent results of safety and efficacy between sonothombolysis vs. non- sonothombolysis in acute ischemic stroke (AIS). We implemented a meta-analysis to explore the value of sonothrombolysis in AIS treatment. The MEDLINE, EMBASE, and Cochrane Library databases were searched for randomized controlled trials (RCTs) which had evaluated sonothrombolysis or ultrasound thrombolysis in AIS. One hundred five studies were retrieved and analyzed, among them, 7 RCTs were included in the current meta-analysis. In comparison with the non-sonothombolysis, sonothrombolysis significantly improved complete recanalization (RR 2.16, 95% CI 1.51 to 3.08, P < 0.001), complete or partial recanalization (RR 1.90, 95% CI 1.26 to 2.88, P = 0.002), there is also a tendency to improvement of >= 4 points in NIHSS score (RR 1.43, 95% CI 0.99 to 2.07, P = 0.057). However, sonothrombolysis and non-sonothrombolysis had insignificant differences in neurological recovery and adverse events. In subgroup analysis, we found that "With t-PA", "NIHSS > 15", "Treatment time <= 150min", and "Age <= 65 years" are potential favorable factors for efficacy outcomes of sonothombolysis. Sonothrombolysis can significantly increase the rate of recanalization in patients with AIS compared with non-sonothrombolysis, but there is no significant effect on improving neurological functional recovery and avoiding complications.
C1 [Chen, Zhouqing; Xue, Tao; Wang, Zhong] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China.
   [Chen, Zhouqing; Xue, Tao; Wang, Zhong] Soochow Univ, Affiliated Hosp 1, Brain & Nerve Res Lab, Suzhou, Jiangsu, Peoples R China.
   [Huang, Huachen] Harbin Med Univ, Affiliate Hosp 1, Dept Neurol, Harbin, Heilongjiang, Peoples R China.
   [Xu, Jiayi] Soochow Univ, Affiliated Hosp 1, Dept Ophthalmol, Suzhou, Jiangsu, Peoples R China.
   [Shankar, Sandhya] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA.
   [Yu, Hao] First Peoples Hosp Nantong City, Dept Neurosurg, Nantong, Jiangsu, Peoples R China.
RP Wang, Z (reprint author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China.; Wang, Z (reprint author), Soochow Univ, Affiliated Hosp 1, Brain & Nerve Res Lab, Suzhou, Jiangsu, Peoples R China.; Yu, H (reprint author), First Peoples Hosp Nantong City, Dept Neurosurg, Nantong, Jiangsu, Peoples R China.
EM ichsah@163.com; wangzhong761@163.com
FU National Natural Science Foundation of China [81571115]
FX This study was supported by the National Natural Science Foundation of
   China (No. 81571115).
CR ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35
   Alexandrov AV, 2008, STROKE, V39, P1464, DOI 10.1161/STROKEAHA.107.505727
   Alexandrov AV, 2004, NEW ENGL J MED, V351, P2170, DOI 10.1056/NEJMoa041175
   Alexandrov AV, 2004, J NEUROIMAGING, V14, P5
   Amaral-Silva A, 2011, EXPERT REV NEUROTHER, V11, P265, DOI [10.1586/ern.11.3, 10.1586/ERN.11.3]
   Auboire L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191788
   Balucani Clotilde, 2010, Curr Cardiol Rep, V12, P34, DOI 10.1007/s11886-009-0082-0
   Daffertshofer M, 2003, LANCET NEUROL, V2, P283, DOI 10.1016/S1474-4422(03)00380-6
   de St Victor M, 2014, EXPERT OPIN DRUG DEL, V11, P187, DOI 10.1517/17425247.2014.868434
   Dinia L, 2016, THE 2ND EUROPEAN STR, P37
   Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7
   Dwedar AZ, 2014, NEUROL INDIA, V62, P62, DOI 10.4103/0028-3886.128308
   Eggers J, 2005, NEUROLOGY, V64, P1052, DOI 10.1212/01.WNL.0000154599.45969.D6
   Eggers J, 2003, ANN NEUROL, V53, P797, DOI 10.1002/ana.10590
   Eggers J, 2008, STROKE, V39, P1470, DOI 10.1161/STROKEAHA.107.503870
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Larrue V, 2007, STROKE, V38, P472
   Leung T, 2017, J NEUROL NEUROSUR PS, V88, P86, DOI 10.1136/jnnp-2015-311849
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700
   MCMANUS JJ, 1974, COMP BIOCHEM PHYSIOL, V49, P169, DOI 10.1016/0300-9629(74)90552-0
   Meairs Stephen, 2009, Cerebrovasc Dis, V27 Suppl 2, P55, DOI 10.1159/000203127
   Moher D, 2015, SYST REV, V4, DOI [10.1186/2046-4053-4-1, 10.1136/bmj.b2535]
   Molina CA, 2006, STROKE, V37, P425, DOI 10.1161/01.STR.0000199064.94588.39
   Molina Carlos A, 2007, Cerebrovasc Dis, V24 Suppl 1, P1, DOI 10.1159/000107373
   Molina CA, 2009, ANN NEUROL, V66, P28, DOI 10.1002/ana.21723
   Nacu A, 2017, STROKE, V48, P335, DOI 10.1161/STROKEAHA.116.014644
   Perren F, 2008, J THROMB THROMBOLYS, V25, P219, DOI 10.1007/s11239-007-0044-6
   Quinn TJ, 2017, NEUROLOGY, V89, P997, DOI 10.1212/WNL.0000000000004332
   Ricci S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008348.pub3
   Rubiera M, 2008, ULTRASOUND MED BIOL, V34, P1573, DOI 10.1016/j.ultrasmedbio.2008.02.011
   Rubiera M, 2010, AM J CARDIOVASC DRUG, V10, P5, DOI 10.2165/11316850-000000000-00000
   Saqqur M, 2014, J NEUROIMAGING, V24, P209, DOI 10.1111/jon.12026
   Schleicher N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152898
   Skoloudik D, 2006, EUROPEAN J NEUROLOGY, V13, P1
   Tsivgoulis G, 2008, ULTRASONICS, V48, P303, DOI 10.1016/j.ultras.2007.11.008
   Tsivgoulis G, 2007, NEUROTHERAPEUTICS, V4, P420, DOI 10.1016/j.nurt.2007.05.012
   Tsivgoulis G, 2010, STROKE, V41, P280, DOI 10.1161/STROKEAHA.109.563304
   Wood SC, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-29
NR 38
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 9
PY 2019
VL 14
IS 1
AR e0210516
DI 10.1371/journal.pone.0210516
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HG9VK
UT WOS:000455359400093
PM 30625224
OA DOAJ Gold
DA 2019-06-18
ER

PT J
AU Forbes, HJ
   Williamson, E
   Benjamin, L
   Breuer, J
   Brown, MM
   Langan, SM
   Minassian, C
   Smeeth, L
   Thomas, SL
   Warren-Gash, C
AF Forbes, Harriet J.
   Williamson, Elizabeth
   Benjamin, Laura
   Breuer, Judith
   Brown, Martin M.
   Langan, Sinead M.
   Minassian, Caroline
   Smeeth, Liam
   Thomas, Sara L.
   Warren-Gash, Charlotte
TI Association of herpesviruses and stroke: Systematic review and
   meta-analysis
SO PLOS ONE
LA English
DT Review
ID HERPES-ZOSTER; ISCHEMIC-STROKE; MYOCARDIAL-INFARCTION; HUMAN
   CYTOMEGALOVIRUS; CHLAMYDIA-PNEUMONIAE; TERM PERSISTENCE; GLOBAL BURDEN;
   OLDER-ADULTS; RISK-FACTORS; COHORT
AB Background
   Herpesviruses induce a range of inflammatory effects potentially contributing to an increased risk of stroke.
   Objectives
   To investigate whether patients with infection, or reactivation of, human herpesviruses are at increased stroke risk, compared to those without human herpesviruses.
   Data sources
   Six medical databases and grey literature sources from inception to January 2017.
   Study eligibility criteria
   Studies where the exposure was any human herpesvirus and the outcome was stroke. We included randomised controlled trials, cohort, case-control, case-crossover and self-controlled case series designs.
   Methods
   Meta-analyses when sufficiently homogeneous studies were available. Quality of evidence across studies was assessed.
   Results
   We identified 5012 publications; 41 met the eligibility criteria. Across cohort and self-controlled case series studies, there was moderate quality evidence that varicella infection in children was associated with a short-term increased stroke risk. Zoster was associated with a 1.5-fold increased stroke risk four weeks following onset (summary estimate: 1.55, 95% CI 1.46-1.65), which resolved after one year. Subgroup analyses suggested post-zoster stroke risk was greater among ophthalmic zoster patients, younger individuals and those not prescribed antivirals. Recent infection/reactivation of cytomegalovirus and herpes simplex viruses, but not past infection, was associated with increased stroke risk; however the evidence across studies was mainly derived from small, very low quality case-control studies.
   Conclusions
   Our review shows an increased stroke risk following zoster and suggests that recent infection or reactivation of other herpesviruses increases stroke risk, although better evidence is needed. Herpesviruses are common and potentially preventable; these findings may have implications for reducing stroke burden.
C1 [Forbes, Harriet J.; Williamson, Elizabeth; Langan, Sinead M.; Minassian, Caroline; Smeeth, Liam; Thomas, Sara L.; Warren-Gash, Charlotte] LSHTM, Fac Epidemiol & Populat Hlth, London, England.
   [Benjamin, Laura] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Benjamin, Laura; Brown, Martin M.] UCL, UCL Inst Neurol, Dept Brain Repair & Rehabil, Ctr Stroke Res, London, England.
   [Breuer, Judith] UCL, UCL Div Infect & Immun, London, England.
RP Forbes, HJ (reprint author), LSHTM, Fac Epidemiol & Populat Hlth, London, England.
EM harriet.forbes@lshtm.ac.uk
OI Benjamin, Laura/0000-0002-9685-1664; Breuer, Judith/0000-0001-8246-0534;
   Warren-Gash, Charlotte/0000-0003-4524-3180; Minassian,
   Caroline/0000-0001-9406-1928
FU Wellcome Trust Intermediate Clinical Fellowship [201440/Z/16/Z]
FX Funded by a Wellcome Trust Intermediate Clinical Fellowship to CWG
   (201440/Z/16/Z).
CR Al-Ghamdi A, 2012, PAK J PHARM SCI, V25, P89
   Asiki G, 2015, TROP MED INT HEALTH, V20, P1306, DOI 10.1111/tmi.12556
   Askalan R, 2001, STROKE, V32, P1257, DOI 10.1161/01.STR.32.6.1257
   Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
   Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015
   Baxter R, 2012, VACCINE, V30, P6636, DOI 10.1016/j.vaccine.2012.08.070
   Breuer J, 2014, NEUROLOGY, V83, pE27, DOI 10.1212/WNL.0000000000000584
   Calabrese LH, 2017, ARTHRITIS RHEUMATOL, V69, P439, DOI 10.1002/art.39855
   Coles KA, 2003, EUR J CARDIOV PREV R, V10, P278, DOI 10.1097/01.hjr.0000085252.65733.a6
   Donahue JG, 2009, PEDIATRICS, V123, pE228, DOI 10.1542/peds.2008-2384
   Elkind MSV, 2016, CIRCULATION, V133, P732, DOI 10.1161/CIRCULATIONAHA.115.018595
   Elkind MSV, 2010, ARCH NEUROL-CHICAGO, V67, P33, DOI 10.1001/archneurol.2009.271
   Erskine N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181565
   Esenwa CC, 2016, NAT REV NEUROL, V12, P594, DOI 10.1038/nrneurol.2016.125
   Fagerberg B, 1999, STROKE, V30, P299, DOI 10.1161/01.STR.30.2.299
   Feigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P161, DOI 10.1159/000441085
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Fields B. N., 2013, VIROLOGY
   Forbes HJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016427
   Forbes HJ, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659277
   Fugate JE, 2014, LANCET INFECT DIS, V14, P869, DOI 10.1016/S1473-3099(14)70755-8
   Fullerton HJ, 2017, STROKE, V48, P2875, DOI 10.1161/STROKEAHA.117.018272
   Gonzalez-Quijada S, 2015, CLIN MICROBIOL INFEC, V21, P362, DOI 10.1016/j.cmi.2014.11.028
   Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Hosamirudsari H, 2018, J MED VIROL, V90, P1370, DOI 10.1002/jmv.25202
   Huang ZR, 2012, CNS NEUROSCI THER, V18, P457, DOI 10.1111/j.1755-5949.2012.00326.x
   Kang JH, 2009, STROKE, V40, P3443, DOI 10.1161/STROKEAHA.109.562017
   Kenina Viktorija, 2010, Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences, V64, P133, DOI 10.2478/v10046-010-0023-8
   Kim MC, 2017, J AM COLL CARDIOL, V70, P295, DOI 10.1016/j.jacc.2017.05.015
   Kis Z, 2007, NEW MICROBIOL, V30, P213
   Kovac M, 2018, VACCINE, V36, P1537, DOI 10.1016/j.vaccine.2018.02.029
   Kwon SU, 2016, CLIN MICROBIOL INFEC, V22, P542, DOI 10.1016/j.cmi.2016.03.003
   Langan SM, 2014, CLIN INFECT DIS, V58, P1497, DOI 10.1093/cid/ciu098
   Li M. L., 2005, CHINESE J CLIN REHAB, V9, P158
   Lian Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171182
   Liao TL, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006304
   Lin HC, 2010, NEUROLOGY, V74, P792, DOI 10.1212/WNL.0b013e3181d31e5c
   Liu XC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165203
   MacDonald SE, 2018, VACCINE, V36, P2764, DOI 10.1016/j.vaccine.2018.04.012
   Marra F, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2278-z
   MCKENDRICK MW, 1986, BRIT MED J, V293, P1529, DOI 10.1136/bmj.293.6561.1529
   Minassian C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001919
   Morrison VA, 2015, CLIN INFECT DIS, V60, P900, DOI 10.1093/cid/ciu918
   Nagel M. A., 2010, Infectious Disorders - Drug Targets, V10, P105
   Oliveras A, 2003, CLIN TRANSPLANT, V17, P1, DOI 10.1034/j.1399-0012.2003.02042.x
   Ozturk A., 2013, Turkiye Klinikleri tip Bilimleri Dergisi, V33, P726, DOI 10.5336/medsci.2012-30806
   Patterson B., C 70 ANN M AM AC NEU
   Ridker PM, 1998, CIRCULATION, V98, P2796, DOI 10.1161/01.CIR.98.25.2796
   Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca
   Tania S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166554
   Schmader KE, 2012, CLIN INFECT DIS, V55, P1320, DOI 10.1093/cid/cis638
   Sealy-Jefferson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065959
   Sebire G, 1999, ANN NEUROL, V45, P679, DOI 10.1002/1531-8249(199905)45:5<679::AID-ANA22>3.0.CO;2-E
   Shen Xue-li, 2011, Journal of China Medical University, V40, P346
   Smieja M, 2003, CIRCULATION, V107, P251, DOI 10.1161/01.CIR.0000044940.65226.1F
   Sreenivasan N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069156
   Steiner I, 2007, LANCET NEUROL, V6, P1015, DOI 10.1016/S1474-4422(07)70267-3
   Sterne JA, 2016, BMJ, V355
   Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919
   Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002
   Sundstrom K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1170-y
   Tarnacka B, 2002, STROKE, V33, P936, DOI 10.1161/01.STR.0000014562.75483.6B
   Thomas SL, 2014, CLIN INFECT DIS, V58, P61, DOI 10.1093/cid/cit659
   Tseng HF, 2012, J INTERN MED, V271, P510, DOI 10.1111/j.1365-2796.2011.02474.x
   Tseng HF, 2011, J EPIDEMIOL COMMUN H, V65, pA167, DOI 10.1136/jech.2011.142976f.52
   Wang H., 2017, J AM HEART ASS, V6
   Xu J, 2010, HAMOSTASEOLOGIE, V30, P5
   Yang S-Y, 2016, J STROKE CEREBROVASC
   Yawn BP, 2016, MAYO CLIN PROC, V91, P33, DOI 10.1016/j.mayocp.2015.09.015
   Yen Y., 2016, PLOS ONE, V11
   Yen YF, 2017, JAIDS-J ACQ IMM DEF, V74, P117, DOI 10.1097/QAI.0000000000001216
   Yi L, 2008, J FORMOS MED ASSOC, V107, P774, DOI 10.1016/S0929-6646(08)60190-4
   Zhang YT, 2017, J STROKE CEREBROVASC, V26, P1807, DOI 10.1016/j.jstrokecerebrovasdis.2017.04.013
   Zheng LQ, 2016, CIRC J, V80, P2235, DOI 10.1253/circj.CJ-16-0493
   Ziemann M., 2016, J CARDIOTHORACIC VAS
NR 76
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 21
PY 2018
VL 13
IS 11
AR e0206163
DI 10.1371/journal.pone.0206163
PG 33
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HB4VL
UT WOS:000451054800014
PM 30462656
OA Green Published, Other Gold
DA 2019-06-18
ER

PT J
AU Sipila, JOT
   Posti, JP
   Ruuskanen, JO
   Rautava, P
   Kyto, V
AF Sipila, Jussi O. T.
   Posti, Jussi P.
   Ruuskanen, Jori O.
   Rautava, Paivi
   Kyto, Ville
TI Stroke hospitalization trends of the working-aged in Finland
SO PLOS ONE
LA English
DT Article
ID CARDIOVASCULAR RISK-FACTORS; SUBARACHNOID HEMORRHAGE; ISCHEMIC-STROKE;
   SECULAR TRENDS; GLOBAL BURDEN; SMOKING; POPULATION; ADULTS
AB Background
   The age-standardized incidence of stroke has decreased globally but, for reasons unknown, conflicting results have been observed regarding trend in incidence of major stroke subtypes in young adults. We studied these trends among people of working age in a population-based setting in Finland, where cardiovascular risk factor profiles have developed favorably.
   Methods
   All hospitalizations for stroke in 2004-2005 and 2013-2014 for persons 18-64 years of age were identified from a national register. The search included all hospitals that provide acute stroke care on mainland Finland.
   Results
   Hospitalizations for both intracerebral hemorrhage (ICH; -15.2%; p = 0.0008) and subarachnoid hemorrhage (SAH; -26.5%; p<0.0001) decreased overall and for both sexes separately. Concerning IS, hospitalizations decreased only for men (-6.3%; p = 0.0190) but not for women or overall. However, there was an increase in IS hospitalizations in men 35-44 years of age (+37.5%; p = 0.0019). The length of stay (LOS) of IS patients declined in nearly all subgroups (overall -20.8%, p<0.0001) whereas no change in LOS was observed for patients with ICH or SAH. In-hospital mortality decreased in patients with IS (-42.8%; p = 0.0092) but remained unchanged in patients with ICH or SAH.
   Conclusions
   Stroke hospitalizations of young people declined in Finland, except for men 35-44 years of age for whom IS hospitalizations increased. Declining LOS and in-hospital mortality of IS patients suggests admission of less severe cases, improved care or both.
C1 [Sipila, Jussi O. T.] North Karelia Cent Hosp, Dept Neurol, Siun Sote, Joensuu, Finland.
   [Sipila, Jussi O. T.; Ruuskanen, Jori O.] Turku Univ Hosp, Dept Neurol, Div Clin Neurosci, Turku, Finland.
   [Sipila, Jussi O. T.; Posti, Jussi P.; Ruuskanen, Jori O.] Univ Turku, Dept Neurol, Turku, Finland.
   [Posti, Jussi P.] Turku Univ Hosp, Turku Brain Injury Ctr, Turku, Finland.
   [Posti, Jussi P.] Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, Turku, Finland.
   [Rautava, Paivi] Univ Turku, Dept Publ Hlth, Turku, Finland.
   [Rautava, Paivi] Turku Univ Hosp, Turku Clin Res Ctr, Turku, Finland.
   [Kyto, Ville] Turku Univ Hosp, Heart Ctr, Turku, Finland.
   [Kyto, Ville] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland.
RP Sipila, JOT (reprint author), North Karelia Cent Hosp, Dept Neurol, Siun Sote, Joensuu, Finland.; Sipila, JOT (reprint author), Turku Univ Hosp, Dept Neurol, Div Clin Neurosci, Turku, Finland.; Sipila, JOT (reprint author), Univ Turku, Dept Neurol, Turku, Finland.
EM jussi.sipila@utu.fi
RI Sipila, Jussi/C-8585-2015
OI Sipila, Jussi/0000-0003-0183-9054; Posti, Jussi/0000-0002-5925-5193
FU Government's Special Financial Transfer tied to academic research in
   Health Sciences (Finland) of the hospital district of Southwestern
   Finland; Finnish Cardiac Society
FX This research was supported by the Government's Special Financial
   Transfer tied to academic research in Health Sciences (Finland) of the
   hospital district of Southwestern Finland
   (http://www.vsshp.fi/fi/tutkijoille/rahoitus/Sivut/default.aspx) and the
   Finnish Cardiac Society (https://www.fincardio.fi/in-english/). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Anderson CS, 2004, STROKE, V35, P633, DOI 10.1161/01.STR.0000115751.45473.48
   Ay H, 2005, STROKE, V36, P2632, DOI 10.1161/01.STR.0000189991.23918.01
   Bennett DA, 2014, GLOB HEART, V9, P107, DOI 10.1016/j.gheart.2014.01.001
   Borodulin K, 2015, EUR J PUBLIC HEALTH, V25, P539, DOI 10.1093/eurpub/cku174
   Burke JF, 2017, JAMA NEUROL, V74, P639, DOI 10.1001/jamaneurol.2017.0161
   de los Rios F, 2012, STROKE, V43, P3179, DOI 10.1161/STROKEAHA.112.667808
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Finland, 2018, COUNTR DRUG REP 2018
   Fromm A, 2011, STROKE RES TREAT, DOI 10.4061/2011/183256
   Furuta Y, 2018, ATHEROSCLEROSIS, V273, P84, DOI 10.1016/j.atherosclerosis.2018.04.010
   George MG, 2017, JAMA NEUROL, V74, P695, DOI 10.1001/jamaneurol.2017.0020
   Kim CK, 2012, J NEUROL NEUROSUR PS, V83, P1100, DOI 10.1136/jnnp-2012-302538
   Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d
   Kleindorfer D, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0421-2
   Korja M, 2016, NEUROLOGY, V87, P1118, DOI 10.1212/WNL.0000000000003091
   Koton S, 2018, STROKE, V49, P1348, DOI 10.1161/STROKEAHA.117.019822
   Krishnamurthi RV, 2014, GLOB HEART, V9, P101, DOI 10.1016/j.gheart.2014.01.003
   Kugler C, 2003, J NEUROL, V250, P676, DOI 10.1007/s00415-003-1054-8
   Kyto V, 2015, EUR J PREV CARDIOL, V22, P1003, DOI 10.1177/2047487314539434
   Kyto V, 2014, EUR J CLIN INVEST, V44, P902, DOI 10.1111/eci.12321
   Lecoffre C, 2017, STROKE, V48, P2939, DOI 10.1161/STROKEAHA.117.017640
   Lindbohm JV, 2016, STROKE, V47, P1975, DOI 10.1161/STROKEAHA.116.012957
   Madsen TE, 2016, ACAD EMERG MED, V23, P1128, DOI 10.1111/acem.13029
   MERETOJA A., 2011, THESIS
   Meretoja A, 2011, ANN MED, V43, pS22, DOI 10.3109/07853890.2011.586361
   Nuotio J, 2014, SCAND J PUBLIC HEALT, V42, P563, DOI 10.1177/1403494814541597
   Putaala J, 2016, EUR STROKE J, V1, P28, DOI 10.1177/2396987316629860
   Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052
   Sipila JOT, 2017, ANN MED, V49, P310, DOI 10.1080/07853890.2016.1254350
   Sivenius J, 2009, INT J STROKE, V4, P340, DOI 10.1111/j.1747-4949.2009.00330.x
   Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637
NR 31
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 1
PY 2018
VL 13
IS 8
AR e0201633
DI 10.1371/journal.pone.0201633
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GO9GY
UT WOS:000440415500105
PM 30067825
OA Other Gold
DA 2019-06-18
ER

PT J
AU Pindus, DM
   Mullis, R
   Lim, L
   Wellwood, I
   Rundell, AV
   Abd Aziz, NA
   Mant, J
AF Pindus, Dominika M.
   Mullis, Ricky
   Lim, Lisa
   Wellwood, Ian
   Rundell, A. Viona
   Abd Aziz, Noor Azah
   Mant, Jonathan
TI Stroke survivors' and informal caregivers' experiences of primary care
   and community healthcare services - A systematic review and
   meta-ethnography
SO PLOS ONE
LA English
DT Review
ID AMERICAN-HEART-ASSOCIATION; SECONDARY PREVENTION; DYAD INTERVENTIONS;
   FAMILY CAREGIVER; NEEDS; REHABILITATION; APHASIA; PEOPLE; FRAMEWORK;
   LIFE
AB Objective
   To describe and explain stroke survivors and informal caregivers' experiences of primary care and community healthcare services. To offer potential solutions for how negative experiences could be addressed by healthcare services.
   Design
   Systematic review and meta-ethnography.
   Data sources
   Medline, CINAHL, Embase and PsycINFO databases (literature searched until May 2015, published studies ranged from 1996 to 2015).
   Eligibility criteria
   Primary qualitative studies focused on adult community-dwelling stroke survivors' and/or informal caregivers' experiences of primary care and/or community healthcare services.
   Data synthesis
   A set of common second order constructs (original authors' interpretations of participants' experiences) were identified across the studies and used to develop a novel integrative account of the data (third order constructs). Study quality was assessed using the Critical Appraisal Skills Programme checklist. Relevance was assessed using Dixon-Woods' criteria.
   Results
   51 studies (including 168 stroke survivors and 328 caregivers) were synthesised. We developed three inter-dependent third order constructs: (1) marginalisation of stroke survivors and caregivers by healthcare services, (2) passivity versus proactivity in the relationship between health services and the patient/caregiver dyad, and (3) fluidity of stroke related needs for both patient and caregiver. Issues of continuity of care, limitations in access to services and inadequate information provision drove perceptions of marginalisation and passivity of services for both patients and caregivers. Fluidity was apparent through changing information needs and psychological adaptation to living with long-term consequences of stroke.
   Limitations
   Potential limitations of qualitative research such as limited generalisability and inability to provide firm answers are offset by the consistency of the findings across a range of countries and healthcare systems.
   Conclusions
   Stroke survivors and caregivers feel abandoned because they have become marginalised by services and they do not have the knowledge or skills to re-engage. This can be addressed by: (1) increasing stroke specific health literacy by targeted and timely information provision, and (2) improving continuity of care between specialist and generalist services.
C1 [Pindus, Dominika M.; Mullis, Ricky; Lim, Lisa; Wellwood, Ian; Rundell, A. Viona; Mant, Jonathan] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Primary Care Unit, Worts Causeway, Cambridge CB1 8RN, England.
   [Abd Aziz, Noor Azah] Natl Univ Malaysia, Dept Family Med, Kuala Lumpur, Malaysia.
RP Mant, J (reprint author), Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Primary Care Unit, Worts Causeway, Cambridge CB1 8RN, England.
EM jm677@medschl.cam.ac.uk
OI Pindus, Dominika/0000-0001-7288-7921; Lim, Lisa/0000-0002-3779-6095
FU National Institute for Health Research (NIHR) under its Programme Grants
   for Applied Research Programme [PTC-RP-PG-0213-20001]
FX This qualitative systematic review presents independent research funded
   by the National Institute for Health Research (NIHR) under its Programme
   Grants for Applied Research Programme (Reference Number
   PTC-RP-PG-0213-20001). The views expressed are those of the author(s)
   and not necessarily those of the NHS, the NIHR or the Department of
   Health. The funder had no involvement in the design, conduct, analyses
   or interpretation of study findings.
CR Adams R, 2002, STROKE, V33, P326
   Allison R, 2008, FAM PRACT, V25, P355, DOI 10.1093/fampra/cmn048
   [Anonymous], 2013, EC IMP STROK AUSTR
   Aziz NA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009244
   Bakas T, 2017, STROKE, V48, pE122, DOI 10.1161/STROKEAHA.117.016052
   Bakas T, 2014, STROKE, V45, P2836, DOI 10.1161/STR.0000000000000033
   Barnsley L, 2012, AUST OCCUP THER J, V59, P71, DOI 10.1111/j.1440-1630.2011.00935.x
   Bennion AE, 2012, SOC SCI MED, V75, P976, DOI 10.1016/j.socscimed.2012.04.023
   Blixen C, 2014, TOP STROKE REHABIL, V21, P432, DOI 10.1310/tsr2105-432
   Britten Nicky, 2002, J Health Serv Res Policy, V7, P209, DOI 10.1258/135581902320432732
   Brown K, 2011, TOP STROKE REHABIL, V18, P536, DOI 10.1310/tsr1805-536
   Brunborg B, 2014, J CLIN NURS, V23, P1055, DOI 10.1111/jocn.12324
   Burman M E, 2001, Rehabil Nurs, V26, P94
   Burton CR, 2000, J ADV NURS, V32, P595, DOI 10.1046/j.1365-2648.2000.01517.x
   Cameron JI, 2013, DISABIL REHABIL, V35, P315, DOI 10.3109/09638288.2012.691937
   CASP, 2013, CRIT APPR SKILLS PRO
   Cecil R, 2013, J ADV NURS, V69, P1761, DOI 10.1111/jan.12037
   Cecil R, 2011, J CLIN NURS, V20, P1723, DOI 10.1111/j.1365-2702.2010.03400.x
   Corbin J, 1988, UNENDING WORK CARE M
   Dalvandi A, 2010, INT NURS REV, V57, P247, DOI 10.1111/j.1466-7657.2009.00786.x
   Danzl MM, 2013, J RURAL HEALTH, V29, P368, DOI 10.1111/jrh.12023
   Denman A, 1998, DISABIL REHABIL, V20, P411, DOI 10.3109/09638289809166103
   Dixon-Woods Mary, 2006, BMC Med Res Methodol, V6, P35, DOI 10.1186/1471-2288-6-35
   Dixon-Woods Mary, 2007, J Health Serv Res Policy, V12, P42, DOI 10.1258/135581907779497486
   Donnellan C, 2013, DISABIL REHABIL, V35, P483, DOI 10.3109/09638288.2012.702844
   Eaves YD, 2002, TOP GERIATR REHABIL, V17, P72, DOI 10.1097/00013614-200203000-00007
   Eilertsen G, 2010, J CLIN NURS, V19, P2004, DOI 10.1111/j.1365-2702.2009.03138.x
   El Masry Y, 2013, TOP STROKE REHABIL, V20, P356, DOI 10.1310/tsr2004-356
   Engelter ST, 2006, STROKE, V37, P1379, DOI 10.1161/01.STR.0000221815.64093.8c
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Finfgeld DL, 2003, QUAL HEALTH RES, V13, P893, DOI 10.1177/1049732303253462
   Foot C, 2014, MANAGING QUALITY COM
   Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3
   Gallacher K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001473
   Gosman-Hedstrom G, 2012, SCAND J CARING SCI, V26, P587, DOI 10.1111/j.1471-6712.2012.00975.x
   Grant J S, 1996, Home Healthc Nurse, V14, P892, DOI 10.1097/00004045-199611000-00008
   Graven C, 2013, DISABIL REHABIL, V35, P578, DOI 10.3109/09638288.2012.703755
   Greenwood N, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-57
   Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219
   Hare R, 2006, FAM PRACT, V23, P131, DOI 10.1093/fampra/cmi098
   Hart E, 1999, HEALTH SOC CARE COMM, V7, P248, DOI 10.1046/j.1365-2524.1999.00183.x
   Jones SP, 2008, J CLIN NURS, V17, P1270, DOI 10.1111/j.1365-2702.2007.02259.x
   Kirkevold M, 2002, DISABIL REHABIL, V24, P887, DOI 10.1080/09638280210142239
   Law J, 2010, INT J LANG COMM DIS, V45, P551, DOI 10.3109/13682820903308509
   Lawrence M, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-97
   Le Dorze G, 2014, APHASIOLOGY, V28, P421, DOI 10.1080/02687038.2013.869305
   Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0
   Lilley SA, 2003, CLIN REHABIL, V17, P540, DOI 10.1191/0269215503cr647oa
   Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01
   Low JTS, 2004, CLIN REHABIL, V18, P776, DOI 10.1191/0269215504cr748oa
   Mackenzie C, 2013, INT J LANG COMM DIS, V48, P402, DOI 10.1111/1460-6984.12017
   Malpass A, 2009, SOC SCI MED, V68, P154, DOI 10.1016/j.socscimed.2008.09.068
   Martinsen R, 2015, J NEUROSCI NURS, V47, P27, DOI 10.1097/JNN.0000000000000107
   McKevitt C, 2004, STROKE, V35, P1499, DOI 10.1161/01.STR.0000127532.64840.36
   Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350
   Murray J, 2003, BRIT J GEN PRACT, V53, P137
   Noblit George W., 1988, METAETHNOGRAPHY SYNT
   Nutbeam D, 1998, HEALTH PROMOT INT, V13, P349, DOI 10.1093/heapro/13.4.349
   Osborne RH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-658
   Reed M, 2010, CLIN REHABIL, V24, P16, DOI 10.1177/0269215509347433
   Saban KL, 2012, J NEUROSCI NURS, V44, P2, DOI 10.1097/JNN.0b013e31823ae4f9
   Sabari JS, 2000, DISABIL REHABIL, V22, P330
   Sadler E, 2014, DISABIL REHABIL, V36, P1911, DOI 10.3109/09638288.2014.882416
   Saka O, 2009, AGE AGEING, V38, P27, DOI 10.1093/ageing/afn281
   Sharma H, 2012, PHYSIOTHERAPY, V98, P341, DOI 10.1016/j.physio.2011.05.004
   Simon Chantal, 2002, Br J Community Nurs, V7, P158
   Ski Chantal, 2007, J Neurosci Nurs, V39, P172
   Smith LN, 2004, J ADV NURS, V46, P235, DOI 10.1111/j.1365-2648.2004.02983.x
   Souter Caroline, 2014, Int J Pharm Pract, V22, P424, DOI 10.1111/ijpp.12104
   Stewart M J, 1998, Can J Nurs Res, V30, P87
   Stroke Association, 2016, WHAT YOU CAN EXP US
   Stroke Association, 2016, STAT NAT STROK STAT
   Stroke Association, 2012, STROK CAR GUID
   Strudwick A, 2010, CLIN REHABIL, V24, P159, DOI 10.1177/0269215509343847
   Talbot Lise R, 2004, Health Qual Life Outcomes, V2, P53, DOI 10.1186/1477-7525-2-53
   Taule T, 2015, SCAND J CARING SCI, V29, P651, DOI 10.1111/scs.12193
   The Joanna Briggs Institute, 2011, JOANN BRIGGS I REV M
   Tholin H, 2014, SCAND J CARING SCI, V28, P822, DOI 10.1111/scs.12116
   Tunney Anne Marie, 2014, Nurs Older People, V26, P28, DOI 10.7748/nop2014.02.26.1.28.e500
   van der Gaag A, 2005, CLIN REHABIL, V19, P372, DOI 10.1191/0269215505cr785oa
   White Carole L, 2007, Can J Neurosci Nurs, V29, P5
   White JH, 2014, CAN J OCCUP THER, V81, P124, DOI 10.1177/0008417414527257
   White JH, 2013, DISABIL REHABIL, V35, P931, DOI 10.3109/09638288.2012.717578
   White JH, 2009, CAN J OCCUP THER, V76, P81, DOI 10.1177/000841740907600205
   Wiles R, 1998, J ADV NURS, V28, P794, DOI 10.1046/j.1365-2648.1998.00709.x
   Wiles R, 2008, DISABIL REHABIL, V30, P1966, DOI 10.1080/09638280701772997
   Wolfe CDA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001033
NR 87
TC 6
Z9 6
U1 3
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 21
PY 2018
VL 13
IS 2
AR e0192533
DI 10.1371/journal.pone.0192533
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FW8RO
UT WOS:000425604300064
PM 29466383
OA Green Published, Other Gold
DA 2019-06-18
ER

PT J
AU Auboire, L
   Sennoga, CA
   Hyvelin, JM
   Ossant, F
   Escoffre, JM
   Tranquart, F
   Bouakaz, A
AF Auboire, Laurent
   Sennoga, Charles A.
   Hyvelin, Jean-Marc
   Ossant, Frederic
   Escoffre, Jean-Michel
   Tranquart, Francois
   Bouakaz, Ayache
TI Microbubbles combined with ultrasound therapy in ischemic stroke: A
   systematic review of in-vivo preclinical studies
SO PLOS ONE
LA English
DT Review
ID BLOOD-BRAIN-BARRIER; TISSUE-PLASMINOGEN ACTIVATOR; FOCUSED ULTRASOUND;
   INTRAVENOUS MICROBUBBLES; TRANSCRANIAL ULTRASOUND; INFLAMMATORY
   RESPONSE; ENHANCED THROMBOLYSIS; CLINICAL-TRIAL; STANDING-WAVE; RABBIT
   MODEL
AB Background
   Microbubbles (MBs) combined with ultrasound sonothrombolysis (STL) appears to be an alternative therapeutic strategy for acute ischemic stroke (IS), but clinical results remain controversial.
   Objective
   The aim of this systematic review is to identify the parameters tested; to assess evidence on the safety and efficacy on preclinical data on STL; and to assess the validity and publication bias.
   Methods
   Pubmed (R) and Web of Science (TM) databases were systematically searched from January 1995 to April 2017 in French and English. We included studies evaluating STL on animal stroke model. This systematic review was conducted in accordance with the PRISMA guidelines. Data were extracted following a pre-defined schedule by two of the authors. The CAMARADES criteria were used for quality assessment. A narrative synthesis was conducted.
   Results
   Sixteen studies met the inclusion criteria. The result showed that ultrasound parameters and types of MBs were heterogeneous among studies. Numerous positive outcomes on efficacy were found, but only four studies demonstrated superiority of STL versus recombinant tissue-type plasminogen activator on clinical criteria. Data available on safety are limited.
   Limitations
   Quality assessment of the studies reviewed revealed a number of biases.
   Conclusion
   Further in vivo studies are needed to demonstrate a better efficacy and safety of STL compared to currently approved therapeutic options.
C1 [Auboire, Laurent; Sennoga, Charles A.; Ossant, Frederic; Escoffre, Jean-Michel; Bouakaz, Ayache] Univ Francois Rabelais Tours, Inserm U930, UMR Imagerie & Cerveau, Tours, France.
   [Auboire, Laurent] CHRU Tours, Serv Echog Doppler, Tours, France.
   [Hyvelin, Jean-Marc] Bracco Suisse SA, Geneva, Switzerland.
   [Ossant, Frederic] CHRU Tours, CIC IT, Tours, France.
   [Tranquart, Francois] Advice US Consulting, Nernier, France.
RP Bouakaz, A (reprint author), Univ Francois Rabelais Tours, Inserm U930, UMR Imagerie & Cerveau, Tours, France.
EM Ayache.bouakaz@univ-tours.fr
RI Escoffre, Jean-Michel/Q-4370-2019; Bouakaz, Ayache/G-1757-2013;
   Escoffre, Jean-Michel/P-5606-2014
OI Escoffre, Jean-Michel/0000-0003-1041-6950; Bouakaz,
   Ayache/0000-0001-5709-7120; Escoffre, Jean-Michel/0000-0003-1041-6950;
   auboire, laurent/0000-0002-7379-8506
FU INSERM
FX This work was funded by INSERM. The funder had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript. This does not alter our adherence to PLOS ONE policies on
   sharing data and materials.
CR ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35
   Alexandrov AV, 2004, J NEUROIMAGING, V14, P113, DOI 10.1177/1051228403261462
   Alonso A, 2009, THROMB RES, V124, P70, DOI 10.1016/j.thromres.2008.11.019
   Ammi AY, 2008, ULTRASOUND MED BIOL, V34, P1578, DOI 10.1016/j.ultrasmedbio.2008.02.012
   Azuma T, 2005, JPN J APPL PHYS 1, V44, P4625, DOI 10.1143/JJAP.44.4625
   Bader KB, 2016, ADV EXP MED BIOL, V880, P339, DOI 10.1007/978-3-319-22536-4_19
   Bader KB, 2015, ULTRASOUND MED BIOL, V41, P187, DOI 10.1016/j.ultrasmedbio.2014.08.018
   Baron C, 2009, ULTRASOUND MED BIOL, V35, P1148, DOI 10.1016/j.ultrasmedbio.2008.11.014
   Barreto AD, 2013, STROKE, V44, P3376, DOI 10.1161/STROKEAHA.113.002713
   Benchenane K, 2004, TRENDS NEUROSCI, V27, P155, DOI 10.1016/j.tins.2003.12.011
   Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587
   Brown AT, 2011, INVEST RADIOL, V46, P202, DOI 10.1097/RLI.0b013e318200757a
   Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792
   Clement GT, 2002, PHYS MED BIOL, V47, P1219, DOI 10.1088/0031-9155/47/8/301
   Culp WC, 2004, STROKE, V35, P2407, DOI 10.1161/01.STR.0000140890.86779.79
   Culp WC, 2003, J VASC INTERV RADIOL, V14, P1433, DOI 10.1097/01.RVI.0000096767.47047.FA
   Culp WC, 2011, STROKE, V42, P2280, DOI 10.1161/STROKEAHA.110.607150
   Daffertshofer M, 2005, STROKE, V36, P1441, DOI 10.1161/01.STR.0000170707.86793.1a
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Fisher M, 2004, CEREBROVASC DIS, V17, P1, DOI 10.1159/000074790
   Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128
   Flores R, 2011, INVEST RADIOL, V46, P419, DOI 10.1097/RLI.0b013e31820e143a
   Gao SJ, 2014, INVEST RADIOL, V49, P593, DOI 10.1097/RLI.0000000000000059
   Ghanouni P, 2015, AM J ROENTGENOL, V205, P150, DOI 10.2214/AJR.14.13632
   Huang XY, 2015, LANCET NEUROL, V14, P368, DOI 10.1016/S1474-4422(15)70017-7
   Kaur J, 2004, J CEREBR BLOOD F MET, V24, P945, DOI 10.1097/01.WCB.0000137868.50767.E8
   Larrue V, 2007, STROKE, V38, P472
   Liu WS, 2012, THROMB RES, V130, P547, DOI 10.1016/j.thromres.2012.06.020
   Lu YK, 2016, STROKE, V47, P1344, DOI 10.1161/STROKEAHA.115.012056
   MARLER JR, 1995, NEW ENGL J MED, V333, P1581
   McMahon D, 2017, THERANOSTICS, V7, P3989, DOI 10.7150/thno.21630
   Meairs S, 2008, EUR NEUROL, V59, P17, DOI 10.1159/000114456
   Meairs S, 2012, STROKE, V43, P1706, DOI 10.1161/STROKEAHA.111.636332
   Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005
   Molina CA, 2009, ANN NEUROL, V66, P28, DOI 10.1002/ana.21723
   Moumouh A, 2010, ULTRASOUND MED BIOL, V36, P51, DOI 10.1016/j.ultrasmedbio.2009.06.1103
   Nacu A, 2017, STROKE, V48, P335, DOI 10.1161/STROKEAHA.116.014644
   Nedelmann M, 2010, J CEREBR BLOOD F MET, V30, P1712, DOI 10.1038/jcbfm.2010.82
   O'Reilly MA, 2012, RADIOLOGY, V263, P96, DOI 10.1148/radiol.11111417
   O'Reilly MA, 2010, PHYS MED BIOL, V55, P5251, DOI 10.1088/0031-9155/55/18/001
   Pan J, 2007, NEURORADIOLOGY, V49, P93, DOI 10.1007/s00234-006-0183-z
   Ren ST, 2012, J THROMB THROMBOLYS, V33, P74, DOI 10.1007/s11239-011-0644-z
   Ren XP, 2015, THROMB RES, V136, P1027, DOI 10.1016/j.thromres.2015.08.027
   Ricci S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008348.pub2
   Saqqur M, 2014, J NEUROIMAGING, V24, P209, DOI 10.1111/jon.12026
   Schleicher N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152898
   Sena E, 2007, TRENDS NEUROSCI, V30, P433, DOI 10.1016/j.tins.2007.06.009
   Stride E, 2015, FRONT NEUROL NEUROSC, V36, P11, DOI 10.1159/000366223
   TACHIBANA K, 1995, CIRCULATION, V92, P1148, DOI 10.1161/01.CIR.92.5.1148
   Tang SC, 2010, IEEE T BIO-MED ENG, V57, P203, DOI 10.1109/TBME.2009.2028653
   Tomkins Amelia J, 2015, Exp Transl Stroke Med, V7, P2, DOI 10.1186/s13231-014-0014-y
   Wang B, 2008, THROMB HAEMOSTASIS, V100, P356, DOI 10.1160/TH07-09-0583
   Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014
   Woods Sean D, 2011, Open Neurol J, V5, P55, DOI 10.2174/1874205X01105010055
   Wright C, 2012, INVEST RADIOL, V47, P217, DOI 10.1097/RLI.0b013e31823cc75c
   Wu SY, 2014, IEEE T ULTRASON FERR, V61, P966, DOI 10.1109/TUFFC.2014.2992
NR 56
TC 5
Z9 6
U1 2
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 8
PY 2018
VL 13
IS 2
AR e0191788
DI 10.1371/journal.pone.0191788
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FV4BG
UT WOS:000424517900023
PM 29420546
OA Green Published, Other Gold
DA 2019-06-18
ER

PT J
AU Pugliese, M
   Ramsay, T
   Johnson, D
   Dowlatshahi, D
AF Pugliese, Michael
   Ramsay, Tim
   Johnson, Dylan
   Dowlatshahi, Dar
TI Mobile tablet-based therapies following stroke: A systematic scoping
   review of administrative methods and patient experiences
SO PLOS ONE
LA English
DT Review
ID SELF-DIRECTED THERAPY; COPENHAGEN STROKE; REHABILITATION; COMPUTERS;
   RECOVERY; PROGRAM; TELEREHABILITATION; INTERVENTIONS; PERSPECTIVE;
   SURVIVORS
AB Background and purpose
   Stroke survivors are often left with deficits requiring rehabilitation to recover function and yet, many are unable to access rehabilitative therapies. Mobile tablet-based therapies (MTBTs) may be a resource-efficient means of improving access to timely rehabilitation. It is unclear what MTBTs have been attempted following stroke, how they were administered, and how patients experienced the therapies. The review summarizes studies of MTBTs following stroke in terms of administrative methods and patient experiences to inform treatment feasibility.
   Methods
   Articles were eligible if they reported the results of an MTBT attempted with stroke participants. Six research databases were searched along with grey literature sources, trial registries, and article references. Intervention administration details and patient experiences were summarized.
   Results
   The search returned 903 articles of which 23 were eligible for inclusion. Most studies were small, observational, and enrolled chronic stroke patients. Interventions commonly targeted communication, cognition, or fine-motor skills. Therapies tended to be personalized based on patient deficits using commercially available applications. The complexity of therapy instructions, fine-motor requirements, and unreliability of internet or cellular connections were identified as common barriers to tablet-based care.
   Conclusions
   Stroke patients responded positively to MTBTs in both the inpatient and home settings. However, some support from therapists or caregivers may be required for patients to overcome barriers to care. Feasibility studies should continue to identify the administrative methods that minimize barriers to care and maximize patient adherence to prescribed therapy regiments.
C1 [Pugliese, Michael; Ramsay, Tim; Johnson, Dylan; Dowlatshahi, Dar] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.
   [Ramsay, Tim] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.
   [Dowlatshahi, Dar] Ottawa Hosp, Res Inst, Neurosci Program, Ottawa, ON, Canada.
   [Dowlatshahi, Dar] Ottawa Hosp, Med Neurol, Ottawa, ON, Canada.
RP Pugliese, M (reprint author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.
EM mpugl038@uottawa.ca
OI Dowlatshahi, Dar/0000-0003-1379-3612; Pugliese,
   Michael/0000-0003-2794-1436; Ramsay, Tim/0000-0001-8478-8170
FU Canadian Institutes of Health Research Canadian Graduate Scholarship
   Master's Award; University of Ottawa Ontario Graduate Scholarship;
   University of Ottawa Brain and Mind Research Institute; Canadian
   Partnership for Stroke Recovery; University of Ottawa Department of
   Medicine
FX This work was supported by a Canadian Institutes of Health Research
   Canadian Graduate Scholarship Master's Award
   (http://www.cihr-irsc.gc.ca/e/49440.html; M.P.), a University of Ottawa
   Ontario Graduate Scholarship
   (https://www.uottawa.ca/graduate-studies/students/awards/ontario-graduat
   e-scholarship; M.P.), the University of Ottawa Brain and Mind Research
   Institute (https://www.uottawa.ca/brain/; D.D), the Canadian Partnership
   for Stroke Recovery (http://www.canadianstroke.ca/en/; D.D.), and the
   University of Ottawa Department of Medicine (https://med.uottawa.ca/en;
   D.D.). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Andrews G, 2010, PLOS ONE, V5
   Ansari MT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000151
   Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40
   Carabeo CGG, 2014, SIMULAT GAMING, V45, P151, DOI 10.1177/1046878114531102
   Choi YH, 2016, RESTOR NEUROL NEUROS, V34, P455, DOI 10.3233/RNN-150626
   Choi YH, 2016, TELEMED E-HEALTH, V22, P434, DOI 10.1089/tmj.2015.0138
   Cifu DX, 1999, ARCH PHYS MED REHAB, V80, pS35, DOI 10.1016/S0003-9993(99)90101-6
   Consensus Panel on the Stroke Rehabilitation System, 2007, TIM IS FUNCT REP CON
   Crotty M, 2014, J TELEMED TELECARE, V20, P370, DOI 10.1177/1357633X14552382
   Davis B, INT BRAIN INJ ASS C, P1
   Des Roches CA, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01015
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Foley N, EVIDENCE BASED SYSTE
   Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003437.pub3
   Hiyamizu M, 2013, CEREBROVASC DIS, V35, P778
   Hoover EL, 2014, SEMIN SPEECH LANG, V35, P25, DOI 10.1055/s-0033-1362990
   Jang SH, 2016, SOMATOSENS MOT RES, V33, P124, DOI 10.1080/08990220.2016.1197117
   Janssen H, 2016, INT J STROKE, V11, P15
   JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P27, DOI 10.1016/S0003-9993(95)80038-7
   Katalinic O, 2013, J TELEMED TELECARE, V19, P418, DOI 10.1177/1357633X13506513
   Kizony R, 2016, J NEUROL PHYS THER, V40, P31, DOI 10.1097/NPT.0000000000000110
   Kurland J, 2014, SEMIN SPEECH LANG, V35, P51, DOI 10.1055/s-0033-1362991
   Lavoie M, 2016, NEUROCASE, V22, P109, DOI 10.1080/13554794.2015.1051055
   Lawrence M, 2013, INT J STROKE, V8, P465, DOI 10.1111/ijs.12135
   Mallet KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167950
   Mallet KH, 2016, INT J STROKE, V11, P73
   McCormick SA, 2016, STROKE, V47
   Mehrholz J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006185.pub3
   Mehrholz J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006876.pub4
   Moher D, 2015, SYST REV, V4, P1, DOI DOI 10.1186/2046-4053-4-1
   NAKAYAMA H, 1994, ARCH PHYS MED REHAB, V75, P394, DOI 10.1016/0003-9993(94)90161-9
   OTTENBACHER KJ, 1993, ARCH NEUROL-CHICAGO, V50, P37, DOI 10.1001/archneur.1993.00540010033014
   Peters MDJ, 2015, INT J EVID-BASED HEA, V13, P141, DOI 10.1097/XEB.0000000000000050
   Rand D., 2013, 2013 International Conference on Virtual Rehabilitation (ICVR), P109, DOI 10.1109/ICVR.2013.6662068
   Routhier S, 2016, APHASIOLOGY, V30, P269, DOI 10.1080/02687038.2014.973361
   Salaris M, 2016, INT J STROKE, V11, P21
   Salaris M, 2016, INT J STROKE, V11, P13
   Salter K, EVIDENCE BASED SYSTE
   Stark Brielle C, 2018, Neuropsychol Rehabil, V28, P818, DOI 10.1080/09602011.2016.1146150
   Teasell R, EVIDENCE BASED SYSTE
   The Heart and Stroke Foundation, 2014, CAN STORK BEST PRACT
   White JH, 2015, DISABIL REHABIL, V37, P593, DOI 10.3109/09638288.2014.935876
   Williams AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057447
   Xie J., 2007, Morbidity and Mortality Weekly Report, V56, P504
NR 44
TC 3
Z9 3
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 23
PY 2018
VL 13
IS 1
AR e0191566
DI 10.1371/journal.pone.0191566
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FT4YS
UT WOS:000423161800037
PM 29360872
OA DOAJ Gold, Green Published
DA 2019-06-18
ER

PT J
AU Aminov, A
   Rogers, JM
   Johnstone, SJ
   Middleton, S
   Wilson, PH
AF Aminov, Anna
   Rogers, Jeffrey M.
   Johnstone, Stuart J.
   Middleton, Sandy
   Wilson, Peter H.
TI Acute single channel EEG predictors of cognitive function after stroke
SO PLOS ONE
LA English
DT Article
ID FRONTAL-MIDLINE THETA; ISCHEMIC-STROKE; QUANTITATIVE EEG; DELTA/ALPHA
   RATIO; POWER; POSTSTROKE; RELIABILITY; IMPAIRMENT; PREVALENCE;
   DEPRESSION
AB Background
   Early and accurate identification of factors that predict post-stroke cognitive outcome is important to set realistic targets for rehabilitation and to guide patients and their families accordingly. However, behavioral measures of cognition are difficult to obtain in the acute phase of recovery due to clinical factors (e.g. fatigue) and functional barriers (e.g. language deficits). The aim of the current study was to test whether single channel wireless EEG data obtained acutely following stroke could predict longer-term cognitive function.
   Methods
   Resting state Relative Power (RP) of delta, theta, alpha, beta, delta/alpha ratio (DAR), and delta/ theta ratio (DTR) were obtained from a single electrode over FP1 in 24 participants within 72 hours of a first-ever stroke. The Montreal Cognitive Assessment (MoCA) was administered at 90-days post-stroke. Correlation and regression analyses were completed to identify relationships between 90-day cognitive function and electrophysiological data, neurological status, and demographic characteristics at admission.
   Results
   Four acute qEEG indices demonstrated moderate to high correlations with 90-day MoCA scores: DTR (r = -0.57, p = 0.01), RP theta (r = 0.50, p = 0.01), RP delta (r = -0.47, p = 0.02), and DAR (r = -0.45, p = 0.03). Acute DTR (b = -0.36, p < 0.05) and stroke severity on admission (b = -0.63, p < 0.01) were the best linear combination of predictors of MoCA scores 90days post-stroke, accounting for 75% of variance.
   Conclusions
   Data generated by a single pre-frontal electrode support the prognostic value of acute DAR, and identify DTR as a potential marker of post-stroke cognitive outcome. Use of single channel recording in an acute clinical setting may provide an efficient and valid predictor of cognitive function after stroke.
C1 [Aminov, Anna] Australian Catholic Univ, Sch Psychol, Sydney, NSW, Australia.
   [Rogers, Jeffrey M.] South Eastern Sydney Local Hlth Dist, Sydney, NSW, Australia.
   [Johnstone, Stuart J.] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia.
   [Middleton, Sandy] St Vincents Hlth Australia, Nursing Res Inst, Sydney, NSW, Australia.
   [Middleton, Sandy] Australian Catholic Univ, Sydney, NSW, Australia.
   [Wilson, Peter H.] Australian Catholic Univ, Sch Psychol, Melbourne, Vic, Australia.
   [Wilson, Peter H.] Australian Catholic Univ, Ctr Disabil & Dev Res, Melbourne, Vic, Australia.
RP Rogers, JM (reprint author), South Eastern Sydney Local Hlth Dist, Sydney, NSW, Australia.
EM jeffrey.regers@health.nsw.gov.au
RI Middleton, Sandy/J-5526-2015; Wilson, Peter/E-2881-2018
OI Middleton, Sandy/0000-0002-7201-4394; Wilson, Peter/0000-0003-3747-0287;
   Rogers, Jeffrey M/0000-0002-0320-969X; Aminov, Anna/0000-0003-4805-5476
FU Australian Catholic University Faculty Research Grant; Australian
   Postgraduate Award
FX This research was supported by an Australian Catholic University Faculty
   Research Grant provided to authors JR, SM, and SJ and an Australian
   Postgraduate Award provided to AA, https://research.acu.edu.au/. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adhikari MH, 2017, BRAIN, V140, P1068, DOI 10.1093/brain/awx021
   Alcott D, 1997, DISABIL REHABIL, V19, P355, DOI 10.3109/09638289709166551
   Andersen KK, 2009, STROKE, V40, P2068, DOI 10.1161/STROKEAHA.108.540112
   Andreassi JL, 2013, PSYCHOPHYSIOLOGY HUM
   BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O
   Barker-Collo SL, 2007, ARCH CLIN NEUROPSYCH, V22, P519, DOI 10.1016/j.acn.2007.03.002
   Bhalla A, 2013, STROKE, V44, P2174, DOI 10.1161/STROKEAHA.113.001263
   BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864
   Carducci F, 2016, INT J PSYCHOPHYSIOL, V103, P110
   Chi Yu Mike, 2010, IEEE Rev Biomed Eng, V3, P106, DOI 10.1109/RBME.2010.2084078
   Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017
   Cohen J., 1988, STAT POWER ANAL BEHA
   Crichton SL, 2016, J NEUROL NEUROSUR PS, V87, P1091, DOI 10.1136/jnnp-2016-313361
   Cumming TB, 2013, ACTA NEUROL SCAND, V128, P122, DOI 10.1111/ane.12084
   Cumming TB, 2011, STROKE, V42, P2642, DOI 10.1161/STROKEAHA.111.619486
   Cumming TB, 2010, CEREBROVASC DIS, V30, P7, DOI 10.1159/000313438
   Cummins TDR, 2008, INT J PSYCHOPHYSIOL, V70, P75, DOI 10.1016/j.ijpsycho.2008.06.002
   Cummins TDR, 2007, INT J PSYCHOPHYSIOL, V66, P10, DOI 10.1016/j.ijpsycho.2007.05.008
   Cuspineda E, 2007, CLIN EEG NEUROSCI, V38, P155, DOI 10.1177/155005940703800312
   de Haan EH, 2006, CURR OPIN NEUROL, V19, P559, DOI 10.1097/01.wco.0000247612.21235.d9
   Douiri A, 2013, STROKE, V44, P138, DOI 10.1161/STROKEAHA.112.670844
   Ekandem JI, 2012, ERGONOMICS, V55, P592, DOI 10.1080/00140139.2012.662527
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Felberg R A, 2000, CNS Spectr, V5, P52
   Finnigan S, 2016, CLIN NEUROPHYSIOL, V127, P1452, DOI 10.1016/j.clinph.2015.07.014
   Finnigan S, 2013, CLIN NEUROPHYSIOL, V124, P10, DOI 10.1016/j.clinph.2012.07.003
   Finnigan S, 2011, PSYCHOPHYSIOLOGY, V48, P1083, DOI 10.1111/j.1469-8986.2010.01173.x
   Finnigan SP, 2007, CLIN NEUROPHYSIOL, V118, P2525, DOI 10.1016/j.clinph.2007.07.021
   Fong KNK, 2001, BRAIN INJURY, V15, P443, DOI 10.1080/02699050010005940
   Foreman B, 2012, CRIT CARE, V16, DOI 10.1186/cc11230
   Gargiulo G, 2010, CLIN NEUROPHYSIOL, V121, P686, DOI 10.1016/j.clinph.2009.12.025
   George S, 2017, UNDERGRAD RES J, P3
   Goldstein LH, 2013, CLIN NEUROPSYCHOLOGY
   Hashimoto R, 2017, BRAIN STIMUL, V10, P426
   He W, 2017, BRAIN STIMUL, V10, P363
   Hewetson R, 2017, APHASIOLOGY, P1
   Hofgren C, 2007, ACTA NEUROL SCAND, V115, P73, DOI 10.1111/j.1600-0404.2006.00768.x
   Hosking SG, 2000, AGING NEUROPSYCHOL C, V7, P205, DOI 10.1076/anec.7.4.205.798
   Johnstone SJ, 2012, CLIN EEG NEUROSCI, V43, P112, DOI 10.1177/1550059411435857
   Jokinen H, 2015, EUR J NEUROL, V22, P1288, DOI 10.1111/ene.12743
   Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390
   Kardos Z, 2014, NEUROSCIENCE, V273, P152, DOI 10.1016/j.neuroscience.2014.04.071
   Kober SE, 2017, APPL PSYCHOPHYS BIOF, V42, P69, DOI 10.1007/s10484-017-9353-5
   KOPRUNER V, 1984, PROG BRAIN RES, V62, P29
   Le HH, 2017, BIOSYST BIOROBOT, V15, P369, DOI 10.1007/978-3-319-46669-9_62
   Leon-Carrion J, 2009, CLIN NEUROPHYSIOL, V120, P1039, DOI 10.1016/j.clinph.2009.01.021
   Lezak M, 2012, NEUROPSYCHOLOGICAL A
   Li J, 2017, EXP THER MED, V13, P909, DOI 10.3892/etm.2017.4035
   Lindow J, 2015, CLIN NEUROPHYSIOL, V126, pe93
   Lithfous S, 2015, NEUROBIOL AGING, V36, P2821, DOI 10.1016/j.neurobiolaging.2015.07.007
   Livingston-Thomas J, 2016, NEUROTHERAPEUTICS, V13, P395, DOI 10.1007/s13311-016-0423-9
   Makedonov I, 2016, NEUROBIOL AGING, V37, P12, DOI 10.1016/j.neurobiolaging.2015.09.010
   Mitchell DJ, 2008, PROG NEUROBIOL, V86, P156, DOI 10.1016/j.pneurobio.2008.09.005
   Moriya M, 2016, Adv Exp Med Biol, V923, P203, DOI 10.1007/978-3-319-38810-6_27
   Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x
   Naunheim RS, 2010, BRAIN INJURY, V24, P1324, DOI 10.3109/02699052.2010.506862
   NESTO RW, 1987, AM J CARDIOL, V59, pC23, DOI 10.1016/0002-9149(87)90192-5
   Ni L, 2017, SCI REP, P7
   Nys GMS, 2007, CEREBROVASC DIS, V23, P408, DOI 10.1159/000101464
   Planton M, 2012, EUR J NEUROL, V19, P212, DOI 10.1111/j.1468-1331.2011.03450.x
   RANKIN J, 1957, Scott Med J, V2, P200
   Renton T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177290
   Rijsdijk M, 2008, NETH J CRIT CARE, V12, P157
   Rogers JM, 2016, INT J PSYCHOPHYSIOL, V106, P87, DOI 10.1016/j.ijpsycho.2016.06.006
   Rogers JM, 2015, NEUROREPORT, V26, P903, DOI 10.1097/WNR.0000000000000445
   Scherg M, 1996, Electroencephalogr Clin Neurophysiol Suppl, V46, P127
   Scheuer ML, 2002, EPILEPSIA, V43, P114, DOI 10.1046/j.1528-1157.43.s.3.7.x
   Schleiger E, 2014, INT J PSYCHOPHYSIOL, V94, P19, DOI 10.1016/j.ijpsycho.2014.06.012
   Strauss E, 2006, COMPENDIUM NEUROPSYC
   Toth B, 2014, NEUROBIOL LEARN MEM, V114, P58, DOI 10.1016/j.nlm.2014.04.009
   Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799
   van Zandvoort MJE, 2005, CLIN NEUROL NEUROSUR, V107, P385, DOI 10.1016/j.clineuro.2004.10.012
   Ward SA, 2017, INT J STROKE, V12, P108, DOI 10.1177/1747493016669848
NR 74
TC 5
Z9 5
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 2
PY 2017
VL 12
IS 10
AR e0185841
DI 10.1371/journal.pone.0185841
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FI5MY
UT WOS:000412029600058
PM 28968458
OA Green Published, Other Gold
DA 2019-06-18
ER

PT J
AU Markaki, I
   Klironomos, S
   Kostulas, K
   Sjostrand, C
AF Markaki, Ioanna
   Klironomos, Stefanos
   Kostulas, Konstantinos
   Sjostrand, Christina
TI Elevated plasma homocysteine upon ischemic stroke is associated with
   increased long-term mortality in women
SO PLOS ONE
LA English
DT Article
ID GLOMERULAR-FILTRATION-RATE; DISEASE; DEATH; RISK
AB Background
   Ischemic stroke is a leading cause of death worldwide, despite preventive and therapeutic advances during the last twenty years. Blood-borne biomarkers have been studied in association to short-and long-term outcome, in order to investigate possible modifiable predictors of disability and death. Increased homocysteine has been associated with increased vascular risk and unfavorable outcome, but homocysteine lowering treatment has not consistently been successful in risk reduction. The aim of this study was to investigate homocysteine levels upon acute ischemic stroke in association to long-term mortality.
   Methods
   Of 622 patients included in our hospital-based registry, 331 survived the first month after admission, and had a diagnosis of ischemic stroke and available homocysteine values. All-cause and vascular mortality were investigated based on the national patient-and cause of death-registries. Survival analysis and Cox proportional hazard models were used to investigate time to death and predictors of outcome.
   Results
   Of 331 patients, 148 (45%) had low homocysteine (<13 micromol/L) and 183 (55%) had high homocysteine (>= 13 micromol/L). During 10 years of follow-up (median 5.5 years), 47 patients (32%) with low homocysteine and 94 (51%) with high homocysteine died (p<0.0001). Estimated median survival was not reached for the low homocysteine group, and was 80 months in the high homocysteine group (p with log-rank test 0.002). High homocysteine was not independently associated with increased risk for death after adjustment for age, sex, comorbidities, and eGFR (HR 1.29, 95% CI 0.86-1.93; p = 0.2). Subgroup analysis by sex showed that high homocysteine was an independent predictor of mortality in women after adjustment for age and vascular comorbidities (HR 1.85; 95% CI 1.03-3.31; p = 0.04), but not in men (HR 0.87; 95% CI 0.52-1.43; p = 0.6).
   Conclusion
   Increased plasma homocysteine (>= 13 micromol/L) upon acute ischemic stroke was not independently associated with mortality in our study. In the subgroup of women, high homocysteine was associated with increased five-year risk of death. Our study's retrospective design and the exploratory nature of subgroup analysis, prevent robust conclusions based on that observation. Future studies on homocysteine levels before as well as upon stroke will shed further light on a possible causal association.
C1 [Markaki, Ioanna; Klironomos, Stefanos; Kostulas, Konstantinos; Sjostrand, Christina] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.
RP Markaki, I (reprint author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.
EM ioanna.markaki@ki.se
OI Markaki, Ioanna/0000-0003-3328-5746
FU Stockholm County Council (ALF project) [20150335, 20160454]
FX This study was supported by grants (20150335, 20160454) provided by the
   Stockholm County Council (ALF project). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Arnadottir M, 1996, SCAND J CLIN LAB INV, V56, P41, DOI 10.3109/00365519609088586
   Barron E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127550
   Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Forti P, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.460
   Ham AC, 2014, DRUG AGING, V31, P611, DOI 10.1007/s40266-014-0192-2
   Hankey GJ, 2012, LANCET NEUROL, V11, P512, DOI 10.1016/S1474-4422(12)70091-1
   Ji Y, 2013, NEUROLOGY, V81, P1298, DOI 10.1212/WNL.0b013e3182a823cc
   Koton S, 2010, NEUROEPIDEMIOLOGY, V34, P90, DOI 10.1159/000264826
   Lewerin C, 2007, J INTERN MED, V261, P65, DOI 10.1111/j.1365-2796.2006.01732
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Mueller C, 2008, SWISS MED WKLY, V138, P225, DOI 2008/15/smw-12180
   Sahebkar A, 2016, CURR MED CHEM, V23, P4490, DOI 10.2174/0929867323666161007155310
   Shi ZH, 2015, STROKE, V46, P2419, DOI 10.1161/STROKEAHA.115.009136
   Swart KMA, 2012, EUR J CLIN NUTR, V66, P188, DOI 10.1038/ejcn.2011.186
   Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565
   Zhong C, 2016, MOL NEUROBIOL
NR 17
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 28
PY 2017
VL 12
IS 8
AR e0183571
DI 10.1371/journal.pone.0183571
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FE8EO
UT WOS:000408438600037
PM 28846725
OA DOAJ Gold, Green Published
DA 2019-06-18
ER

PT J
AU van Dijk, MM
   Meyer, S
   Sandstad, S
   Wiskerke, E
   Thuwis, R
   Vandekerckhove, C
   Myny, C
   Ghosh, N
   Beyens, H
   Dejaeger, E
   Verheyden, G
AF van Dijk, Margaretha M.
   Meyer, Sarah
   Sandstad, Solveig
   Wiskerke, Evelyne
   Thuwis, Rhea
   Vandekerckhove, Chesny
   Myny, Charlotte
   Ghosh, Nitesh
   Beyens, Hilde
   Dejaeger, Eddy
   Verheyden, Geert
TI A cross-sectional study comparing lateral and diagonal maximum weight
   shift in people with stroke and healthy controls and the correlation
   with balance, gait and fear of falling
SO PLOS ONE
LA English
DT Article
ID STANDING BALANCE; PRESSURE MEASURES; REHABILITATION COHORT; POSTACUTE
   STROKE; FORCE PLATFORM; STABILITY; COMMUNITY; INDIVIDUALS; RELIABILITY;
   PERFORMANCE
AB Impaired balance is common post stroke and can be assessed by means of force-platforms measuring center of pressure (COP) displacements during static standing, or more dynamically during lateral maximum weight shift (MWS). However, activities of daily life also include diagonal MWS and since force platforms are nowadays commercially available, investigating lateral and diagonal MWS in a clinical setting might be feasible and clinically relevant. We investigated lateral and diagonal MWS while standing in patients with stroke (PwS) and healthy controls (HC), evaluated MWS towards the affected and the non-affected side for PwS and correlated MWS with measures of balance, gait and fear of falling. In a cross-sectional observational study including 36 ambulatory sub-acute inpatients and 32 age-matched HC, a force platform (BioRescue, RM Ingenierie, France) was used to measure lateral and diagonal MWS in standing. Clinical outcome measures collected were Berg Balance Scale and Community Balance and Mobility Scale (CBMS) for balance, 10-meter walk test (10MWT) for gait speed and Falls Efficacy Scale-international version for fear of falling. MWS for PwS towards the affected side was significantly smaller compared to HC (lateral: p = 0.029; diagonal-forward: p = 0.000). MWS for PwS was also significantly reduced towards the affected side in the diagonal-forward direction (p = 0.019) compared to the non-affected side of PwS. Strong correlations were found for MWS for PwS in the diagonal-forward direction towards the affected side, and clinical measures of balance (CBMS: r = 0.66) and gait speed (10MWT: r = 0.66). Our study showed that ambulatory sub-acute PwS, in comparison to HC, have decreased ability to shift their body weight diagonally forward in standing towards their affected side. This reduced ability is strongly related to clinical measures of balance and gait speed. Our results suggest that MWS in a diagonal-forward direction should receive attention in rehabilitation of ambulatory sub-acute PwS in an inpatient setting.
C1 [van Dijk, Margaretha M.; Beyens, Hilde] Univ Hosp Leuven, UZ Leuven, Dept Phys Med & Rehabil, Pellenberg, Belgium.
   [Meyer, Sarah; Sandstad, Solveig; Wiskerke, Evelyne; Thuwis, Rhea; Vandekerckhove, Chesny; Myny, Charlotte; Ghosh, Nitesh; Verheyden, Geert] Univ Leuven, KU Leuven, Dept Rehabil Sci, Leuven, Belgium.
   [Dejaeger, Eddy] Univ Hosp Leuven, UZ Leuven, Dept Geriatr, Pellenberg, Belgium.
RP van Dijk, MM (reprint author), Univ Hosp Leuven, UZ Leuven, Dept Phys Med & Rehabil, Pellenberg, Belgium.
EM margaretha.vandijk@uzleuven.be
OI van Dijk, Margaretha/0000-0002-6688-2152; Verheyden,
   Geert/0000-0003-3095-8175
CR Chen BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135932
   CLARK MC, 1990, HUM FACTORS, V32, P537, DOI 10.1177/001872089003200504
   Corriveau H, 2004, ARCH PHYS MED REHAB, V85, P1095, DOI 10.1016/j.apmr.2003.09.023
   de Haart M, 2005, ARCH PHYS MED REHAB, V86, P755, DOI 10.1016/j.apmr.2004.10.010
   de Haart M, 2004, ARCH PHYS MED REHAB, V85, P886, DOI 10.1016/j.apmr.2003.05.012
   de Oliveira CB, 2008, J REHABIL RES DEV, V45, P1215, DOI 10.1682/JRRD.2007.09.0150
   Eng JJ, 2002, ARCH PHYS MED REHAB, V83, P1138, DOI 10.1053/apmr.2002.33644
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Ganesan M, 2009, PARKINSONISM RELAT D, V15, P435
   Ganesan M, 2012, GAIT POSTURE, V35, P625, DOI 10.1016/j.gaitpost.2011.12.012
   Genthon N, 2008, STROKE, V39, P489, DOI 10.1161/STROKEAHA.107.493478
   Geroin C, 2013, J REHABIL MED, V45, P987, DOI 10.2340/16501977-1234
   Geronimi M., 2014, NEUROPHYSIOL CLIN NE, V44, P139
   Geurts ACH, 2005, GAIT POSTURE, V22, P267, DOI 10.1016/j.gaitpost.2004.10.002
   GOLDIE P, 1996, GAIT POSTURE, V4, P315
   Goldie PA, 1996, CLIN BIOMECH, V11
   Gray VL, 2014, GAIT POSTURE, V40, P198, DOI 10.1016/j.gaitpost.2014.03.191
   Han TR, 1999, GAIT POSTURE, V10, P248, DOI 10.1016/S0966-6362(99)00040-5
   Hyndman D, 2003, DISABIL REHABIL, V25, P817, DOI 10.1080/0963828031000122221
   Hyndman D, 2002, ARCH PHYS MED REHAB, V83, P165, DOI 10.1053/apmr.2002.28030
   Karlsson A, 2000, CLIN BIOMECH, V15, P365, DOI 10.1016/S0268-0033(99)00096-0
   Knorr S, 2010, ARCH PHYS MED REHAB, V91, P890, DOI 10.1016/j.apmr.2010.02.010
   Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5
   Legters K, 2002, PHYS THER, V82, P264
   Mansfield A, 2012, NEUROREHAB NEURAL RE, V26, P627, DOI 10.1177/1545968311429688
   Mansfield A, 2011, CLIN BIOMECH, V26, P312, DOI 10.1016/j.clinbiomech.2010.10.001
   Mizelle C, 2006, GAIT POSTURE, V24, P356, DOI 10.1016/j.gaitpost.2005.11.003
   Nachreiner NM, 2007, J WOMENS HEALTH, V16, P1437, DOI 10.1089/jwh.2006.0245
   Nardone A, 2009, GAIT POSTURE, V30, P5, DOI 10.1016/j.gaitpost.2009.02.006
   Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18
   Paillex R, 2005, GAIT POSTURE, V21, P403, DOI 10.1016/j.gaitpost.2004.04.011
   Piirtola M, 2006, GERONTOLOGY, V52, P1, DOI 10.1159/000089820
   Portney LG, 1995, FDN CLIN RES APPL PR
   Pyoria O, 2004, PHYS THER, V84, P128
   Roerdink M, 2009, NEUROREHAB NEURAL RE, V23, P267, DOI 10.1177/1545968308323928
   Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012
   SHUMWAYCOOK A, 1988, ARCH PHYS MED REHAB, V69, P395
   Tyson SF, 2009, CLIN REHABIL, V23, P824, DOI 10.1177/0269215509335018
   Tyson SF, 2006, PHYS THER, V86, P30, DOI 10.1093/ptj/86.1.30
   Verheyden G, 2014, J NEUROL PHYS THER, V38, P239, DOI 10.1097/NPT.0000000000000054
   Warlow C, 2003, LANCET, V362, P1211, DOI 10.1016/S0140-6736(03)14544-8
   Weerdesteyn V, 2008, J REHABIL RES DEV, V45, P1195, DOI 10.1682/JRRD.2007.09.0145
   Yardley L, 2005, AGE AGEING, V34, P614, DOI 10.1093/ageing/afi196
   Yu E, 2008, ARCH PHYS MED REHAB, V89, P1133, DOI 10.1016/j.apmr.2007.10.047
NR 44
TC 3
Z9 3
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 15
PY 2017
VL 12
IS 8
AR e0183020
DI 10.1371/journal.pone.0183020
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FD5DG
UT WOS:000407550500035
PM 28809939
OA Other Gold, Green Published
DA 2019-06-18
ER

PT J
AU Wan, H
   Pan, YS
   Meng, X
   Wang, CJ
   Liao, XL
   Wang, D
   Zhao, XQ
   Liu, LP
   Li, H
   Wang, YL
   Wang, YJ
AF Wan, Hui
   Pan, Yuesong
   Meng, Xia
   Wang, Chunjuan
   Liao, Xiaoling
   Wang, David
   Zhao, Xingquan
   Liu, Liping
   Li, Hao
   Wang, Yilong
   Wang, Yongjun
TI Validation of the mSOAR and SOAR scores to predict early mortality in
   Chinese acute stroke patients
SO PLOS ONE
LA English
DT Article
ID PROJECT CLASSIFICATION; CEREBRAL INFARCTION; COMMUNITY STROKE;
   ISCHEMIC-STROKE; THROMBOLYSIS; OUTCOMES; SCALE; AGE; ALTEPLASE; OLD
AB Background
   It is unclear in Chinese patients with acute stroke how the SOAR (stroke subtype, Oxfordshire Community Stroke Project classification, age, and prestrike modified Rankin) and mSOAR (modified-SOAR) scores performed in predicting discharge mortality and 3-month mortality. We aimed to validate the predictability of these scores in this cohort.
   Methods
   Data from the China National Stroke Registry (CNSR) study was used to perform the mSOAR and SOAR scores for predicting the discharge and 3-month mortality in acute stroke patients.
   Results
   A total of 11073 acute stroke patients were included in present study. The increased mSOAR and SOAR scores were closely related to higher death risk in acute stroke patients. For discharge mortality, the area under the receiver-operator curve (AUC) of the mSOAR and SOAR scores were 0.784 (95% CI 0.761-0.807) and 0.722 (95% CI: 0.698-0.746). For 3-month mortality, they were 0.787 (95% CI: 0.771-0.803) and 0.704 (95% CI: 0.6870.721), respectively. The mSOAR and SOAR scores showed significant correlation between the predicted and observed probabilities of discharge mortality (mSOAR: r=0.945, P=0.001; SOAR: r=0.994, P<0.001) and 3-month mortality (mSOAR: r=0.984, P<0.001; SOAR: r=0.999; P<0.001).
   Conclusions
   The mSOAR score predicted reliably the risk of death in Chinese acute stroke patients.
C1 [Wan, Hui; Pan, Yuesong; Meng, Xia; Wang, Chunjuan; Liao, Xiaoling; Zhao, Xingquan; Liu, Liping; Li, Hao; Wang, Yilong; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.
   [Wan, Hui; Pan, Yuesong; Meng, Xia; Wang, Chunjuan; Liao, Xiaoling; Zhao, Xingquan; Liu, Liping; Li, Hao; Wang, Yilong; Wang, Yongjun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.
   [Wan, Hui; Pan, Yuesong; Meng, Xia; Wang, Chunjuan; Liao, Xiaoling; Zhao, Xingquan; Liu, Liping; Li, Hao; Wang, Yilong; Wang, Yongjun] Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China.
   [Wan, Hui; Pan, Yuesong; Meng, Xia; Wang, Chunjuan; Liao, Xiaoling; Zhao, Xingquan; Liu, Liping; Li, Hao; Wang, Yilong; Wang, Yongjun] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China.
   [Wan, Hui; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Monogen Dis Res Ctr Neurol Disorders, Beijing, Peoples R China.
   [Pan, Yuesong] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China.
   [Wang, David] Univ Illinois, Coll Med, Illinois Neurol Inst Stroke Network, Sisters Order St Francis Healthcare Syst 3, Peoria, IL 61656 USA.
RP Wang, YL; Wang, YJ (reprint author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.; Wang, YL; Wang, YJ (reprint author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.; Wang, YL; Wang, YJ (reprint author), Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China.; Wang, YL; Wang, YJ (reprint author), Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China.; Wang, YJ (reprint author), Capital Med Univ, Beijing Tiantan Hosp, Monogen Dis Res Ctr Neurol Disorders, Beijing, Peoples R China.
EM yongjunwangl962@gmail.com; yilong528@gmail.com
FU Ministry of Science and Technology of the People's Republic of China
   [2006BA101A11, 2011BAI081301, 2011BA108602, 2012ZX09303005-001,
   2013BA109B03]; Beijing Biobank of Cerebral Vascular Disease
   [D131100005313003]; Beijing Institute for Brain Disorders
   [BIBDPXM2013_014226_07_000084]
FX This study was supported by grants from the Ministry of Science and
   Technology of the People's Republic of China (2006BA101A11,
   2011BAI081301, 2011BA108602, 2012ZX09303005-001, 2013BA109B03), a grant
   from the Beijing Biobank of Cerebral Vascular Disease (D131100005313003)
   and a grant from Beijing Institute for Brain Disorders
   (BIBDPXM2013_014226_07_000084).
CR Abdul-Rahim AH, 2016, STROKE, V47, P74, DOI 10.1161/STROKEAHA.115.009898
   BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O
   BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864
   Castonguay AC, 2014, STROKE, V45, P3631, DOI 10.1161/STROKEAHA.114.006487
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Ford GA, 2010, STROKE, V41, P2568, DOI 10.1161/STROKEAHA.110.581884
   Gensicke H, 2016, STROKE, V47, P450, DOI 10.1161/STROKEAHA.115.011674
   Heuschmann PU, 2004, ARCH INTERN MED, V164, P1761, DOI 10.1001/archinte.164.16.1761
   Janssen PM, 2010, CEREBROVASC DIS, V29, P137, DOI 10.1159/000262309
   Kammersgaard LP, 2004, AGE AGEING, V33, P149, DOI 10.1093/ageing/afh052
   Kasner SE, 2006, LANCET NEUROL, V5, P603, DOI 10.1016/S1474-4422(06)70495-1
   Kim BJ, 2015, STROKE, V46, P2541, DOI 10.1161/STROKEAHA.115.010180
   Koenig IR, 2008, STROKE, V39, P1821, DOI 10.1161/STROKEAHA.107.505867
   Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5
   Kwok CS, 2013, STROKE, V44, P2010, DOI 10.1161/STROKEAHA.113.001148
   Machado C, 2015, STROKE, V46, P2312, DOI 10.1161/STROKEAHA.115.009842
   Mishra NK, 2014, INT J STROKE, V9, P613, DOI 10.1111/ijs.12162
   Myint PK, 2014, INT J STROKE, V9, P278, DOI 10.1111/ijs.12088
   Pittock Sean J, 2003, J Stroke Cerebrovasc Dis, V12, P1
   Saposnik G, 2013, NEUROLOGY, V80, P21, DOI 10.1212/WNL.0b013e31827b1ace
   Strbian D, 2012, NEUROLOGY, V78, P427, DOI 10.1212/WNL.0b013e318245d2a9
   Sung SF, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-39
   Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x
NR 23
TC 1
Z9 1
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 6
PY 2017
VL 12
IS 7
AR e0180444
DI 10.1371/Journal.pone.0180444
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FA3HX
UT WOS:000405335200036
OA DOAJ Gold, Green Published
DA 2019-06-18
ER

PT J
AU Dierick, F
   Dehas, M
   Isambert, JL
   Injeyan, S
   Bouche, AF
   Bleyenheuft, Y
   Portnoy, S
AF Dierick, Frederic
   Dehas, Melanie
   Isambert, Jean-Luc
   Injeyan, Soizic
   Bouche, Anne-France
   Bleyenheuft, Yannick
   Portnoy, Sigal
TI Hemorrhagic versus ischemic stroke: Who can best benefit from blended
   conventional physiotherapy with robotic-assisted gait therapy?
SO PLOS ONE
LA English
DT Article
ID RANDOMIZED CLINICAL-TRIAL; INTRACEREBRAL HEMORRHAGE; FUNCTIONAL
   RECOVERY; POSTURAL CONTROL; REHABILITATION; BALANCE; LOKOMAT; SCALE;
   CLASSIFICATION; HEMIPARESIS
AB Background
   Contrary to common belief of clinicians that hemorrhagic stroke survivors have better functional prognoses than ischemic, recent studies show that ischemic survivors could experience similar or even better functional improvements. However, the influence of stroke subtype on gait and posture outcomes following an intervention blending conventional physiotherapy with robotic-assisted gait therapy is missing.
   Objective
   This study compared gait and posture outcome measures between ambulatory hemorrhagic patients and ischemic patients, who received a similar 4 weeks' intervention blending a conventional bottom-up physiotherapy approach and an exoskeleton top-down robotic-assisted gait training (RAGT) approach with Lokomat.
   Methods
   Forty adult hemiparetic stroke inpatient subjects were recruited: 20 hemorrhagic and 20 ischemic, matched by age, gender, side of hemisphere lesion, stroke severity, and locomotor impairments. Functional Ambulation Category, Postural Assessment Scale for Stroke, Tinetti Performance Oriented Mobility Assessment, 6 Minutes Walk Test, Timed Up and Go and 10-Meter Walk Test were performed before and after a 4-week long intervention. Functional gains were calculated for all tests.
   Results
   Hemorrhagic and ischemic subjects showed significant improvements in Functional Ambulation Category (P<0.001 and P = 0.008, respectively), Postural Assessment Scale for Stroke (P<0.001 and P = 0.003), 6 Minutes Walk Test (P = 0.003 and P = 0.015) and 10 Meter Walk Test (P = 0.001 and P = 0.024). lschemic patients also showed significant improvements in Timed Up and Go. Significantly greater mean Functional Ambulation Category and Tinetti Performance Oriented Mobility Assessment gains were observed for hemorrhagic compared to ischemic, with large (dz = 0.81) and medium (dz = 0.66) effect sizes, respectively.
   Conclusion
   Overall, both groups exhibited quasi similar functional improvements and benefits from the same type, length and frequency of blended conventional physiotherapy and RAGT protocol. The use of intensive treatment plans blending top p-down physiotherapy and bottom-up robotic approaches is promising for post-stroke rehabilitation.
C1 [Dierick, Frederic; Dehas, Melanie; Bouche, Anne-France] Haute Ecole Louvain Hainaut, Dept Phys Therapy, Forme & Fonctionnement Humain Res Unit, Montignies Sur Sambre, Belgium.
   [Dierick, Frederic] Catholic Univ Louvain, Fac Motor Sci, Louvain La Neuve, Belgium.
   [Isambert, Jean-Luc; Injeyan, Soizic] Le Normandy Rehabil Ctr, Granville, OH, France.
   [Bouche, Anne-France] Rehabil Unit Le Richemont, Bioul, Belgium.
   [Bleyenheuft, Yannick] Catholic Univ Louvain, Inst Neurosci, Brussels, Belgium.
   [Portnoy, Sigal] Tel Aviv Univ, Sackler Sch Med, Dept Occupat Therapy, Tel Aviv, Israel.
RP Dierick, F (reprint author), Haute Ecole Louvain Hainaut, Dept Phys Therapy, Forme & Fonctionnement Humain Res Unit, Montignies Sur Sambre, Belgium.; Dierick, F (reprint author), Catholic Univ Louvain, Fac Motor Sci, Louvain La Neuve, Belgium.
EM frederic.dierick@gmail.com
RI sahely, ahmad/R-6293-2017
OI Bleyenheuft, Yannick/0000-0002-6688-932X
CR ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35
   Bang DH, 2016, NEUROREHABILITATION, V38, P343, DOI 10.3233/NRE-161325
   Belda-Lois JM, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-66
   Benaim C, 1999, STROKE, V30, P1862, DOI 10.1161/01.STR.30.9.1862
   Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485
   Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205
   Bowden MG, 2013, CURR OPIN NEUROL, V26, P37, DOI 10.1097/WCO.0b013e32835c5ba0
   Bragoni Maura, 2013, Am J Phys Med Rehabil, V92, pe16, DOI 10.1097/PHM.0b013e3182a20a34
   Chae J, 1996, AM J PHYS MED REHAB, V75, P177, DOI 10.1097/00002060-199605000-00004
   Chisari C, 2015, EUR J PHYS REHAB MED, V51, P59
   Chiu D, 2010, J STROKE CEREBROVASC, V19, P225, DOI 10.1016/j.jstrokecerebrovasdis.2009.06.002
   Cho DY, 2015, J PHYS THER SCI, V27, P3053, DOI 10.1589/jpts.27.3053
   Conesa L, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-13
   Dias D, 2007, Eura Medicophys, V43, P499
   Dobkin BH, 2004, LANCET NEUROL, V3, P528, DOI 10.1016/S1474-4422(04)00851-8
   Enright Paul L, 2003, Respir Care, V48, P783
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215
   FRANKE CL, 1992, J NEUROL NEUROSUR PS, V55, P653, DOI 10.1136/jnnp.55.8.653
   Gama GL, 2017, TOP STROKE REHABIL, P1
   Geroin C, 2013, J REHABIL MED, V45, P987, DOI 10.2340/16501977-1234
   Goto A, 2009, J STROKE CEREBROVASC, V18, P60, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.003
   Graham JV, 2009, TOP STROKE REHABIL, V16, P57, DOI 10.1310/tsr1601-57
   Hidler J, 2009, NEUROREHAB NEURAL RE, V23, P5, DOI 10.1177/1545968308326632
   Hillis A. E., 2014, ADV MED, V2014, DOI [10.1155/2014/378263, DOI 10.1155/2014/378263]
   Hornby TG, 2008, STROKE, V39, P1786, DOI 10.1161/STROKEAHA.107.504779
   Husemann B, 2007, STROKE, V38, P349, DOI 10.1161/01.STR.0000254607.48765.cb
   Iosa M, 2011, J REHABIL RES DEV, V48, P135, DOI 10.1682/JRRD.2010.04.0069
   JORGENSEN HS, 1995, ANN NEUROL, V38, P45, DOI 10.1002/ana.410380110
   Katrak PH, 2009, PM&R, V1, P427, DOI 10.1016/j.pmrj.2009.03.002
   Kelley CP, 2013, DISABIL REHABIL-ASSI, V8, P161, DOI 10.3109/17483107.2012.714052
   Kelly PJ, 2003, ARCH PHYS MED REHAB, V84, P968, DOI 10.1016/S0003-9993(03)00040-6
   Kim JY, 2017, J STROKE, V19, P28, DOI 10.5853/jos.2016.01935
   Knaepen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140626
   Koh GCH, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003483
   Kugler C, 2003, J NEUROL, V250, P676, DOI 10.1007/s00415-003-1054-8
   Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5
   Laufer Y, 2003, NEUROREHAB NEURAL RE, V17, P207, DOI 10.1177/088439003259169
   Levin MF, 2009, NEUROREHAB NEURAL RE, V23, P313, DOI 10.1177/1545968308328727
   Lombardi R, 2001, Technol Health Care, V9, P403
   LUNDGREN J, 1982, SCAND J REHABIL MED, V14, P141
   MAHONEY F I, 1965, Md State Med J, V14, P61
   Mao HF, 2002, STROKE, V33, P1022, DOI 10.1161/01.STR.0000012516.63191.C5
   Masiero S, 2014, EXPERT REV MED DEVIC, V11, P187, DOI 10.1586/17434440.2014.882766
   Mayr A, 2007, NEUROREHAB NEURAL RE, V21, P307, DOI 10.1177/1545968307300697
   Mehrholz J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006185.pub3
   Mehrholz J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002840.pub3
   Mehrholz J, 2012, J REHABIL MED, V44, P193, DOI 10.2340/16501977-0943
   Mestriner RG, 2011, EXP NEUROL, V227, P53, DOI 10.1016/j.expneurol.2010.09.009
   Morone G, 2012, STROKE, V43, P1140, DOI 10.1161/STROKEAHA.111.638148
   Morone G, 2011, NEUROREHAB NEURAL RE, V25, P636, DOI 10.1177/1545968311401034
   Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735
   Obembe AO, 2012, J MED MED SCI, V3, P556
   Organization WH, 2001, INT CLASS FUNCT DIS
   Paolucci S, 2003, STROKE, V34, P2861, DOI 10.1161/01.STR.0000102902.39759.D3
   Paolucci S, 2000, ARCH PHYS MED REHAB, V81, P695, DOI 10.1053/apmr.2000.5583
   Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x
   Perna R, 2015, BEHAV NEUROL, DOI 10.1155/2015/891651
   PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982
   Peurala SH, 2004, J NEUROL, V251, P449, DOI 10.1007/s00415-004-0352-0
   PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x
   Poli P, 2013, BIOMED RES INT, DOI 10.1155/2013/153872
   Pollock A, 2007, CLIN REHABIL, V21, P395, DOI 10.1177/0269215507073438
   Prabhakaran S, 2008, NEUROREHAB NEURAL RE, V22, P64, DOI 10.1177/1545968307305302
   Quinn TJ, 2011, STROKE, V42, P1146, DOI 10.1161/STROKEAHA.110.598540
   Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8
   Roth DL, 2011, STROKE, V42, P626, DOI 10.1161/STROKEAHA.110.595322
   Schepers VPM, 2008, J REHABIL MED, V40, P487, DOI 10.2340/16501977-0198
   Schlegel D, 2003, STROKE, V34, P134, DOI 10.1161/01.STR.0000048217.44714.02
   SCHULING J, 1993, STROKE, V24, P1173, DOI 10.1161/01.STR.24.8.1173
   SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6
   Taveggia G, 2016, INT J REHABIL RES, V39, P29, DOI 10.1097/MRR.0000000000000137
   Ucar DE, 2014, NEUROREHABILITATION, V34, P447, DOI 10.3233/NRE-141054
   Vaughan-Graham J, 2015, DISABIL REHABIL, V37, P1793, DOI 10.3109/09638288.2014.985802
   Veerbeek JM, 2011, STROKE, V42, P3311, DOI 10.1161/STROKEAHA.111.623819
   Wagner TH, 2011, STROKE, V42, P2630, DOI 10.1161/STROKEAHA.110.606442
   Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844
   Ween JE, 1996, NEUROLOGY, V47, P388, DOI 10.1212/WNL.47.2.388
   Werner C, 2002, EUR J NEUROL, V9, P639, DOI 10.1046/j.1468-1331.2002.00492.x
   Westlake KP, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-18
   Wevers L, 2009, STROKE, V40, P2450, DOI 10.1161/STROKEAHA.108.541946
   Xing CH, 2012, INT J STROKE, V7, P378, DOI 10.1111/j.1747-4949.2012.00839.x
   Yoshikawa K, 2017, NEUROREHABILITATION, V40, P87, DOI 10.3233/NRE-161393
NR 83
TC 3
Z9 3
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 2
PY 2017
VL 12
IS 6
AR e0178636
DI 10.1371/journal.pone.0178636
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EW6MJ
UT WOS:000402624300084
PM 28575054
OA Green Published, Other Gold
DA 2019-06-18
ER

PT J
AU Shen, JT
   Li, XL
   Li, YP
   Wu, B
AF Shen, Jiantong
   Li, Xianglian
   Li, Youping
   Wu, Bing
TI Comparative accuracy of CT perfusion in diagnosing acute ischemic
   stroke: A systematic review of 27 trials
SO PLOS ONE
LA English
DT Review
ID COMPUTED TOMOGRAPHIC PERFUSION; SOURCE IMAGES; ANGIOGRAPHY; DIFFUSION;
   BRAIN; EXPOSURE; DISEASE; ROW
AB Objective
   To systematically evaluate and compare the diagnostic accuracy of CT perfusion (CTP), non-enhanced computed tomography (NCCT) and computed tomography angiography (CTA) in detecting acute ischemic stroke.
   Methods
   We searched seven databases and screened the reference lists of the included studies. The risk of bias in the study quality was assessed using QUADASII. We produced paired forest plots in RevMan to show the variation of the sensitivity and specificity estimates together with their 95% CI. We used a hierarchical summary ROC model to summarize the sensitivity and specificity of CTP in detecting ischemic stroke.
   Results
   We identified 27 studies with a total of 2168 patients. The pooled sensitivity of CTP for acute ischemic stroke was 82% (95% CI 75-88%), and the specificity was 96% (95% CI 89-99%). CTP was more sensitive than NCCT and had a similar accuracy with CTA. There were no statistically significant differences in the sensitivity and specificity between patients who underwent CTP within 6 hours of symptom onset and beyond 6 hours after symptom onset. No adverse events were reported in the included studies.
   Conclusions
   CTP is more accurate than NCCT and has similar accuracy to CTA in detecting acute ischemic stroke. However, the evidence is not strong. There is potential benefit of using CTP to select stroke patients for treatment, but more high-quality evidence is needed to confirm this result.
C1 [Shen, Jiantong; Li, Youping] Sichuan Univ, West China Hosp, Key Lab Transplant Engn & Immunol, Minist Hlth China, Chengdu, Peoples R China.
   [Shen, Jiantong; Li, Xianglian; Li, Youping] Sichuan Univ, West China Hosp, Chinese Cochrane Ctr, Chengdu, Peoples R China.
   [Wu, Bing] Sichuan Univ, West China Hosp, Dept Radiol, Chengdu, Peoples R China.
RP Li, YP (reprint author), Sichuan Univ, West China Hosp, Key Lab Transplant Engn & Immunol, Minist Hlth China, Chengdu, Peoples R China.; Li, YP (reprint author), Sichuan Univ, West China Hosp, Chinese Cochrane Ctr, Chengdu, Peoples R China.
EM lypgroup1@163.com
FU Chinese Ministry of Health [ZX0000026]
FX The study was funded by Chinese Ministry of Health (ZX0000026). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abels B, 2012, EUR RADIOL, V22, P2559, DOI 10.1007/s00330-012-2529-8
   Alves JE, 2014, NEURORADIOL J, V27, P91, DOI 10.15274/NRJ-2014-10010
   Biesbroek JM, 2013, CEREBROVASC DIS, V35, P493, DOI 10.1159/000350200
   Campbell BCV, 2013, J NEUROL NEUROSUR PS, V84, P613, DOI 10.1136/jnnp-2012-303752
   [陈婷 Chen Ting], 2012, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V28, P1290
   Cohnen M, 2006, AM J NEURORADIOL, V27, P1741
   Dai Feng, 2009, Chinese Journal of Medical Imaging Technology, V25, P1160
   Diekmann S, 2010, AM J NEURORADIOL, V31, P1003, DOI 10.3174/ajnr.A1971
   Eastwood JD, 2003, AM J NEURORADIOL, V24, P1869
   Eckert B, 2011, NEURORADIOLOGY, V53, P79, DOI 10.1007/s00234-010-0702-9
   Esteban JM, 2004, NEURORADIOLOGY, V46, P705, DOI 10.1007/s00234-004-1235-x
   Fahmi F, 2012, AM J NEURORADIOL, V33, P2074, DOI 10.3174/ajnr.A3110
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Hana T, 2014, J MED INVESTIG, V61, P41, DOI 10.2152/jmi.61.41
   Harbord RM, 2007, BIOSTATISTICS, V8, P239, DOI 10.1093/biostatistics/kxl004
   Hoeffner EG, 2004, RADIOLOGY, V231, P632, DOI 10.1148/radiol.2313021488
   Huisa BN, 2014, J STROKE CEREBROVASC, V23, P114, DOI 10.1016/j.jstrokecerebrovasdis.2012.10.020
   Jain AR, 2013, AM J NEURORADIOL, V34, P1895, DOI 10.3174/ajnr.A3502
   Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a
   Kloska SP, 2004, RADIOLOGY, V233, P79, DOI 10.1148/radiol.2331030028
   Koenig M, 1998, RADIOLOGY, V209, P85, DOI 10.1148/radiology.209.1.9769817
   Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5
   Kudo K, 2013, RADIOLOGY, V267, P201, DOI 10.1148/radiol.12112618
   Langer RD, 2007, AUSTRALAS RADIOL, V51, P532, DOI 10.1111/j.1440-1673.2007.01901.x
   [冷振璞 Leng Zhenpu], 2003, [中华神经科杂志, Chinese Journal of Neurology], V36, P199
   Lin K, 2009, CEREBROVASC DIS, V28, P72, DOI 10.1159/000219300
   [刘银红 Liu Yinhong], 2005, [中华神经科杂志, Chinese Journal of Neurology], V38, P418
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Macaskill P., 2010, COCHRANE HDB SYSTEMA
   Mnyusiwalla A, 2009, NEURORADIOLOGY, V51, P635, DOI 10.1007/s00234-009-0543-6
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Pepper EM, 2006, J CLIN NEUROSCI, V13, P199, DOI 10.1016/j.jocn.2005.03.030
   Rai AT, 2008, J EMERG MED, V35, P287, DOI 10.1016/j.jemermed.2007.08.071
   Reichenbach JR, 1999, AM J NEURORADIOL, V20, P1842
   Roberts HC, 2001, AM J NEURORADIOL, V22, P1077
   Rother J, 2000, ARCH NEUROL-CHICAGO, V57, P1161, DOI 10.1001/archneur.57.8.1161
   Sabarudin A, 2014, QUANT IMAGING MED SU, V4, P282, DOI 10.3978/j.issn.2223-4292.2014.07.10
   Schramm P, 2004, STROKE, V35, P1652, DOI 10.1161/01.STR.0000131271.54098.22
   Sillanpaa N, 2011, CEREBROVASC DIS EXTR, V1, P6, DOI 10.1159/000324324
   Sporns P, 2016, CEREBROVASC DIS, V41, P242, DOI 10.1159/000443618
   Suzuki Y, 2005, NEUROL MED-CHIR, V45, P333, DOI 10.2176/nmc.45.333
   Tan JC, 2007, ANN NEUROL, V61, P533, DOI 10.1002/ana.21130
   van der Hoeven EJRJ, 2015, STROKE, V46, P1113, DOI 10.1161/STROKEAHA.115.008718
   Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009
   Wintermark M, 2005, AM J NEURORADIOL, V26, P104
   Yamauchi-Kawara C, 2010, BRIT J RADIOL, V83, P1029, DOI 10.1259/bjr/52267127
   Youn SW, 2008, AM J ROENTGENOL, V191, pW120, DOI 10.2214/AJR.07.2519
   Zebedin D, 2013, EUR J RADIOL, V82, P1059, DOI 10.1016/j.ejrad.2011.11.044
   [朱建国 Zhu Jianguo], 2011, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V27, P710
NR 50
TC 4
Z9 4
U1 2
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 17
PY 2017
VL 12
IS 5
AR e0176622
DI 10.1371/journal.pone.0176622
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV1DX
UT WOS:000401487700025
PM 28520753
OA DOAJ Gold, Green Published
DA 2019-06-18
ER

PT J
AU Arikan, F
   Martinez-Valverde, T
   Sanhez-Guerrero, A
   Campos, M
   Esteves, M
   Gandara, D
   Torne, R
   Castro, L
   Dalmau, A
   Tibau, J
   Sahuquillo, J
AF Arikan, Fuat
   Martinez-Valverde, Tamara
   Sanchez-Guerrero, Angela
   Campos, Mireia
   Esteves, Marielle
   Gandara, Dario
   Torne, Ramon
   Castro, Lidia
   Dalmau, Antoni
   Tibau, Joan
   Sahuquillo, Juan
TI Malignant infarction of the middle cerebral artery in a porcine model. A
   pilot study
SO PLOS ONE
LA English
DT Article
ID SULFONYLUREA RECEPTOR 1; ISCHEMIC-STROKE; WHITE-MATTER; BLOOD-FLOW;
   DECOMPRESSIVE CRANIECTOMY; INTERSTITIAL GLYCEROL; TISSUE OXYGENATION;
   HEMISPHERIC STROKE; GLOBAL BURDEN; OCCLUSION
AB Background and purpose
   Interspecies variability and poor clinical translation from rodent studies indicate that large gyrencephalic animal stroke models are urgently needed. We present a proof-of-principle study describing an alternative animal model of malignant infarction of the middle cerebral artery (MCA) in the common pig and illustrate some of its potential applications. We report on metabolic patterns, ionic profile, brain partial pressure of oxygen (PtiO(2)), expression of sulfonylurea receptor 1 (SUR1), and the transient receptor potential melastatin 4 (TRPM4).
   Methods
   A 5-hour ischemic infarct of the MCA territory was performed in 5 2.5-to-3-month-old female hybrid pigs (Large White x Landrace) using a frontotemporal approach. The core and penumbra areas were intraoperatively monitored to determine the metabolic and ionic profiles. To determine the infarct volume, 2,3,5-triphenyltetrazolium chloride staining and immunohistochemistry analysis was performed to determine SUR1 and TRPM4 expression.
   Results
   PtiO(2) monitoring showed an abrupt reduction in values close to 0 mmHg after MCA occlusion in the core area. Hourly cerebral microdialysis showed that the infarcted tissue was characterized by reduced concentrations of glucose (0.03 mM) and pyruvate (0.003 mM) and increases in lactate levels (8.87mM), lactate-pyruvate ratio (4202), glycerol levels (588 mu M), and potassium concentration (27.9 mmol/L). Immunohistochemical analysis showed increased expression of SUR1-TRPM4 channels.
   Conclusions
   The aim of the present proof-of-principle study was to document the feasibility of a large animal model of malignant MCA infarction by performing transcranial occlusion of the MCA in the common pig, as an alternative to lisencephalic animals. This model may be useful for detailed studies of cerebral ischemia mechanisms and the development of neuroprotective strategies.
C1 [Arikan, Fuat; Gandara, Dario; Torne, Ramon; Sahuquillo, Juan] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain.
   [Arikan, Fuat; Martinez-Valverde, Tamara; Sanchez-Guerrero, Angela; Torne, Ramon; Castro, Lidia; Sahuquillo, Juan] Univ Autonoma Barcelona, Vall dHebron Res Inst VHIR, Neurotraumatol & Neurosurg Res Unit UNINN, Barcelona, Spain.
   [Campos, Mireia; Esteves, Marielle] Univ Autonoma Barcelona, Vall dHebron Res Inst VHIR, Expt Surg Unit, Barcelona, Spain.
   [Dalmau, Antoni; Tibau, Joan] IRTA, Anim Breeding & Genet Program, Monells, Girona, Spain.
RP Arikan, F (reprint author), Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain.; Arikan, F (reprint author), Univ Autonoma Barcelona, Vall dHebron Res Inst VHIR, Neurotraumatol & Neurosurg Res Unit UNINN, Barcelona, Spain.
EM arikan@neurotrauma.net
RI Dalmau, Antoni/M-3745-2017; Sahuquillo, Juan/B-3577-2008; Castro,
   Lidia/J-3976-2017
OI Dalmau, Antoni/0000-0003-2248-6796; Sahuquillo,
   Juan/0000-0003-0713-5875; Castro, Lidia/0000-0001-8513-7388; Gandara
   Sabatini, Dario/0000-0003-1303-9847; Torne, Ramon/0000-0001-7932-2528;
   Arikan Abello, Fuat/0000-0002-9459-0915
FU Departament d'Universitats, Recerca i Societat de la Informacio de la
   Generalitat de Catalunya [SGR 2014-844]; Fondo de Investigacion
   Sanitaria (Institute de Salud Carlos III) [FIS PI11/00700]; European
   Regional Development Fund (ERDF); Institute de Salud Carlos III
   [FI12/00074]
FX The Neurotraumatology and Neurosurgery Research Unit is supported by a
   grant from the Departament d'Universitats, Recerca i Societat de la
   Informacio de la Generalitat de Catalunya (SGR 2014-844). This work has
   been supported in part by the Fondo de Investigacion Sanitaria
   (Institute de Salud Carlos III) with grant FIS PI11/00700, which was
   co-financed by the European Regional Development Fund (ERDF) and awarded
   to Dr. J. Sahuquillo. A. Sanchez-Guerrero is the recipient of a personal
   pre-doctoral grant from the Institute de Salud Carlos III (grant number
   grant number FI12/00074).
CR Arikan F, 2008, NEUROCIRUGIA, V19, P113
   Arikan F, 2014, J NEUROSURG ANESTH, V26, P328, DOI 10.1097/ANA.0000000000000033
   Barone R, 2004, ANATOMIE COMP MAMMIF, V6
   Bennett DA, 2014, GLOB HEART, V9, P107, DOI 10.1016/j.gheart.2014.01.001
   Bollen B JA, 2010, THE LAB SWINE
   Burbridge B, 2004, CAN ASSOC RADIOL J, V55, P326
   Cheng Yu Dennis, 2004, NeuroRx, V1, P36, DOI 10.1007/BF03206566
   Doerfler A, 1996, J NEUROSURG, V85, P853, DOI 10.3171/jns.1996.85.5.0853
   Engelhorn T, 1999, STROKE, V30, P1456, DOI 10.1161/01.STR.30.7.1456
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128
   FRAHM HD, 1982, J HIRNFORSCH, V23, P375
   GILLILAN LA, 1976, AM J ANAT, V146, P237, DOI 10.1002/aja.1001460303
   Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X
   Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012
   Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486
   Imai H, 2006, J NEUROSURG, V104, P123, DOI 10.3171/ped.2006.104.2.123
   Kuroiwa T, 2003, NEUROPATHOLOGY, V23, P79, DOI 10.1046/j.1440-1789.2003.00479.x
   Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003
   MACRAE IM, 1992, BRIT J CLIN PHARMACO, V34, P302
   Martinez-Valverde T., 2016, J NEUROTRAUMA
   Martinez-Valverde T, 2015, J NEUROTRAUM, V32, P1478, DOI 10.1089/neu.2014.3706
   Martinez-Valverde T, 2015, J NEUROTRAUM, V32, P7, DOI 10.1089/neu.2014.3473
   Mehta RI, 2015, J NEUROPATH EXP NEUR, V74, P835, DOI 10.1097/NEN.0000000000000223
   Morancho A, 2012, NEUROPATH APPL NEURO, V38, P617, DOI 10.1111/j.1365-2990.2012.01252.x
   Peerdeman SM, 2003, INTENS CARE MED, V29, P1825, DOI 10.1007/s00134-003-1850-8
   Prabhakaran S, 2015, JAMA-J AM MED ASSOC, V313, P1451, DOI 10.1001/jama.2015.3058
   Qiu MG, 2011, NEUROREHAB NEURAL RE, V25, P275, DOI 10.1177/1545968310389183
   Russell WMS BR, 1992, PRINCIPLES HUMANE EX
   Sahuquillo J, 2002, ACT NEUR S, V81, P303
   Sakoh M, 2003, AM J PHYSIOL-HEART C, V285, pH17, DOI 10.1152/ajpheart.01112.2002
   Sakoh M, 2001, J NEUROSURG, V95, P450, DOI 10.3171/jns.2001.95.3.0450
   Sakoh M, 2000, STROKE, V31, P1958, DOI 10.1161/01.STR.31.8.1958
   Sakoh M, 2000, J NEUROSURG, V93, P647, DOI 10.3171/jns.2000.93.4.0647
   Schattling B, 2012, NAT MED, V18, P1805, DOI 10.1038/nm.3015
   Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8
   Simard JM, 2011, CURR TREAT OPTION NE, V13, P217, DOI 10.1007/s11940-010-0110-9
   Simard JM, 2009, STROKE, V40, P604, DOI 10.1161/STROKEAHA.108.522409
   Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172
   Stokum JA, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0239-6
   TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6
   Tosun C, 2013, STROKE, V44, P3522, DOI 10.1161/STROKEAHA.113.002904
   Ventura-Antunes L, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00003
   Watanabe H, 2007, J NEUROSCI METH, V160, P109, DOI 10.1016/j.jneumeth.2006.08.016
   Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219
   Xu SY, 2013, MED SCI MONIT BASIC, V19, P37, DOI 10.12659/MSMBR.883750
   Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197
NR 47
TC 2
Z9 2
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 24
PY 2017
VL 12
IS 2
AR e0172637
DI 10.1371/journal.pone.0172637
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EL5VB
UT WOS:000394688200106
PM 28235044
OA Green Published, Other Gold
DA 2019-06-18
ER

PT J
AU Wagemans, BAJM
   van Zwam, WH
   Nelemans, PJ
   van Oostenbrugge, RJ
   Postma, AA
AF Wagemans, Bart A. J. M.
   van Zwam, Wim H.
   Nelemans, Patricia J.
   van Oostenbrugge, Robert J.
   Postma, Alida A.
TI 4D-CTA improves diagnostic certainty and accuracy in the detection of
   proximal intracranial anterior circulation occlusion in acute ischemic
   stroke
SO PLOS ONE
LA English
DT Article
ID 4D CT ANGIOGRAPHY; PERFUSION
AB Introduction
   In acute ischemic stroke, imaging of the cranio-cervical vessels is essential for intra-arterial treatment selection. Fast, reliable and easy accessible imaging is necessary 24 hours a day, 7 days a week. Radiologists in training and non-expert readers often perform initial reviewing. In this pilot study, the potential benefit of adding 4Dimensional-CT Angiography (4D-CTA) to the patient selection protocol for intra-arterial therapy is investigated.
   Materials and methods
   Twenty-five datasets of prospectively recruited patients, eligible for intra-arterial treatment, were enrolled. Four radiologists-in-training consecutively reviewed CTA, CT-Perfusion and 4D-CTA (post-processed from CTP datasets) and scored: occlusion-presence and diagnostic certainty (scale 1-10). Time-to-diagnosis was registered.
   Results
   Arterial occlusion was present in 8 patients. Accuracy improved from 88-92% after CTA and CTP assessment to 96-100% after 4D-CTA assessment (P-values >0,05). Mean diagnostic certainty improved from 7,2-8,6 to 8,8-9,3 (P-values all < 0,05). Mean time to diagnosis increased from 3, 5, 5 and 4 minutes after CTA to 9, 14, 12, and 10 minutes after 4D-CTA.
   Conclusion
   4D-CTA as an additive to regular CTA and CT-Perfusion in patients with acute ischemic stroke eligible for intra-arterial treatment shows a tendency to increase diagnostic accuracy and improves diagnostic certainty, when reviewed by radiologist in training, while only mildly prolonging time to diagnosis.
C1 [Wagemans, Bart A. J. M.; van Zwam, Wim H.; Postma, Alida A.] Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands.
   [Nelemans, Patricia J.] Maastricht Univ, Med Ctr, Dept Clin Epidemiol, Maastricht, Netherlands.
   [van Oostenbrugge, Robert J.] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands.
RP Wagemans, BAJM (reprint author), Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands.
EM bart.wagemans@mumc.nl
CR Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587
   Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792
   Dehkharghani S, 2015, AJNR AM J NEURORADIO
   DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Frolich AMJ, 2014, EUR RADIOL, V24, P390, DOI 10.1007/s00330-013-3024-6
   Frolich AMJ, 2013, AM J NEURORADIOL, V34, P1908, DOI 10.3174/ajnr.A3533
   Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905
   Hopyan J, 2010, RADIOLOGY, V255, P142, DOI 10.1148/radiol.09091021
   Kaschka IN, 2014, CLIN NEURORADIOL
   Kortman HG, 2014, AJNR AM J NEURORADIO
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Ng FC, 2016, J NEUROIMAGING, V26, P588, DOI 10.1111/jon.12375
   Power S, 2015, EUR J RADIOL, V84, P1333, DOI 10.1016/j.ejrad.2015.04.012
   Sabarudin A, 2014, QUANT IMAGING MED SU, V4, P282, DOI 10.3978/j.issn.2223-4292.2014.07.10
   Saver JL, 2014, INT J STROKE, V9, P658, DOI 10.1111/j.1747-4949.2012.00856.x
   Vachha BA, 2015, RADIOL CLIN N AM, V53, P801, DOI 10.1016/j.rcl.2015.02.012
   Wardlaw JM, 2004, STROKE, V35, P2477, DOI 10.1161/01.STR.0000143453.78005.44
NR 18
TC 1
Z9 1
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 24
PY 2017
VL 12
IS 2
AR e0172356
DI 10.1371/journal.pone.0172356
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EL5VB
UT WOS:000394688200073
PM 28234928
OA Green Published, Other Gold
DA 2019-06-18
ER

PT J
AU Zhao, J
   Bai, Y
   Jin, L
   Weng, YF
   Wang, YJ
   Wu, H
   Li, X
   Huang, Y
   Wang, SY
AF Zhao, Jing
   Bai, Yun
   Jin, Lei
   Weng, Yingfeng
   Wang, Yujie
   Wu, Hui
   Li, Xia
   Huang, Ying
   Wang, Shengyue
TI A functional variant in the 3 '-UTR of VEGF predicts the 90-day outcome
   of ischemic stroke in Chinese patients
SO PLOS ONE
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; FACTOR GENE POLYMORPHISMS;
   BLOOD-BRAIN-BARRIER; CEREBRAL INFARCTION; ATRIAL-FIBRILLATION; INCREASED
   RISK; BINDING-SITE; EXPRESSION; SUSCEPTIBILITY; ANGIOGENESIS
AB Vascular endothelial growth factor (VEGF) plays critical roles in angiogenesis and vasculogenesis, which are associated with post-stroke functional recovery. However, the effects of the VEGFA polymorphisms on the outcome of ischemic stroke (IS) have been rarely reported. We therefore investigated the associations of + 936C/T variant (rs3025039) with the susceptibilities and the 90-day outcomes from 494 IS patients and 337 healthy controls in Chinese population through the establishment of logistic multivariate regression model. Stroke severity at admission and outcome of 90 days were respectively assessed according to the National Institutes of Health Stroke Scale and the modified Rankin Scale. The analysis showed that there were no significant associations of the rs3025039 genotypes with the susceptibility (P = 0.229) and the severity (P = 0.734). However, when we divided the 308 IS patients into two groups according to the different outcomes, we found that the rs3025039 TC+ TT genotype significantly increased the risk of poor recovery [adjusted odds ratio (OR), 1.99; 95% confidence interval (CI), 1.18-3.37]. Interestingly, we observed another 3'UTR variant, + 1451C/T (rs3025040), exhibited strong linkage disequilibrium (r(2) = 1.0) with + 936C/T and was located in a predicted microRNA-binding site. The rs3025040 T allele significantly decreased the luciferase activities in four cell lines, which indicated a potential disruption of the miRNA-mRNA interaction that would result in lower VEGF expression levels. Our data suggested that the + 936C/T variants significantly increased the risk of poorer stroke outcome by affecting the bindings of miR-199a and miR-199b to VEGF mRNA at the rs30250340 polymorphic site.
C1 [Zhao, Jing; Weng, Yingfeng; Wu, Hui] Minhang Dist Cent Hosp, Dept Neurol, Shanghai, Peoples R China.
   [Bai, Yun; Jin, Lei; Wang, Yujie; Li, Xia; Wang, Shengyue] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China.
   [Jin, Lei] Fudan Univ, Sch Life Sci, Shanghai, Peoples R China.
   [Huang, Ying] Luoxin Biotechnol Co Shanghai, Shanghai, Peoples R China.
RP Bai, Y; Wang, SY (reprint author), Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China.
EM baiyun@chgc.sh.cn; wangsy@chgc.sh.cn
FU National Natural Science Foundation of China [30901240, 81572232,
   81271868]; Shanghai Natural Science Foundation [13ZR1429500,
   13ZR1436600]; Shanghai Municipal Commission for Science and Technology
   [15DZ2291400]
FX This work was supported by the National Natural Science Foundation of
   China (30901240, 81572232, 81271868), Shanghai Natural Science
   Foundation (13ZR1429500, 13ZR1436600), Shanghai Municipal Commission for
   Science and Technology (15DZ2291400).
CR Abumiya T, 1999, J CEREBR BLOOD F MET, V19, P1038, DOI 10.1097/00004647-199909000-00012
   ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35
   Al-Habboubi HH, 2011, EUR CYTOKINE NETW, V22, P154, DOI 10.1684/ecn.2011.0289
   Aro E, 2012, J BIOL CHEM, V287, P37134, DOI 10.1074/jbc.M112.352872
   Atzeni F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062330
   Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081
   Bhattacharya A, 2014, NUCLEIC ACIDS RES, V42, pD86, DOI 10.1093/nar/gkt1028
   Chen HK, 2015, GENE, V558, P181, DOI 10.1016/j.gene.2015.01.023
   Chen J, 2006, NEUROSCIENCE, V141, P737, DOI 10.1016/j.neuroscience.2006.04.042
   Chen T, 2015, STEM CELLS, V33, P1405, DOI 10.1002/stem.1930
   Fan X, 2009, BRAIN RES REV, V62, P99, DOI 10.1016/j.brainresrev.2009.09.006
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Fu Y, 2011, EUR NEUROL, V66, P47, DOI 10.1159/000329276
   Goda N, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0219-5
   Goldstein LB, 2001, STROKE, V32, P280, DOI 10.1161/01.STR.32.1.280
   Gong J, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav029
   Gretarsdottir S, 2008, ANN NEUROL, V64, P402, DOI 10.1002/ana.21480
   Gu S, 2012, INT J MOL SCI, V13, P8449, DOI 10.3390/ijms13078449
   Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417
   Hassan A, 2000, BRAIN, V123, P1784, DOI 10.1093/brain/123.9.1784
   HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P533
   Holliday EG, 2012, NAT GENET, V44, P1147, DOI 10.1038/ng.2397
   Ikram MA, 2009, NEW ENGL J MED, V360, P1718, DOI 10.1056/NEJMoa0900094
   Ikuhashi Y, 2007, ACTA OBSTET GYN SCAN, V86, P1352, DOI 10.1080/00016340701644991
   Jiang GH, 2016, INT J NEUROSCI, V126, P326, DOI 10.3109/00207454.2014.994209
   Kim JG, 2008, CLIN CANCER RES, V14, P62, DOI 10.1158/1078-0432.CCR-07-1537
   Kim OJ, 2011, STROKE, V42, P2393, DOI 10.1161/STROKEAHA.110.607739
   Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003
   Kovacs Z, 1996, STROKE, V27, P1865, DOI 10.1161/01.STR.27.10.1865
   Krippl P, 2003, INT J CANCER, V106, P468, DOI 10.1002/ijc.11238
   LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986
   Liu CX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-661
   Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755
   Maeda M, 2003, BBA-GEN SUBJECTS, V1623, P41, DOI 10.1016/S0304-4165(03)00161-2
   Meyer BC, 2002, STROKE, V33, P1261, DOI 10.1161/01.STR.0000015625.87603.A7
   Miller CL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004263
   Quinn TJ, 2007, STROKE, V38, pE144, DOI 10.1161/STROKEAHA.107.490110
   Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1021/rna.5248604
   Reitmeir R, 2012, ACTA NEUROPATHOL, V123, P273, DOI 10.1007/s00401-011-0914-z
   Renner W, 2000, J VASC RES, V37, P443, DOI 10.1159/000054076
   Soliman S, 2014, J PHARMACOL EXP THER, V349, P444, DOI 10.1124/jpet.113.212613
   Song GG, 2014, HUM IMMUNOL, V75, P541, DOI 10.1016/j.humimm.2014.02.022
   Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977
   Tu JW, 2014, MED SCI MONITOR, V20, P2520, DOI 10.12659/MSM.891394
   Wang CX, 2011, J GASTROEN HEPATOL, V26, P1630, DOI 10.1111/j.1440-1746.2011.06758.x
   Waters RJ, 2005, CURR OPIN CRIT CARE, V11, P105, DOI 10.1097/01.ccx.0000155354.78617.91
   Wu T, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.482
   Yang SB, 2015, FEBS LETT, V589, P2087, DOI 10.1016/j.febslet.2015.06.029
   Yang YQ, 2014, GENET MOL RES, V13, P5011, DOI 10.4238/2014.July.4.16
   Yuan M, 2013, ATHEROSCLEROSIS, V226, P447, DOI 10.1016/j.atherosclerosis.2012.11.026
   Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369
   Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002
   Zhao J, 2013, BRAIN RES, V1537, P312, DOI 10.1016/j.brainres.2013.08.061
NR 53
TC 1
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 24
PY 2017
VL 12
IS 2
AR e0172709
DI 10.1371/journal.pone.0172709
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EL5VB
UT WOS:000394688200120
PM 28234972
OA Green Published, Other Gold
DA 2019-06-18
ER

PT J
AU dos Santos, GL
   Souza, MB
   Desloovere, K
   Russo, TL
AF dos Santos, Gabriela Lopes
   Souza, Matheus Braganca
   Desloovere, Kaat
   Russo, Thiago Luiz
TI Elastic Tape Improved Shoulder Joint Position Sense in Chronic
   Hemiparetic Subjects: A Randomized Sham-Controlled Crossover Study
SO PLOS ONE
LA English
DT Article
ID SENSORIMOTOR SYSTEM; STROKE PATIENTS; UPPER-LIMB; HEMIPLEGIC SHOULDER;
   UPPER EXTREMITY; KINESIO TAPE; EFFECT SIZE; PROPRIOCEPTION; PAIN;
   DEFICITS
AB Background
   Elastic tape has been widely used in clinical practice in order to improve upper limb (UL) sensibility. However, there is little evidence that supports this type of intervention in stroke patients.
   Objective
   To verify the effect of elastic tape, applied to the paretic shoulder, on joint position sense (JPS) during abduction and flexion in subjects with chronic hemiparesis compared to sham tape (non-elastic tape). Furthermore, to verify if this potential effect is correlated to shoulder subluxation measurements and sensorimotor impairment.
   Methods
   A crossover and sham-controlled study was conducted with post-stroke patients who were randomly allocated into two groups: 1) those who received Sham Tape (ST) first and after one month they received Elastic Tape (ET); 2) those who received Elastic Tape (ET) first and after one month they received Sham Tape (ST). The JPS was evaluated using a dynamometer. The absolute error for shoulder abduction and flexion at 30 and 60 was calculated. Sensorimotor impairment was determined by Fugl-Meyer, and shoulder subluxation was measured using a caliper.
   Results
   Thirteen hemiparetic subjects (average time since stroke 75.23 months) participated in the study. At baseline (before interventions), the groups were not different for abduction at 30 (p = 0.805; p = 0.951), and 60 (p = 0.509; p = 0.799), or flexion at 30 (p = 0.872; p = 0.897) and 60 (p = 0.853; p = 0.970). For the ET group, differences between pre and post-elastic tape for abduction at 30 (p<0.010) and 60 (p<0.010), and flexion at 30 p<0.010) and 60 (p<0.010) were observed. For the ST group, differences were also observed between pre and post-elastic tape for abduction at 30 (p<0.010) and 60 (p<0.010), and flexion at 30 (p<0.010,) and 60 (p<0.010). Potential effects were only correlated with shoulder subluxation during abduction at 30 (p = 0.001, r = -0.92) and 60 (p = 0.020, r = -0.75).
   Conclusion
   Elastic tape improved shoulder JPS of subjects with chronic hemiparesis regardless of the level of UL sensorimotor impairment. However, this improvement was influenced by the subluxation degree at abduction.
C1 [dos Santos, Gabriela Lopes; Souza, Matheus Braganca; Russo, Thiago Luiz] Fed Univ Sao Carlos UFSCar, Dept Phys Therapy, Lab Neurol Physiotherapy Res, Sao Carlos, SP, Brazil.
   [Desloovere, Kaat] Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Dept Rehabil Sci, Leuven, Belgium.
   [Desloovere, Kaat] Univ Hosp Pellenberg, Clin Mot Anal Lab CERM, Pellenberg, Belgium.
RP dos Santos, GL; Russo, TL (reprint author), Fed Univ Sao Carlos UFSCar, Dept Phys Therapy, Lab Neurol Physiotherapy Res, Sao Carlos, SP, Brazil.
EM gabrielalsantos@hotmail.com; thiagoluizrusso@gmail.com
RI Russo, Thiago L/B-7555-2012; Russo, Thiago/I-9298-2017; Desloovere,
   Kaat/F-3240-2014
OI Russo, Thiago L/0000-0002-5483-3097; Russo, Thiago/0000-0002-5483-3097;
   Desloovere, Kaat/0000-0002-8507-5276; Lopes dos Santos,
   Gabriela/0000-0002-6230-999X
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)
   [2014/25845-6, 2015/21695-2]; CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico); FAPESP (Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo) [2014/25845-6, 2015/21695-2]; CNPq (Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico)
FX This study was supported by FAPESP (Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo; process numbers: 2014/25845-6 and 2015/21695-2),
   and CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico).
CR Aarseth LM, 2015, J ATHL TRAINING, V50, P785, DOI 10.4085/1062-6050-50.7.03
   Burfeind SM, 2015, J SPORT REHABIL, V24, P405, DOI [10.1123/jsr.2014-0233, 10-1123/jsr.2014-0233]
   Callaghan MJ, 2008, MANUAL THER, V13, P192, DOI 10.1016/j.math.2006.11.004
   Callaghan MJ, 2012, PHYS THER, V92, P821, DOI 10.2522/ptj.20110209
   Callaghan MJ, 2002, J ATHL TRAINING, V37, P19
   Chang WD, 2015, EVID-BASED COMPL ALT, DOI 10.1155/2015/471208
   Clark NC, 2015, MANUAL THER, V20, P378, DOI 10.1016/j.math.2015.01.009
   Cohen J., 1988, STAT POWER ANAL BEHA
   Colombo R, 2016, NEUROCASE, V22, P191, DOI 10.1080/13554794.2015.1109667
   De Baets Liesbet, 2014, Front Hum Neurosci, V8, P933, DOI 10.3389/fnhum.2014.00933
   Donec V, 2012, POL ANN MED, V19, P98
   dos Santos GL, 2015, TOP STROKE REHABIL, V22, P271, DOI 10.1179/1074935714Z.0000000014
   Doyle SD, 2014, DISABIL REHABIL, V36, P993, DOI 10.3109/09638288.2013.825649
   Dukelow SP, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-72
   Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267
   Faraone Stephen V, 2008, P T, V33, P700
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Gomez-Soriano J, 2014, MANUAL THER, V19, P131, DOI 10.1016/j.math.2013.09.002
   Grampurohit N, 2015, TOP STROKE REHABIL, V22, P72, DOI 10.1179/1074935714Z.0000000031
   Halseth T, 2004, J SPORT SCI MED, V3, P1
   Hillier S, 2015, NEUROREHAB NEURAL RE, V29, P933, DOI 10.1177/1545968315573055
   Hosp S, 2015, J SCI MED SPORT, V18, P709, DOI 10.1016/j.jsams.2014.09.004
   Huang SW, 2012, J REHABIL MED, V44, P733, DOI 10.2340/16501977-1026
   Huang YC, 2016, EUROPEAN J PHYS REHA
   Hunter SM, 2002, REV CLIN GERONTOLOGY, V12, P66
   Jaraczewska E, 2006, TOP STROKE REHABIL, V13, P31, DOI 10.1310/33KA-XYE3-QWJB-WGT6
   Kalichman L, 2016, INT J REHABIL RES, V39, P272, DOI 10.1097/MRR.0000000000000167
   Kandel E, 2000, PRINCIPLES NEURAL SC
   Kase K, 2003, CLIN THERAPEUTIC APP
   Lee DH, 2015, J PHYS THER SCI, V27, P2101, DOI 10.1589/jpts.27.2101
   Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1111/j.1468-2958.2002.tb00828.x
   Lin JJ, 2011, J ORTHOP RES, V29, P53, DOI 10.1002/jor.21146
   Maki T, 2006, Braz. J. Phys. Ther., V10, P177, DOI 10.1590/S1413-35552006000200007
   Meyer S, 2015, NEUROREHABILITATION, V2015
   Meyer S, 2014, PHYS THER, V94, P1220, DOI 10.2522/ptj.20130271
   Michener LA, 2015, MANUAL THER, V20, P171, DOI 10.1016/j.math.2014.08.008
   Michener LA, 2013, MANUAL THER, V18, P60, DOI 10.1016/j.math.2012.07.003
   Munro B. H., 2005, STAT METHODS HLTH CA
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Myers JB, 2000, J ATHL TRAINING, V35, P351
   Niessen M, 2008, J REHABIL MED, V40, P482, DOI 10.2340/16501977-0201
   Niessen MH, 2008, ARCH PHYS MED REHAB, V89, P333, DOI 10.1016/j.apmr.2007.08.157
   Niessen MH, 2009, ARCH PHYS MED REHAB, V90, P1557, DOI 10.1016/j.apmr.2009.04.004
   OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4
   Olejnik S, 2000, CONTEMP EDUC PSYCHOL, V25, P241, DOI 10.1006/ceps.2000.1040
   Paci M, 2005, J REHABIL RES DEV, V42, P557, DOI 10.1682/JRRD.2004.08.0112
   Pandian JD, 2013, NEUROLOGY, V80, P528, DOI 10.1212/WNL.0b013e318281550e
   Phadke V, 2009, BRAZ J PHYS THER, V13, P1, DOI 10.1590/S1413-35552009005000012
   Pillastrini P, 2016, DISABIL REHABIL, V38, P1603, DOI 10.3109/09638288.2015.1107631
   Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011
   Riemann BL, 2002, J ATHL TRAINING, V37, P71
   Riemann BL, 2002, J ATHL TRAINING, V37, P80
   Roijezon U, 2015, MANUAL THER, V20, P368, DOI 10.1016/j.math.2015.01.008
   Parreira PDS, 2014, J PHYSIOTHER, V60, P31, DOI 10.1016/j.jphys.2013.12.008
   Parreira PDS, 2013, J PHYSIOTHER, V59, P52, DOI 10.1016/S1836-9553(13)70147-4
   Taylor RL, 2014, J HAND THER, V27, P235, DOI 10.1016/j.jht.2014.03.004
   Taylor RL, 2014, J HAND THERAPY OFFIC, V27
   Vanti C, 2015, PHYS THER, V95, P493, DOI 10.2522/ptj.20130619
   Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1
   Wu W-T, 2015, EVIDENCE BASED COMPL, V2015
   Yalcin E, 2012, EUR NEUROL, V68, P294, DOI 10.1159/000342025
   YOUDAS JW, 1991, PHYS THER, V71, P98, DOI 10.1093/ptj/71.2.98
   Zanca GG, 2015, CLIN BIOMECH, V30, P903, DOI 10.1016/j.clinbiomech.2015.07.011
NR 65
TC 5
Z9 5
U1 2
U2 28
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 18
PY 2017
VL 12
IS 1
AR e0170368
DI 10.1371/journal.pone.0170368
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EI3HH
UT WOS:000392380100081
PM 28099472
OA DOAJ Gold, Green Published
DA 2019-06-18
ER

PT J
AU Westerlind, E
   Persson, HC
   Sunnerhagen, KS
AF Westerlind, Emma
   Persson, Hanna C.
   Sunnerhagen, Katharina S.
TI Return to Work after a Stroke in Working Age Persons; A Six-Year Follow
   Up
SO PLOS ONE
LA English
DT Article
ID TRAUMATIC BRAIN-INJURY; LIFE SATISFACTION; SICK LEAVE; HEALTH; SCALE;
   DISABILITY; BEHAVIOR; PEOPLE; IMPACT; TRIALS
AB Objectives
   Stroke is one of the most common and resource intensive diseases for society. Stroke in the working age population is increasing in different parts of the world. An incomplete return to work (RTW) after sick leave post stroke entails negative consequences for the affected person and an economical burden for society. The aim of this study was to explore the RTW rate and factors associated with RTW in a six-year follow up post stroke.
   Methods
   Data from 174 persons 63 years or younger, with first ever stroke in 2009-2010 in Gothenburg were analyzed. Baseline characteristics were collected through medical records and the Swedish Health Insurance Office provided information on sick leave up to 6 years post stroke. Time-to-event was presented and cox regression as well as logistic regression were used to analyze risk factors for no-RTW.
   Results
   The RTW rate was 74.7%, at the end of follow up. Participants continued to RTW until just over 3 years post stroke. Dependency at discharge (in the modified Rankin Scale) and sick leave prior to the stroke were significant risk factors for no-RTW after 1 year with odds ratio 4.595 and 3.585, respectively. The same factors were significant in time-to-event within six years post stroke with hazard ratio 2.651 and 1.929, respectively.
   Conclusions
   RTW after a stroke is incomplete, however RTW is possible over a longer period of time than previously thought. More severe disability at discharge from hospital and sick leave prior to the stroke were shown to be risk factors for no-RTW. This knowledge can contribute to more individualized vocational rehabilitation.
C1 [Westerlind, Emma; Persson, Hanna C.; Sunnerhagen, Katharina S.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Gothenburg, Sweden.
RP Westerlind, E (reprint author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Gothenburg, Sweden.
EM westerlind.emma@gmail.com
FU Swedish Heart and Lung Foundation; Swedish Brain Foundation
FX This study was funded in part by the Swedish Heart and Lung Foundation
   and the Swedish Brain Foundation.
CR Altman D. G., 1991, PRACTICAL STAT MED R
   Anema JR, 2009, J OCCUP REHABIL, V19, P419, DOI 10.1007/s10926-009-9202-3
   Ayis SA, 2013, J NEUROL NEUROSUR PS, V84, P604, DOI 10.1136/jnnp-2012-303525
   Bonner B, 2016, EUR J NEUROL, V23, P548, DOI 10.1111/ene.12887
   Burstrom K, 2014, QUAL LIFE RES, V23, P431, DOI 10.1007/s11136-013-0496-4
   Busch MA, 2009, J NEUROL NEUROSUR PS, V80, P888, DOI 10.1136/jnnp.2008.163295
   Chang WH, 2016, J REHABIL MED
   Cioncoloni D, 2012, NEUROREHABILITATION, V30, P315, DOI 10.3233/NRE-2012-0761
   Clayton S, 2012, EUR J PUBLIC HEALTH, V22, P434, DOI 10.1093/eurpub/ckr101
   Cumming TB, 2010, CEREBROVASC DIS, V30, P7, DOI 10.1159/000313438
   de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1
   Endo M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009682
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Ghatnekar O, 2014, INT J TECHNOL ASSESS, V30, P203, DOI 10.1017/S0266462314000075
   Hackett ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041795
   Hannerz H, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000180
   Krishnamurthi R.V., 2013, LANCET GLOB HEALTH, V1, pe259, DOI DOI 10.1016/S2214-109X(13)70089-5
   Larsen LP, 2016, J REHABIL MED, V48, P339, DOI 10.2340/16501977-2061
   Larsson J, 2010, SCAND J PUBLIC HEALT, V38, P541, DOI 10.1177/1403494810371143
   Maruthappu M, 2015, INT J STROKE, V10, P364, DOI 10.1111/ijs.12408
   Medin J, 2007, BRAIN INJURY, V21, P457, DOI 10.1080/02699050701317643
   Mishra NK, 2010, STROKE, V41, P2612, DOI 10.1161/STROKEAHA.110.589317
   Nielsen MBD, 2015, EUR J PUBLIC HEALTH, V25, P96, DOI 10.1093/eurpub/cku016
   Persson HC, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-162
   Peters GO, 2013, DISABIL REHABIL, V35, P455, DOI 10.3109/09638288.2012.697251
   Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087
   Riks-Stroke (the Swedish Stroke Register), 2015, ETT EFT STROK
   Roding J, 2010, J REHABIL MED, V42, P155, DOI 10.2340/16501977-0497
   Rosengren A, 2013, STROKE, V44, P2388, DOI 10.1161/STROKEAHA.113.001170
   Singam A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144344
   Stam M, 2013, WORK, V46, P207, DOI 10.3233/WOR-131747
   Tanaka H, 2011, ARCH PHYS MED REHAB, V92, P743, DOI 10.1016/j.apmr.2010.12.009
   Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6
   Treger I, 2007, DISABIL REHABIL, V29, P1397, DOI 10.1080/09638280701314923
   VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604
   Vestling M, 2003, J REHABIL MED, V35, P127, DOI 10.1080/16501970310010475
   Vikholmen K, 2015, ACTA NEUROL SCAND, V132, P329, DOI 10.1111/ane.12404
   Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x
   Wang YC, 2014, WORK, V47, P553, DOI 10.3233/WOR-131627
   Wolfenden B, 2009, INT J REHABIL RES, V32, P93, DOI 10.1097/MRR.0b013e328325a358
   Wozniak MA, 2002, NEUROEPIDEMIOLOGY, V21, P159, DOI 10.1159/000059516
   Young FB, 2005, STROKE, V36, P2187, DOI 10.1161/01.STR.0000181089.41324.70
NR 42
TC 17
Z9 17
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 6
PY 2017
VL 12
IS 1
AR e0169759
DI 10.1371/journal.pone.0169759
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EH3AX
UT WOS:000391641500135
PM 28061507
OA Other Gold, Green Published
DA 2019-06-18
ER

PT J
AU Pelz, JO
   Weinreich, A
   Karlas, T
   Saur, D
AF Pelz, Johann Otto
   Weinreich, Anna
   Karlas, Thomas
   Saur, Dorothee
TI Evaluation of Freehand B-Mode and Power-Mode 3D Ultrasound for
   Visualisation and Grading of Internal Carotid Artery Stenosis
SO PLOS ONE
LA English
DT Article
ID 3-DIMENSIONAL ULTRASOUND; DOPPLER SONOGRAPHY; DIAGNOSTIC STRATEGIES;
   COST-EFFECTIVENESS; ISCHEMIC-STROKE; ENDARTERECTOMY; ANGIOGRAPHY;
   DISEASE
AB Background
   Currently, colour-coded duplex sonography (2D-CDS) is clinical standard for detection and grading of internal carotid artery stenosis (ICAS). However, unlike angiographic imaging modalities, 2D-CDS assesses ICAS by its hemodynamic effects rather than luminal changes. Aim of this study was to evaluate freehand 3D ultrasound (3DUS) for direct visualisation and quantification of ICAS.
   Methods
   Thirty-seven patients with 43 ICAS were examined with 2D-CDS as reference standard and with freehand B-mode respectively power-mode 3DUS. Stenotic value of 3D reconstructed ICAS was calculated as distal diameter respectively distal cross-sectional area (CSA) reduction percentage and compared with 2D-CDS.
   Results
   There was a trend but no significant difference in successful 3D reconstruction of ICAS between B-mode and power mode (examiner 1 {Ex1} 81% versus 93%, examiner 2 {Ex2} 84% versus 88%). Inter-rater agreement was best for power-mode 3DUS and assessment of stenotic value as distal CSA reduction percentage (intraclass correlation coefficient {ICC} 0.90) followed by power-mode 3DUS and distal diameter reduction percentage (ICC 0.81). Inter-rater agreement was poor for B-mode 3DUS (ICC, distal CSA reduction 0.36, distal diameter reduction 0.51). Intra-rater agreement for power-mode 3DUS was good for both measuring methods (ICC, distal CSA reduction 0.88 {Ex1} and 0.78 {Ex2}; ICC, distal diameter reduction 0.83 {Ex1} and 0.76 {Ex2}). In comparison to 2D-CDS inter-method agreement was good and clearly better for power-mode 3DUS (ICC, distal diameter reduction percentage: Ex1 0.85, Ex2 0.78; distal CSA reduction percentage: Ex1 0.63, Ex2 0.57) than for B-mode 3DUS (ICC, distal diameter reduction percentage: Ex1 0.40, Ex2 0.52; distal CSA reduction percentage: Ex1 0.15, Ex2 0.51).
   Conclusions
   Non-invasive power-mode 3DUS is superior to B-mode 3DUS for imaging and quantification of ICAS. Thereby, further studies are warranted which should now compare power-mode 3DUS with the angiographic gold standard imaging modalities for quantification of ICAS, i.e. with CTA or CE-MRA.
C1 [Pelz, Johann Otto; Weinreich, Anna; Saur, Dorothee] Leipzig Univ Hosp, Dept Neurol, Leipzig, Germany.
   [Karlas, Thomas] Leipzig Univ Hosp, Dept Gastroenterol & Rheumatol, Leipzig, Germany.
RP Pelz, JO (reprint author), Leipzig Univ Hosp, Dept Neurol, Leipzig, Germany.
EM johann.pelz@medizin.uni-leipzig.de
RI Saur, Dorothee/C-5900-2019; Karlas, Thomas/I-1782-2019
OI Saur, Dorothee/0000-0002-1808-0913; Karlas, Thomas/0000-0002-8109-8526
CR ALEXANDROV AV, 1993, STROKE, V24, P1292, DOI 10.1161/01.STR.24.9.1292
   Arning C, 2010, ULTRASCHALL MED, V31, P251, DOI 10.1055/s-0029-1245336
   Bendick PJ, 1998, AM J SURG, V176, P183, DOI 10.1016/S0002-9610(98)00165-2
   BLAND JM, 1986, LANCET, V1, P307
   Bucek RA, 2003, AM J NEURORADIOL, V24, P1294
   Buskens E, 2004, RADIOLOGY, V233, P101, DOI 10.1148/radiol.2331030863
   Dodds SR, 2002, EUR J VASC ENDOVASC, V24, P332, DOI 10.1053/ejvs.2002.1729
   Farrell B, 1998, LANCET, V351, P1379
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Fenster A, 2011, INTERFACE FOCUS, V1, P503, DOI 10.1098/rsfs.2011.0019
   Grau AJ, 2001, STROKE, V32, P2559, DOI 10.1161/hs1101.098524
   Halliday A, 2013, EUR J VASC ENDOVASC, V46, P510, DOI 10.1016/j.ejvs.2013.07.020
   Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a
   Kaufmann TJ, 2007, RADIOLOGY, V243, P812, DOI 10.1148/radiol.2433060536
   Keberle M, 2000, J CLIN ULTRASOUND, V28, P441, DOI 10.1002/1097-0096(200011/12)28:9<441::AID-JCU1>3.0.CO;2-D
   Kozakova M, 2001, J AM SOC ECHOCARDIOG, V14, P1203, DOI 10.1067/mje.2001.115619
   MAYBERG MR, 1991, JAMA-J AM MED ASSOC, V266, P3289, DOI 10.1001/jama.266.23.3289
   Merz E, 2015, ULTRASCHALL MED, V36, P3, DOI 10.1055/s-0034-1398866
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   Ota H, 2005, RADIOGRAPHICS, V25, P1141, DOI 10.1143/rg.255055014
   Pelz JO, 2015, ULTRASCHALL MED, V36, P487, DOI 10.1055/s-0034-1398749
   Pfister K, 2009, CLIN HEMORHEOL MICRO, V41, P103, DOI 10.3233/CH-2009-1161
   Portney L. G., 2000, FDN CLIN RES APPL PR, P560
   Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3
   TAYLOR DW, 1991, NEW ENGL J MED, V325, P445
   U-King-Im JM, 2005, ANN NEUROL, V58, P506, DOI 10.1002/ana.20591
   Vicenzini E, 2011, EUR NEUROL, V65, P309, DOI 10.1159/000327694
   von Reutern GM, 2012, STROKE, V43, P916, DOI 10.1161/STROKEAHA.111.636084
   Wardlaw JM, 2006, LANCET, V367, P1503, DOI 10.1016/S0140-6736(06)68650-9
   Wessels T, 2004, STROKE, V35, P1847, DOI 10.1161/01.STR.0000133248.71808.38
   Widder B, 2004, DOPPLER DUPLEXSONOGR, P65
   Widder B, 2004, DOPPLER DUPLEXSONOGR, P166
   Yao JF, 1998, STROKE, V29, P2026, DOI 10.1161/01.STR.29.10.2026
   Zhang WW, 2006, J ENDOVASC THER, V13, P723, DOI 10.1583/06-1921.1
NR 34
TC 2
Z9 2
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 3
PY 2017
VL 12
IS 1
AR e0167500
DI 10.1371/journal.pone.0167500
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EH2QJ
UT WOS:000391612300007
PM 28045903
OA DOAJ Gold, Green Published
DA 2019-06-18
ER

PT J
AU Yang, Y
   Shi, YZ
   Zhang, N
   Wang, S
   Ungvari, GS
   Ng, CH
   Wang, YL
   Zhao, XQ
   Wang, YJ
   Wang, CX
   Xiang, YT
AF Yang, Yang
   Shi, Yu-Zhi
   Zhang, Ning
   Wang, Shuo
   Ungvari, Gabor S.
   Ng, Chee H.
   Wang, Yi-Long
   Zhao, Xing-Quan
   Wang, Yong-Jun
   Wang, Chun-Xue
   Xiang, Yu-Tao
TI The Disability Rate of 5-Year Post-Stroke and Its Correlation Factors: A
   National Survey in China
SO PLOS ONE
LA English
DT Article
ID AUCKLAND STROKE OUTCOMES; PERTH COMMUNITY STROKE; MODIFIED-RANKIN-SCALE;
   LONG-TERM DISABILITY; 1ST-EVER STROKE; COGNITIVE IMPAIRMENT; FUNCTIONAL
   RECOVERY; RECURRENT STROKE; PROGNOSTIC VALUE; NATURAL-HISTORY
AB Few studies on long-term functional outcome have been conducted in post-stroke patients in China. The objective of this study was to conduct a nationwide survey in China to investigate the 5-year prevalence of post-stroke disability and its correlation factors. A total of 893 patients with ischemic stroke were included. Demographic, clinical and neuro-imaging information were collected with standardized instruments that assessed stroke severity, depression, cognitive impairment, stroke recurrence and physical disability. Disability was assessed with the modified Ranking Score (mRS), of which a cutoff score >= 2 indicates disability. Statistical analysis included chi-square tests, two independent samples t-tests, Mann-Whitney U test and multiple logistic regression analysis. The frequency of disability in this study population was 45%. Multivariate analyses revealed that older age, lower education level, previous history of stroke, stroke severity at admission, depression, cognitive impairment at 3 months, and stroke recurrence within 5 years follow up were all significantly associated with post-stroke disability. The disability rate in 5-year post-stroke was high in Chinese patients. Treatment of depression, secondary prevention of stroke and rehabilitation may benefit disabled patients with stroke in China.
C1 [Yang, Yang; Shi, Yu-Zhi; Zhang, Ning; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurol, Beijing, Peoples R China.
   [Yang, Yang; Zhang, Ning; Wang, Chun-Xue] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neuropsychiat & Behav Neurol & Clin Psychol, Beijing, Peoples R China.
   [Yang, Yang; Shi, Yu-Zhi; Zhang, Ning; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.
   [Yang, Yang; Shi, Yu-Zhi; Zhang, Ning; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue] Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China.
   [Yang, Yang; Shi, Yu-Zhi; Zhang, Ning; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China.
   [Ungvari, Gabor S.] Univ Notre Dame Australia, Marian Ctr, Perth, WA, Australia.
   [Ungvari, Gabor S.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA, Australia.
   [Ng, Chee H.] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia.
   [Xiang, Yu-Tao] Univ Macau, Fac Hlth Sci, Unit Psychiat, Macau, Macao Sar, Peoples R China.
RP Wang, CX (reprint author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurol, Beijing, Peoples R China.; Wang, CX (reprint author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neuropsychiat & Behav Neurol & Clin Psychol, Beijing, Peoples R China.; Wang, CX (reprint author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.; Wang, CX (reprint author), Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China.; Wang, CX (reprint author), Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China.; Xiang, YT (reprint author), Univ Macau, Fac Hlth Sci, Unit Psychiat, Macau, Macao Sar, Peoples R China.
EM snowsen@126.com; xyutly@gmail.com
FU Ministry of Science and Technology; Ministry of Health of the People's
   Republic of China; National 11th & 12th Five-year S & T Major Project
   [2006BAI01A11, 2011BAI08B01, 2011BAI08B02]; National Key Technology
   Research and Development Program of the Ministry of Science and
   Technology of China [2013BAI09B03]; Ministry of Science and Technology
   of the People's Republic of China [2012ZX09303-005-001]; Beijing
   Institute for Brain Disorders [BIBD-PXM2013_014226_07_000084]; Beijing
   Biobank of Cerebral Vascular Disease [D131100005313003]; Beijing Brain
   Research [Z161100000216131]; Beijing Municipal Science & Technology
   Commission [Z151100004015127, Z151100003915117]
FX This study was funded by the Ministry of Science and Technology and the
   Ministry of Health of the People's Republic of China. Individual grants
   include the National 11th & 12th Five-year S & T Major Project
   (2006BAI01A11, 2011BAI08B01, 2011BAI08B02), the National Key Technology
   Research and Development Program of the Ministry of Science and
   Technology of China (2013BAI09B03), the Ministry of Science and
   Technology of the People's Republic of China (2012ZX09303-005-001),
   Beijing Institute for Brain Disorders (BIBD-PXM2013_014226_07_000084),
   Beijing Biobank of Cerebral Vascular Disease (D131100005313003), Beijing
   Brain Research (Z161100000216131) and Beijing Municipal Science &
   Technology Commission (Z151100004015127 and Z151100003915117).
CR Ayerbe L, 2014, J NEUROL NEUROSUR PS, V85, P514, DOI 10.1136/jnnp-2013-306448
   Ayerbe L, 2013, STROKE, V44, P1105, DOI 10.1161/STROKEAHA.111.679340
   Ayerbe L, 2013, BRIT J PSYCHIAT, V202, P14, DOI 10.1192/bjp.bp.111.107664
   Barker-Collo S, 2010, NEUROLOGY, V75, P1608, DOI 10.1212/WNL.0b013e3181fb44c8
   Dhamoon MS, 2015, NEUROLOGY, V84, P1002, DOI 10.1212/WNL.0000000000001331
   Dhamoon MS, 2009, STROKE, V40, P2805, DOI 10.1161/STROKEAHA.109.549576
   Dong YH, 2012, J NEUROL NEUROSUR PS, V83, P580, DOI 10.1136/jnnp-2011-302070
   Donnellan C, 2010, INT J GERIATR PSYCH, V25, P1288, DOI 10.1002/gps.2482
   Feigin VL, 2010, NEUROLOGY, V75, P1597, DOI 10.1212/WNL.0b013e3181fb44b3
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   First MB, 1994, DIAGNOSTIC STAT MANU, V1994
   FOLSTEIN MF, 1977, J NEUROL NEUROSUR PS, V40, P1018, DOI 10.1136/jnnp.40.10.1018
   Ghosal MK, 2014, J STROKE CEREBROVASC, V23, P2614, DOI 10.1016/j.jstrokecerebrovasdis.2014.06.001
   HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56
   Hankey GJ, 2002, STROKE, V33, P1034, DOI 10.1161/01.STR.0000012515.66889.24
   Hardie K, 2004, STROKE, V35, P731, DOI 10.1161/01.STR.0000116183.50167.D9
   Huybrechts KF, 2008, CEREBROVASC DIS, V26, P381, DOI 10.1159/000151678
   Jia Q, 2011, STROKE, V42, P2758, DOI 10.1161/STROKEAHA.111.621649
   Jokinen H, 2015, EUR J NEUROL, V22, P1288, DOI 10.1111/ene.12743
   Jonsson AC, 2014, STROKE, V45, P1784, DOI 10.1161/STROKEAHA.114.005164
   Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9
   Knoflach M, 2012, NEUROLOGY, V78, P279, DOI 10.1212/WNL.0b013e31824367ab
   KUNITZ SC, 1984, STROKE, V15, P740, DOI 10.1161/01.STR.15.4.740
   Kutlubaev MA, 2014, INT J STROKE, V9, P1026, DOI 10.1111/ijs.12356
   Liman TG, 2012, J NEUROL, V259, P1125, DOI 10.1007/s00415-011-6312-6
   Liman TG, 2011, DEMENT GERIATR COGN, V31, P291, DOI 10.1159/000327358
   LYDEN P, 1994, STROKE, V25, P2220, DOI 10.1161/01.STR.25.11.2220
   Middleton LE, 2014, NEUROREHABILITATION, V34, P305, DOI 10.3233/NRE-131030
   Moon HI, 2016, NEURORADIOLOGY, V58, P723, DOI 10.1007/s00234-016-1672-3
   Narasimhalu K, 2011, STROKE, V42, P883, DOI 10.1161/STROKEAHA.110.594671
   Nys GMS, 2005, NEUROLOGY, V64, P821, DOI 10.1212/01.WNL.0000152984.28420.5A
   Park JH, 2016, EUR J NEUROL, V23, P361, DOI 10.1111/ene.12837
   Quinn TJ, 2009, INT J STROKE, V4, P200, DOI 10.1111/j.1747-4949.2009.00271.x
   Ullberg T, 2015, STROKE, V46, P389, DOI 10.1161/STROKEAHA.114.006538
   Uyttenboogaart M, 2005, STROKE, V36, P1984, DOI 10.1161/01.STR.0000177872.87960.61
   Wallace D, 2002, J CLIN EPIDEMIOL, V55, P922, DOI 10.1016/S0895-4356(02)00410-9
   WOO J, 1992, NEUROEPIDEMIOLOGY, V11, P143, DOI 10.1159/000110924
   Wu LY, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0505-z
   Zhang N, 2012, CNS NEUROSCI THER, V18, P475, DOI 10.1111/j.1755-5949.2012.00312.x
   ZHENG YP, 1988, BRIT J PSYCHIAT, V152, P660, DOI 10.1192/bjp.152.5.660
NR 40
TC 7
Z9 8
U1 1
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 8
PY 2016
VL 11
IS 11
AR e0165341
DI 10.1371/journal.pone.0165341
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EB8BE
UT WOS:000387615200017
PM 27824877
OA DOAJ Gold, Green Published
DA 2019-06-18
ER

PT J
AU Gong, WW
   Wei, XL
   Liang, YJ
   Zou, GY
   Hu, RY
   Deng, SM
   Zhang, ZT
   Pan, J
   Choi, BCK
   Yu, M
AF Gong, Weiwei
   Wei, Xiaolin
   Liang, Yujia
   Zou, Guanyang
   Hu, Ruying
   Deng, Simin
   Zhang, Zhitong
   Pan, Jing
   Choi, Bernard C. K.
   Yu, Min
TI Urban and Rural Differences of Acute Cardiovascular Disease Events: A
   Study from the Population-Based Real-Time Surveillance System in
   Zhejiang, China in 2012
SO PLOS ONE
LA English
DT Article
ID CORONARY-HEART-DISEASE; STROKE INCIDENCE; GLOBAL BURDEN; EPIDEMIOLOGY;
   RISK; PREVALENCE; MORTALITY; MIDDLE; COMMUNITIES; SUBTYPES
AB Zhejiang province, China, has implemented a population based, real-time surveillance system that tracks acute cardiovascular diseases (CVDs) events since 2001. This study aimed to describe the system and report CVD incidence, mortality and case-fatality between urban and rural areas in Zhejiang in 2012. The surveillance system employs a stratified random sampling method covering all permanent residents of 30 counties/districts in Zhejiang. Acute CVD events such as coronary heart disease (CHD) and stroke were defined, registered and reviewed based on the adapted MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) definitions. Data were collected from health facilities, vital registries, supplementary surveys, and additional investigations, and were checked for data quality before input in the system. We calculated the rates and compared them by gender, age and region. In 2012, the incidence, mortality and case-fatality of total acute CVD events were 367.0 (CHD 59.1, stroke 307.9), 127.1 (CHD 43.3, stroke 83.8) per 100,000 and 34.6% (CHD 73.2%, stroke 27.2%), respectively. Compared with rural areas, urban areas reported higher incidence and mortality but lower case-fatality rates for CHD (P<0.001), while lower incidence but higher mortality and case-fatality rates for stroke (P<0.001). We found significant differences on CHD and stroke epidemics between urban and rural areas in Zhejiang. Special attentions need to be given to stroke control, especially in rural areas.
C1 [Gong, Weiwei; Hu, Ruying; Pan, Jing; Yu, Min] Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.
   [Wei, Xiaolin; Choi, Bernard C. K.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Clin Publ Hlth, Toronto, ON, Canada.
   [Wei, Xiaolin; Choi, Bernard C. K.] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
   [Liang, Yujia; Zou, Guanyang; Deng, Simin; Zhang, Zhitong] China Global Hlth Res & Dev, Shenzhen, Peoples R China.
RP Yu, M (reprint author), Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.
EM myu@cdc.zj.com
FU UK aid from the UK government; Department for International Development
   (DFID) [201025]
FX The authors would like to thank the county and municipality CDC,
   hospitals and health care facilities in Zhejiang who reported and
   quality checked the cardiovascular events. We also thank Nilam
   Ashra-McGrath for editorial support. This study obtained data-analysis
   guidance from COMDIS-HSD, a research consortium funded by UK aid from
   the UK government: however, the views expressed do not necessarily
   reflect the UK government's official policies.
CR Ahmad OB, 2001, AGE STANDARDIZATION
   Allender S., 2012, CORONARY HEART DIS S
   [Anonymous], 2015, RAIS BLOOD PRESS SBP
   Barrett-Connor Elizabeth, 2011, NATIONWIDE FRAMEWORK
   Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182
   Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE
   Diseases CNCfC, 2012, REP CARD DIS CHIN
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0
   Giampaoli S, 2007, EUR J CARDIOV PREV R, V14, pS23, DOI 10.1097/01.hjr.0000277987.10473.6f
   Hata J, 2013, CIRC J, V77, P1923, DOI 10.1253/circj.CJ-13-0786
   Koton S, 2014, JAMA-J AM MED ASSOC, V312, P259, DOI 10.1001/jama.2014.7692
   Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755
   Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2
   Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261
   Mendis S, 2011, GLOBAL ATLAS CARDIOV
   Moran A. E., 2014, CIRCULATION
   Moran A, 2010, CIRC-CARDIOVASC QUAL, V3, P243, DOI 10.1161/CIRCOUTCOMES.109.910711
   OECD, 2011, HOSP MORT FOLL AC MY
   Ounpuu S, 2001, AM HEART J, V141, P711, DOI 10.1067/mhj.2001.114974
   Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046
   Statistics ZPBo, 2013, STAT YB ZHEJ
   Sun HX, 2013, J STROKE, V15, P109, DOI 10.5853/jos.2013.15.2.109
   Tang X, 2013, J AM COLL CARDIOLOGY, V61
   Teo K, 2013, JAMA-J AM MED ASSOC, V309, P1613, DOI 10.1001/jama.2013.3519
   Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019
   Tsai CF, 2013, NEUROLOGY, V81, P264, DOI 10.1212/WNL.0b013e31829bfde3
   Turin TC, 2007, CIRC J, V71, P1617, DOI 10.1253/circj.71.1617
   Wang JH, 2015, NEUROLOGY, V84, P374, DOI 10.1212/WNL.0000000000001175
   WANG Xiao-ping WY-k, 2007, CHINESE PRIMARY HLTH, V21
   Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x
   Wegner M. V., 2010, Chronic disease epidemiology and control, P95
   Wei XL, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-354
   Wei XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054169
   WHO, TOB US DAT COUNTR
   WHO, 1999, WHO MONICA MAN
   Wu YF, 2006, CIRCULATION, V114, P2217, DOI 10.1161/CIRCULATIONAHA.105.607499
   Wu ZS, 2001, CIRCULATION, V103, P462
   Xu H, 2015, AM HEART J
   Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1
   [俞敏 Yu Min], 2002, [中国卫生统计, Chinese Journal of Health Statistics], V19, P151
   Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9
   Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C
   Zhang XH, 2008, HEART, V94, P1126, DOI 10.1136/hrt.2007.132423
   Zhang Y, 2012, STROKE RES TREATMENT, V2012
NR 45
TC 2
Z9 2
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 1
PY 2016
VL 11
IS 11
AR e0165647
DI 10.1371/journal.pone.0165647
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EA6CX
UT WOS:000386714200033
PM 27802321
OA DOAJ Gold, Green Published
DA 2019-06-18
ER

PT J
AU Kim, J
   Choi, GH
   Ko, KH
   Kim, JO
   Oh, SH
   Park, YS
   Kim, OJ
   Kim, NK
AF Kim, Jinkwon
   Choi, Gun Ho
   Ko, Ki Han
   Kim, Jung Oh
   Oh, Seung Hun
   Park, Young Seok
   Kim, Ok Joon
   Kim, Nam Keun
TI Association of the Single Nucleotide Polymorphisms in microRNAs 130b,
   200b, and 495 with Ischemic Stroke Susceptibility and Post-Stroke
   Mortality
SO PLOS ONE
LA English
DT Article
ID HUMAN PLATELET MICRORNA; CARDIOVASCULAR-DISEASE; EXPRESSION;
   MEGAKARYOCYTOPOIESIS; INFLAMMATION; BIOGENESIS; ACTIVATION; MIR-196A2;
   NETWORKS; MIR-146A
AB The microRNA (miRNA) is a small non-coding RNA molecule that modulates gene expression at the posttranscriptional level. Platelets have a crucial role in both hemostasis and thrombosis, a condition that can occlude a cerebral artery and cause ischemic stroke. miR-130b, miR-200b, and miR-495 are potential genetic modulators involving platelet production and activation. We hypothesized that single nucleotide polymorphisms (SNPs) in these miRNAs might potentially contribute to the susceptibility to ischemic stroke and post-stroke mortality. This study included 523 ischemic stroke patients and 400 control subjects. We investigated the association of three miRNA SNPs (miR-130bT>C, miR-200bT>C, and miR-495A>C) with ischemic stroke prevalence and post-stroke mortality. In the multivariate logistic regression, there was no statistically significant difference in the distribution of miR-130bT>C, miR-200bT>C, or miR-495A>C between the ischemic stroke and control groups. In the subgroup analysis based on ischemic stroke subtype, the miR-200b CC genotype was less frequently found in the large-artery atherosclerosis stroke subtype compared with controls (TT+CT vs CC; adjusted odds ratio for CC, 0.506; 95% confidence interval, 0.265-0.965). During a mean follow-up period of 4.80 +/- 2.11 years after stroke onset, there were 106 all-cause deaths among the 523 stroke patients. Multivariate Cox regression analysis did not find a significant association between post-stroke mortality and three miRNA SNPs. Our findings suggest that the functional SNP of miR-200b might be responsible for the susceptibility to large-artery atherosclerotic stroke.
C1 [Kim, Jinkwon; Oh, Seung Hun; Kim, Ok Joon] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Neurol, Songnam 13496, South Korea.
   [Choi, Gun Ho; Ko, Ki Han; Kim, Jung Oh; Kim, Nam Keun] CHA Univ, Sch Med, CHA Bundang Med Ctr, Inst Clin Res, Songnam 13496, South Korea.
   [Park, Young Seok] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Dept Neurosurg, Cheongju 28644, South Korea.
   [Kim, Nam Keun] CHA Univ, Coll Life Sci, Dept Biomed Sci, 335 Pangyo Ro, Songnam 13488, South Korea.
RP Kim, OJ (reprint author), CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Neurol, Songnam 13496, South Korea.; Kim, NK (reprint author), CHA Univ, Sch Med, CHA Bundang Med Ctr, Inst Clin Res, Songnam 13496, South Korea.; Kim, NK (reprint author), CHA Univ, Coll Life Sci, Dept Biomed Sci, 335 Pangyo Ro, Songnam 13488, South Korea.
EM okjun77@cha.ac.kr; nkkim@cha.ac.kr
RI Kim, Jinkwon/N-1878-2018
OI Kim, Jinkwon/0000-0003-0156-9736
FU grant of the Korea Healthcare technology RD Project [HI15C1972010015,
   HI16C1559]; Ministry for Health, Welfare & Family Affairs, Republic of
   Korea; Basic Science Research Program through National Research
   Foundation of Korea Grants - Korean Government, Republic of Korea
   [2014R1A1A1002067, 2015R1D1A1A09057432]
FX This study was partly supported by a grant of the Korea Healthcare
   technology R&D Project (HI15C1972010015 and HI16C1559), Ministry for
   Health, Welfare & Family Affairs, Republic of Korea and by Basic Science
   Research Program through National Research Foundation of Korea Grants
   funded by the Korean Government (2014R1A1A1002067, 2015R1D1A1A09057432),
   Republic of Korea. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35
   Akbiyik F, 2004, BLOOD, V104, P1361, DOI 10.1182/blood-2004.03.0926
   Bray PF, 2007, HEMATOL ONCOL CLIN N, V21, P633, DOI 10.1016/j.hoc.2007.06.002
   Chu SG, 2010, J THROMB HAEMOST, V8, P148, DOI 10.1111/j.1538-7836.2009.03584.x
   Colangelo T, 2013, NEOPLASIA, V15, P1204, DOI 10.1593/neo.13998
   Cui L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089019
   Dangwal S, 2012, THROMB HAEMOSTASIS, V108, P599, DOI 10.1160/TH12-03-0211
   Duan XM, 2014, J DIABETES COMPLICAT, V28, P705, DOI 10.1016/j.jdiacomp.2014.04.012
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Fuentes E, 2015, LIFE SCI, V133, P29, DOI 10.1016/j.lfs.2015.04.016
   Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103
   Gatsiou A, 2012, CURR VASC PHARMACOL, V10, P524, DOI 10.2174/157016112801784611
   Harker LA, 1998, SEMIN HEMATOL, V35, P241
   Hong KS, 2013, J STROKE, V15, P2, DOI 10.5853/jos.2013.15.1.2
   Huan TX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7601
   Huang SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117007
   Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936
   IWAMOTO T, 1995, STROKE, V26, P52, DOI 10.1161/01.STR.26.1.52
   Jeon YJ, 2013, ARTERIOSCL THROM VAS, V33, P420, DOI 10.1161/ATVBAHA.112.300251
   Kaplan ZS, 2011, HEMATOL-AM SOC HEMAT, P51, DOI 10.1182/asheducation-2011.1.51
   Kondkar AA, 2010, J THROMB HAEMOST, V8, P369, DOI 10.1111/j.1538-7836.2009.03700.x
   Laffont B, 2013, BLOOD, V122, P253, DOI 10.1182/blood-2013-03-492801
   Landry P, 2009, NAT STRUCT MOL BIOL, V16, P961, DOI 10.1038/nsmb.1651
   Li HY, 2011, BRIT J HAEMATOL, V155, P298, DOI 10.1111/j.1365-2141.2011.08859.x
   McManus DD, 2015, NAT REV CARDIOL, V12, P711, DOI 10.1038/nrcardio.2015.101
   Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719
   Obsteter J, 2015, MOL GENET GENOM MED, V3, P30, DOI 10.1002/mgg3.110
   Opalinska JB, 2010, BLOOD, V116, pE128, DOI 10.1182/blood-2010-06-292920
   Osman A, 2011, PLATELETS, V22, P433, DOI 10.3109/09537104.2011.560305
   Rieger JK, 2015, DRUG METAB DISPOS, V43, P884, DOI 10.1124/dmd.114.062844
   Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867
   Salomonis N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000553
   Sevinsky JR, 2004, MOL CELL BIOL, V24, P4534, DOI 10.1128/MCB.24.10.4534-4545.2004
   Simon LM, 2014, BLOOD, V123, pE37, DOI 10.1182/blood-2013-12-544692
   Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706
   Slaby O, 2012, J CELL MOL MED, V16, P8, DOI 10.1111/j.1582-4934.2011.01359.x
   Stakos DA, 2013, PLATELETS, V24, P579, DOI 10.3109/09537104.2012.724483
   Suresh S, 2011, J CELL COMMUN SIGNAL, V5, P183, DOI 10.1007/s12079-011-0139-x
   Undi Ram Babu, 2013, Adv Hematol, V2013, P695754, DOI 10.1155/2013/695754
   van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864
   Weng Z, 2010, BLOOD, V116, P2579, DOI 10.1182/blood-2010-03-277236
   Yu TT, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1031-5
   Zhang ZZ, 2017, MOL NEUROBIOL, V54, P2776, DOI 10.1007/s12035-016-9865-7
   Zhu RX, 2014, NEUROCHEM RES, V39, P1709, DOI 10.1007/s11064-014-1364-5
NR 44
TC 9
Z9 9
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 7
PY 2016
VL 11
IS 9
AR e0162519
DI 10.1371/journal.pone.0162519
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV9IX
UT WOS:000383255200073
PM 27603512
OA Other Gold, Green Published
DA 2019-06-18
ER

PT J
AU Chwojnicki, K
   Krol, E
   Wierucki, L
   Kozera, G
   Sobolewski, P
   Nyka, WM
   Zdrojewski, T
AF Chwojnicki, Kamil
   Krol, Ewa
   Wierucki, Lukasz
   Kozera, Grzegorz
   Sobolewski, Piotr
   Nyka, Walenty M.
   Zdrojewski, Tomasz
TI Renal Dysfunction in Post-Stroke Patients
SO PLOS ONE
LA English
DT Article
ID CHRONIC KIDNEY-DISEASE; STROKE; RISK; EPIDEMIOLOGY; PREVALENCE;
   PREDICTORS; COMMUNITY; URBAN
AB Background
   The presence of chronic kidney disease (CKD) is an indicator of a worse long-term prognosis in patients with ischemic stroke (IS). Unfortunately, not much is known about renal function in the population of post-IS subjects. The aim of our study was to assess the prevalence of renal damage and impaired renal function (IRF) in the population of post-IS subjects.
   Methods
   This prospective analysis concerned 352 consecutive post-IS survivors hospitalized in Pomeranian stroke centers (Poland) in 2009. In this group estimated glomerular filtration rate (eGFR) according to MDRD (modification of diet in renal diseases) and CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) formulas and urine albumin/creatinine ratio (ACR) were determined.
   Results
   Among survivors decreased eGFR (<60 mL/min./1.73m(2) according to MDRD or CKD-EPI) or ACR >= 30mg/g were detected in 40.38% (23.07% Men, 55.32% Women; P<0.01). The highest prevalence of IRF was noted in post-IS subjects with atheromatic and lacunar IS. In multivariate analysis the ACR >= 30mg/g was predicted by older age, diabetes mellitus (DM) and physical disability (modified Rankin scale 3-5 pts.). The association with reduced eGFR was proved for sex (female), DM and physical disability.
   Conclusions
   CKD is a frequently occurring problem in the group of post-IS subjects, especially after lacunar and atheromatic IS. Post-IS patients, mainly the elderly women, with physical disability and diabetes mellitus, should be regularly screened for CKD. This could reduce the risk of further cardiovascular events and delay the progression of IRF.
C1 [Chwojnicki, Kamil; Kozera, Grzegorz; Nyka, Walenty M.] Med Univ Gdansk, Dept Neurol, Gdansk, Poland.
   [Krol, Ewa] Med Univ Gdansk, Dept Nephrol, Gdansk, Poland.
   [Wierucki, Lukasz; Zdrojewski, Tomasz] Med Univ Gdansk, Dept Arterial Hypertens & Diabetol, Gdansk, Poland.
   [Sobolewski, Piotr] Hosp Sandomierz, Dept Neurol, Sandomierz, Poland.
   [Sobolewski, Piotr] Hosp Sandomierz, Stroke Unit, Sandomierz, Poland.
RP Chwojnicki, K (reprint author), Med Univ Gdansk, Dept Neurol, Gdansk, Poland.
EM kchwoj@gumed.edu.pl
OI Zdrojewski, Tomasz/0000-0001-6015-8561; Chwojnicki,
   Kamil/0000-0002-1361-8796
FU Office of the Marshal of Pomeranian Voivodeship, Poland
FX This work was supported by Office of the Marshal of Pomeranian
   Voivodeship, Poland.
CR ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35
   Al-Aly Z, 2010, J AM SOC NEPHROL, V21, P1961, DOI 10.1681/ASN.2009121210
   [Anonymous], 2009, FRES MED CAR 2010, P3
   Bao YS, 2013, EUR J CLIN INVEST, V43, P829, DOI 10.1111/eci.12113
   Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560
   Chudek J, 2013, NEPHROL DIAL TRANSPL, P1
   Fabjan T, EUROPEAN J NEUROLOGY, V14, P1351
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844
   Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4
   Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421
   Hung PH, 2014, NEPHROL DIAL TRANSPL, V29, P873, DOI 10.1093/ndt/gft534
   Kozera G, 2012, ACTA NEUROL SCAND, V126, P171, DOI 10.1111/j.1600-0404.2011.01616.x
   Krol E, 2009, AM J NEPHROL, V29, P264, DOI 10.1159/000158526
   Kumai Y, 2012, NEUROLOGY, V78, P1909, DOI 10.1212/WNL.0b013e318259e110
   Lee M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4249
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   MacWalter RS, 2002, STROKE, V33, P1630, DOI 10.1161/01.STR.0000016344.49819.F7
   Missouris CG, 1998, NEPHROL DIAL TRANSPL, V13, P945, DOI 10.1093/ndt/13.4.945
   Ninomiya T, 2009, AM J KIDNEY DIS, V53, P417, DOI 10.1053/j.ajkd.2008.08.032
   Oksala NKJ, 2010, STROKE, V41, P1914, DOI 10.1161/STROKEAHA.110.587352
   Rutkowski B., 2010, PRZEW LEK, V2, P64
   Rutkowski B, 2009, REPORT RENAL REPLACE
   SACCO RL, 1994, NEUROLOGY, V44, P626, DOI 10.1212/WNL.44.4.626
   Tanner RM, 2013, AM J KIDNEY DIS, V61, P395, DOI 10.1053/j.ajkd.2012.10.018
   Tsagalis G, 2009, NEPHROL DIAL TRANSPL, V24, P194, DOI 10.1093/ndt/gfn471
   Tsukamoto Y, 2012, J STROKE CEREBROVASC, V21, P547, DOI 10.1016/j.jstrokecerebrovasdis.2010.12.005
   US Renal Data System, 2008, USRDS 2008 ANN DAT R
   USRDS, 2010, US REN DAT SYST 2010
   VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604
   WHO Monica Project Investigators, 1988, J CLIN EPIDEMIOL, V41, P105, DOI DOI 10.1016/0895-4356(88)90084-4
   Yahalom G, 2009, STROKE, V40, P1296, DOI 10.1161/STROKEAHA.108.520882
   2002, AM J KIDNEY DIS, V39, P1, DOI DOI 10.1053/AJKD.2002.29865
NR 34
TC 4
Z9 4
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 30
PY 2016
VL 11
IS 8
AR e0159775
DI 10.1371/journal.pone.0159775
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV4EE
UT WOS:000382877200004
PM 27575370
OA DOAJ Gold, Green Published
DA 2019-06-18
ER

PT J
AU Peng, CY
   Chen, YC
   Cui, Y
   Zhao, DL
   Jiao, Y
   Tang, TY
   Ju, SH
   Teng, GJ
AF Peng, Cheng-Yu
   Chen, Yu-Chen
   Cui, Ying
   Zhao, Deng-Ling
   Jiao, Yun
   Tang, Tian-Yu
   Ju, Shenghong
   Teng, Gao-Jun
TI Regional Coherence Alterations Revealed by Resting-State fMRI in
   Post-Stroke Patients with Cognitive Dysfunction
SO PLOS ONE
LA English
DT Article
ID DEFAULT-MODE NETWORK; ALTERED SPONTANEOUS ACTIVITY; DIGIT MODALITIES
   TEST; SUBCORTICAL STROKE; CINGULATE CORTEX; ISCHEMIC-STROKE; BASAL
   GANGLIA; IMPAIRMENT; DEMENTIA; HOMOGENEITY
AB Objectives
   Post-stroke cognitive dysfunction greatly influences patients' quality of life after stroke. However, its neurophysiological basis remains unknown. This study utilized resting-state functional magnetic resonance imaging (fMRI) to investigate the alterations in regional coherence in patients after subcortical stroke.
   Methods
   Resting-state fMRI measurements were acquired from 16 post-stroke patients with poor cognitive function (PSPC), 16 post-stroke patients with good cognitive function (PSGC) and 30 well-matched healthy controls (HC). Regional homogeneity (ReHo) was used to detect alterations in regional coherence. Abnormalities in regional coherence correlated with scores on neuropsychological scales.
   Results
   Compared to the HC and the PSGC, the PSPC showed remarkably decreased ReHo in the bilateral anterior cingulate cortex and the left posterior cingulate cortex/precuneus. ReHo in the bilateral anterior cingulate cortex positively correlated with the scores on the Symbol Digit Modalities Test (r = 0.399, P = 0.036) and the Complex Figure Test-delayed recall subtest (r = 0.397, P = 0.036) in all post-stroke patients. Moreover, ReHo in the left posterior cingulate cortex/precuneus positively correlated with the scores on the Forward Digit Span Test (r = 0.485, P = 0.009) in all post-stroke patients.
   Conclusions
   Aberrant regional coherence was observed in the anterior and posterior cingulate cortices in post-stroke patients with cognitive dysfunction. ReHo could represent a promising indicator of neurobiological deficiencies in post-stroke patients.
C1 [Peng, Cheng-Yu; Cui, Ying; Jiao, Yun; Tang, Tian-Yu; Ju, Shenghong; Teng, Gao-Jun] Southeast Univ, Sch Med, Jiangsu Key Lab Mol & Funct Imaging, Nanjing, Jiangsu, Peoples R China.
   [Peng, Cheng-Yu; Cui, Ying; Zhao, Deng-Ling; Ju, Shenghong; Teng, Gao-Jun] Southeast Univ, Sch Med, Zhongda Hosp, Dept Radiol, Nanjing, Jiangsu, Peoples R China.
   [Chen, Yu-Chen] Nanjing Med Univ, Nanjing Hosp 1, Dept Radiol, Nanjing, Jiangsu, Peoples R China.
RP Teng, GJ (reprint author), Southeast Univ, Sch Med, Jiangsu Key Lab Mol & Funct Imaging, Nanjing, Jiangsu, Peoples R China.; Teng, GJ (reprint author), Southeast Univ, Sch Med, Zhongda Hosp, Dept Radiol, Nanjing, Jiangsu, Peoples R China.
EM gjteng@vip.sina.com
FU National Key Basic Research Program (973 Program) [2013CB733800,
   2013CB733803]; National Natural Science Foundation of China
   [81520108015, 81230034, 81271739]; Jiangsu Provincial Special Program of
   Medical Science [BL2013029]; Key Project of Jiangsu Province Natural
   Science Foundation of China [BK20130577]
FX Funding provided by the National Key Basic Research Program (973
   Program) (nos. 2013CB733800 and 2013CB733803;
   http://program.most.gov.cn/), the National Natural Science Foundation of
   China (nos. 81520108015, 81230034 and 81271739;
   https://isisn.nsfc.gov.cn/egrantweb/), Jiangsu Provincial Special
   Program of Medical Science (no. BL2013029; http://www.jstd.gov.cn/) and
   Key Project of Jiangsu Province Natural Science Foundation of China (no.
   BK20130577; http://www.jstd.gov.cn/). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Amtul Z, 2014, NEUROBIOL AGING, V35, P1605, DOI 10.1016/j.neurobiolaging.2014.01.005
   Ballard C, 2003, STROKE, V34, P2440, DOI 10.1161/01.STR.0000089923.29724.CE
   Brainin M, 2015, EUR J NEUROL, V22, P229, DOI 10.1111/ene.12626
   Brown AM, 2005, COMPUT METH PROG BIO, V79, P89, DOI 10.1016/j.cmpb.2005.02.007
   Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002
   Chen YC, 2015, NEURAL PLAST, DOI 10.1155/2015/475382
   Dacosta-Aguayo R, 2014, HUM BRAIN MAPP, V35, P3819, DOI 10.1002/hbm.22439
   Dacosta-Aguayo R, 2015, HUM BRAIN MAPP, V36, P577, DOI 10.1002/hbm.22648
   Desmond DW, 1996, STROKE, V27, P1798, DOI 10.1161/01.STR.27.10.1798
   Desmond DW, 2002, STROKE, V33, P2254, DOI 10.1161/01STR00000282359177895
   Ding X, 2014, NEUROSCIENCE, V277, P637, DOI 10.1016/j.neuroscience.2014.07.060
   Fan FM, 2013, HUM BRAIN MAPP, V34, P1872, DOI 10.1002/hbm.22034
   FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Fellows LK, 2005, BRAIN, V128, P788, DOI 10.1093/brain/awh405
   Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201
   Gabrieli JDE, 1996, P NATL ACAD SCI USA, V93, P13534, DOI 10.1073/pnas.93.24.13534
   Galea M, 2005, AUST J PHYSIOTHER, V51, P198, DOI 10.1016/S0004-9514(05)70034-9
   Gold G, 2005, STROKE, V36, P1184, DOI 10.1161/01.STR.0000166052.89772.b5
   Guo J, 2014, CLIN NEUROPHYSIOL, V125, P520, DOI 10.1016/j.clinph.2013.08.010
   Ismail Z, 2010, INT J GERIATR PSYCH, V25, P111, DOI 10.1002/gps.2306
   Jiang L, 2013, NEURAL PLAST, DOI 10.1155/2013/924192
   Kiely KM, 2014, ARCH CLIN NEUROPSYCH, V29, P767, DOI 10.1093/arclin/acu055
   Kim Hae-Young, 2015, Restor Dent Endod, V40, P91, DOI 10.5395/rde.2015.40.1.91
   Koh CL, 2011, ARCH CLIN NEUROPSYCH, V26, P356, DOI 10.1093/arclin/acr029
   Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005
   Lee MJ, 2014, JAMA PSYCHIAT, V71, P412, DOI 10.1001/jamapsychiatry.2013.4506
   Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162
   Li W, 2013, NEURAL PLAST, DOI 10.1155/2013/452439
   Liu JC, 2014, J NEUROL SCI, V347, P193, DOI 10.1016/j.jns.2014.08.049
   Liu ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099175
   Mantini D, 2013, NEUROSCIENTIST, V19, P76, DOI 10.1177/1073858412446202
   Park JY, 2014, EUR J NEUROSCI, V40, P2715, DOI 10.1111/ejn.12640
   Pena-Garijo J, 2011, REV NEUROLOGIA, V53, P77, DOI 10.33588/rn.5302.2010767
   Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676
   Rehme AK, 2015, CEREB CORTEX, V25, P3046, DOI 10.1093/cercor/bhu100
   Sachdev PS, 2006, DEMENT GERIATR COGN, V21, P275, DOI 10.1159/000091434
   Sachdev PS, 2014, J NEUROL NEUROSUR PS, V85, P1324, DOI 10.1136/jnnp-2013-306776
   Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B
   Stephens S, 2004, INT J GERIATR PSYCH, V19, P1053, DOI 10.1002/gps.1209
   Tiffin-Richards FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106700
   Tuladhar AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066556
   Wang CH, 2014, J CEREBR BLOOD F MET, V34, P597, DOI 10.1038/jcbfm.2013.238
   Wang X, 2013, NEUROSCIENCE, V236, P281, DOI 10.1016/j.neuroscience.2012.12.074
   Yamamoto Daisuke, 2011, Nihon Rinsho, V69 Suppl 8, P403
   Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030
   Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049
   Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017
NR 48
TC 3
Z9 3
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 25
PY 2016
VL 11
IS 7
AR e0159574
DI 10.1371/journal.pone.0159574
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT5ID
UT WOS:000381515200030
PM 27454170
OA Green Published, Other Gold
DA 2019-06-18
ER

PT J
AU Kim, WS
   Cho, S
   Baek, D
   Bang, H
   Paik, NJ
AF Kim, Won-Seok
   Cho, Sungmin
   Baek, Dongyoub
   Bang, Hyunwoo
   Paik, Nam-Jong
TI Upper Extremity Functional Evaluation by Fugl-Meyer Assessment Scoring
   Using Depth-Sensing Camera in Hemiplegic Stroke Patients
SO PLOS ONE
LA English
DT Article
ID UPPER-LIMB DEXTERITY; RECOVERY; PREDICTORS; DISEASE; SENSOR; SCALE
AB Virtual home-based rehabilitation is an emerging area in stroke rehabilitation. Functional assessment tools are essential to monitor recovery and provide current function-based rehabilitation. We developed the Fugl-Meyer Assessment (FMA) tool using Kinect (Microsoft, USA) and validated it for hemiplegic stroke patients. Forty-one patients with hemiplegic stroke were enrolled. Thirteen of 33 items were selected for upper extremity motor FMA. One occupational therapist assessed the motor FMA while recording upper extremity motion with Kinect. FMA score was calculated using principal component analysis and artificial neural network learning from the saved motion data. The degree of jerky motion was also transformed to jerky scores. Prediction accuracy for each of the 13 items and correlations between real FMA scores and scores using Kinect were analyzed. Prediction accuracies ranged from 65% to 87% in each item and exceeded 70% for 9 items. Correlations were high for the summed score for the 13 items between real FMA scores and scores obtained using Kinect (Pearson's correlation coefficient = 0.873, P<0.0001) and those between total upper extremity scores (66 in full score) and scores using Kinect (26 in full score) (Pearson's correlation coefficient = 0.799, P<0.0001). Log transformed jerky scores were significantly higher in the hemiplegic side (1.81 +/- 0.76) compared to non-hemiplegic side (1.21 +/- 0.43) and showed significant negative correlations with Brunnstrom stage (3 to 6; Spearman correlation coefficient = -0.387, P = 0.046). FMA using Kinect is a valid way to assess upper extremity function and can provide additional results for movement quality in stroke patients. This may be useful in the setting of unsupervised home-based rehabilitation.
C1 [Kim, Won-Seok; Paik, Nam-Jong] Seoul Natl Univ, Dept Rehabil Med, Coll Med, Bundang Hosp, Songnam, Gyeonggi Do, South Korea.
   [Cho, Sungmin; Baek, Dongyoub; Bang, Hyunwoo] Seoul Natl Univ, Dept Mech & Aerosp Engn, Seoul, South Korea.
RP Paik, NJ (reprint author), Seoul Natl Univ, Dept Rehabil Med, Coll Med, Bundang Hosp, Songnam, Gyeonggi Do, South Korea.
EM njpaik@snu.ac.kr
OI Paik, Nam-Jong/0000-0002-5193-8678
FU Microsoft Research, under ICT/SW Creative research program
   [NIPA-2014-(H0510-14-1014), NIPA-2013(H0503-13-1018)]; Ministry of
   Science, ICT and Future Planning (MSIP), Korea
FX This research was supported by the The Ministry of Science, ICT and
   Future Planning (MSIP), Korea and Microsoft Research, under ICT/SW
   Creative research program supervised by the National ICT Industry
   Promotion Agency (NIPA) [NIPA-2014-(H0510-14-1014)] and
   [NIPA-2013(H0503-13-1018)], which were received by N-J.P. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Adam A, 2010, 2010 SECOND INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE, COMMUNICATION SYSTEMS AND NETWORKS (CICSYN), P44, DOI 10.1109/CICSyN.2010.9
   Adams RJ, 2015, IEEE T NEUR SYS REH, V23, P287, DOI 10.1109/TNSRE.2014.2360149
   Barton G, 2007, GAIT POSTURE, V25, P374, DOI 10.1016/j.gaitpost.2006.05.003
   Brainin M, 2007, LANCET NEUROL, V6, P553, DOI 10.1016/S1474-4422(07)70005-4
   BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864
   Brunnstrom  S., 1970, MOVEMENT THERAPY HEM
   Caimmi M, 2008, NEUROREHAB NEURAL RE, V22, P31, DOI 10.1177/1545968307302923
   Centers for Disease Control and Prevention, 2007, MMWR-MORBID MORTAL W, V56, P504
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13
   Gabel M, ENG MED BIOL SOC EMB, P1964
   Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171
   Guna J, 2014, SENSORS-BASEL, V14, P3702, DOI 10.3390/s140203702
   Hsieh YW, 2007, STROKE, V38, P3052, DOI 10.1161/STROKEAHA.107.490730
   KITAZAWA S, 1993, INT CONGR SER, V1024, P11
   Kong KH, 2013, NEUROREHABILITATION, V32, P345, DOI 10.3233/NRE-130854
   Kong KH, 2011, NEUROREHABILITATION, V28, P105, DOI 10.3233/NRE-2011-0639
   Kowalczewski J, 2011, IEEE ENG MED BIO, P7332, DOI 10.1109/IEMBS.2011.6091710
   Kurillo G, 2012, TECHNOLOGY HLTH CARE, V21, P641
   Lambercy O, 2013, REH ROB ICORR 2013 I, P1
   Lu Y, 1998, NEUR NETW P 1998 IEE, P1816
   Nguyen G. H., 2008, P 19 INT C PATT REC, p[A, 1]
   Nichols-Larsen DS, 2005, STROKE, V36, P1480, DOI 10.1161/01.STR.0000170706.13595.4f
   Olesh EV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104487
   Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701
   Rohrer B, 2002, J NEUROSCI, V22, P8297
   Teulings HL, 1997, EXP NEUROL, V146, P159, DOI 10.1006/exnr.1997.6507
   Tresilian JR, 1997, BRAIN, V120, P2093, DOI 10.1093/brain/120.11.2093
   Yu H., 2005, P 2005 INT C COMM CI
   Zhang ZY, 2012, IEEE MULTIMEDIA, V19, P4, DOI 10.1109/MMUL.2012.24
NR 30
TC 19
Z9 19
U1 4
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 1
PY 2016
VL 11
IS 7
AR e0158640
DI 10.1371/journal.pone.0158640
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DQ0TX
UT WOS:000378914900047
PM 27367518
OA Green Published, Other Gold
DA 2019-06-18
ER

PT J
AU Li, X
   Tse, VC
   Lau, WCY
   Cheung, BMY
   Lip, GYH
   Wong, ICK
   Chan, EW
AF Li, Xue
   Tse, Vicki C.
   Lau, Wallis C. Y.
   Cheung, Bernard M. Y.
   Lip, Gregory Y. H.
   Wong, Ian C. K.
   Chan, Esther W.
TI Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with
   Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses
SO PLOS ONE
LA English
DT Article
ID STROKE PREVENTION; ORAL ANTICOAGULANTS; INTRACRANIAL HEMORRHAGE; ASIAN
   PATIENTS; ASPIRIN; QUALITY; THERAPY; DABIGATRAN; MANAGEMENT; EFFICACY
AB Objectives
   Many of the cost-effectiveness analyses of apixaban against warfarin focused on Western populations but Asian evidence remains less clear. The present study aims to evaluate the cost-effectiveness of apixaban against warfarin in Chinese patients with non-valvular atrial fibrillation (NVAF) from a public institutional perspective in Hong Kong.
   Methods
   We used a Markov model incorporating 12 health state transitions, and simulated the disease progression of NVAF in 1,000 hypothetical patients treated with apixaban/warfarin. Risks of clinical events were based on the ARISTOTLE trial and were adjusted with local International Normalized Ratio control, defined as the time in therapeutic range. Real-life input for the model, including patients' demographics and clinical profiles, post-event treatment patterns, and healthcare costs, were determined by a retrospective cohort of 40,569 incident patients retrieved from a Hong Kong-wide electronic medical database. Main outcome measurements included numbers of thromboembolic and bleeding events, life years, quality-adjusted life years (QALYs) and direct healthcare cost. When comparing apixaban and warfarin, treatment with incremental cost-effectiveness ratio (ICER) less than one local GDP per capita (USD 33,534 in 2014) was defined to be cost-effective.
   Results
   In the lifetime simulation, fewer numbers of events were estimated for the apixaban group, resulting in reduced event-related direct medical costs. The estimated ICER of apixaban was USD 7,057 per QALY at base-case analysis and ranged from USD 1,061 to 14,867 per QALY under the 116 tested scenarios in deterministic sensitivity analysis. While in probabilistic sensitivity analysis, the probability of apixaban being the cost-effective alternative to warfarin was 96% and 98% at a willingness to pay threshold of USD 33,534 and 100,602 per QALY, respectively.
   Conclusions
   Apixaban is likely to be a cost-effective alternative to warfarin for stroke prophylaxis in Chinese patients with NVAF in Hong Kong.
C1 [Li, Xue; Tse, Vicki C.; Lau, Wallis C. Y.; Wong, Ian C. K.; Chan, Esther W.] Univ Hong Kong, Dept Pharmacol & Pharm, Ctr Safe Medicat Practice & Res, Hong Kong, Hong Kong, Peoples R China.
   [Cheung, Bernard M. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Hong Kong, Hong Kong, Peoples R China.
   [Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England.
   [Wong, Ian C. K.] UCL, Sch Pharm, Res Dept Practice & Policy, London, England.
RP Chan, EW (reprint author), Univ Hong Kong, Dept Pharmacol & Pharm, Ctr Safe Medicat Practice & Res, Hong Kong, Hong Kong, Peoples R China.
EM ewchan@hku.hk
RI Lau, Wallis/J-3800-2018
OI Lau, Wallis/0000-0003-2320-0470
FU Bristol Myers Squibb; Pfizer [260007295]; Janssen, a division of Johnson
   and Johnson; Eisai; Pharmaceutical Society of Hong Kong; University of
   Hong Kong; Early Career Scheme, Research Grants Council, Hong Kong;
   General Research Fund, Research Grants Council, Hong Kong
FX This study was supported by a grant from Bristol Myers Squibb and Pfizer
   (reference number: 260007295). EWC received financial support from
   Janssen, a division of Johnson and Johnson, Bristol Myers Squibb, Pfizer
   and Eisai; The Pharmaceutical Society of Hong Kong; The University of
   Hong Kong; Early Career Scheme and the General Research Fund, Research
   Grants Council, Hong Kong. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ademi Z, 2015, EUR J PREV CARDIOL, V22, P344, DOI 10.1177/2047487313514019
   Albertsen IE, 2013, STROKE, V44, P1329, DOI 10.1161/STROKEAHA.113.000883
   Boccuzzi SJ, 2009, CURR MED RES OPIN, V25, P2853, DOI 10.1185/03007990903196422
   Camm AJ, 2010, EUR HEART J, V31, P2369, DOI 10.1093/eurheartj/ehq278
   Chan EW, 2016, HEART RHYTHM, V13, P1581, DOI 10.1016/j.hrthm.2016.03.049
   Chiang CE, 2014, THROMB HAEMOSTASIS, V111, P789, DOI 10.1160/TH13-11-0948
   Claassen DO, 2008, ARCH NEUROL-CHICAGO, V65, P1313, DOI 10.1001/archneur.65.10.1313
   Clancy CM, 2005, HEALTH AFFAIR, V24, P151, DOI 10.1377/hlthaff.24.1.151
   Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000
   De Caterina R, 2013, THROMB HAEMOSTASIS, V110, P1087, DOI 10.1160/TH13-06-0443
   Dorian P, 2014, EUR HEART J, V35, P1897, DOI 10.1093/eurheartj/ehu006
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829
   Goto S, 2014, AM HEART J, V168, P303, DOI 10.1016/j.ahj.2014.06.005
   Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039
   Ho CW, 2015, STROKE, V46, P23, DOI 10.1161/STROKEAHA.114.006476
   Ho JCS, 2012, CLIN CARDIOL, V35, pE40, DOI 10.1002/clc.22069
   Hohnloser SH, 2012, EUR HEART J, V33, P2821, DOI 10.1093/eurheartj/ehs274
   Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095
   Hong Kong Government Gazette, PROVISON FOR PUBLIC
   January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040
   Lanitis T, 2014, THROMB RES, V134, P278, DOI 10.1016/j.thromres.2014.05.027
   Lee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047473
   Lip GYH, 2014, CLIN THER, V36, P192, DOI 10.1016/j.clinthera.2013.12.011
   Morgan CL, 2009, THROMB RES, V124, P37, DOI 10.1016/j.thromres.2008.09.016
   National Institute for Health and Care Excellence, 2013, GUIDE TO THE METHODS
   Reynolds MW, 2004, CHEST, V126, P1938, DOI 10.1378/chest.126.6.1938
   Sabir I, 2014, NAT REV CARDIOL, V11, P290, DOI 10.1038/nrcardio.2014.22
   Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098
   Stevanovic J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103974
   Sullivan PW, 2011, MED DECIS MAKING, V31, P800, DOI 10.1177/0272989X11401031
   Suzman R, GLOBAL HEALTH AND AG
   The Commission on Macroeconomics and Health of the World Health Organization, MACROECONOMICS AND H
   The Government of Hong Kong Special Administrative Region, HONG KONG THE FACTS
   The World Bank, HONG KONG GDP PER CA
   Tse HF, 2013, HEART RHYTHM, V10, P1082, DOI 10.1016/j.hrthm.2013.03.017
   van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0
   Wan Y, 2008, CIRC-CARDIOVASC QUAL, V1, P84, DOI 10.1161/CIRCOUTCOMES.108.796185
   Wang CJ, 2014, J STROKE CEREBROVASC, V23, P1157, DOI 10.1016/j.jstrokecerebrovasdis.2013.10.006
   Warren J, 2015, ATRIAL FIBRILLATION
   White HD, 2007, ARCH INTERN MED, V167, P239, DOI 10.1001/archinte.167.3.239
   Witt DM, 2012, ARCH INTERN MED, V172, P1484, DOI 10.1001/archinternmed.2012.4261
   Yasaka M, 2014, CIRC J, V78, P2367, DOI 10.1253/circj.CJ-14-0720
NR 43
TC 2
Z9 2
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 30
PY 2016
VL 11
IS 6
AR e0157129
DI 10.1371/journal.pone.0157129
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DQ0CH
UT WOS:000378865200007
PM 27362421
OA Other Gold, Green Published
DA 2019-06-18
ER

PT J
AU Wu, CL
   Tsai, CC
   Kor, CT
   Tarng, DC
   Lian, IB
   Yang, TH
   Chiu, PF
   Chang, CC
AF Wu, Chia-Lin
   Tsai, Chun-Chieh
   Kor, Chew-Teng
   Tarng, Der-Cherng
   Lian, Ie-Bin
   Yang, Tao-Hsiang
   Chiu, Ping-Fang
   Chang, Chia-Chu
TI Stroke and Risks of Development and Progression of Kidney Diseases and
   End-Stage Renal Disease: A Nationwide Population-Based Cohort Study
SO PLOS ONE
LA English
DT Article
ID ISCHEMIC-STROKE; GLOBAL BURDEN; CHRONIC PHASE; EPIDEMIOLOGY;
   INFLAMMATION; PREVALENCE; VALIDATION; REDUCTION; OUTCOMES; SYSTEM
AB Background
   There is little information about the association between stroke and kidney diseases. We aimed to investigate the impact of stroke on long-term renal outcomes.
   Methods
   In this large population-based retrospective cohort study, we identified 100,353 subjects registered in the National Health Insurance Research Database of Taiwan from January 1, 2000, through December 31, 2012, including 33,451 stroke patients and 66,902 age-, sexand Charlson's comorbidity index score-matched controls.
   Results
   The incidence rate of chronic kidney disease (CKD) was higher in the stroke than in the control cohort (17.5 vs. 9.06 per 1000 person-years). After multivariate adjustment, the risk of developing CKD was significantly higher in patients with stroke (adjusted hazard ratio [aHR] 1.43, 95% confidence interval [CI] 1.36-1.50, P<0.001). Subgroup analysis showed that stroke patients <50 years (aHR 1.61, P<0.001) and those with concomitant diabetes mellitus (aHR 2.12, P<0.001), hyperlipidemia (aHR 1.53, P<0.001) or gout (aHR 1.84, P<0.001) were at higher risk of incident CKD. Additionally, the risks of progression to advanced CKD and end-stage renal disease (ESRD) were significantly higher for stroke patients (aHRs, 1.22 and 1.30; P = 0.04 and P = 0.008, respectively), independent of age, sex, comorbidities and long-term medications.
   Conclusions
   Stroke is associated with higher risks for incident CKD, decline in renal function and ESRD. Younger stroke patients, as well as those with concomitant diabetes mellitus, hyperlipidemia or gout are at greater risk for kidney diseases.
C1 [Wu, Chia-Lin; Tsai, Chun-Chieh; Chiu, Ping-Fang; Chang, Chia-Chu] Changhua Christian Hosp, Dept Internal Med, Div Nephrol, Changhua, Taiwan.
   [Wu, Chia-Lin; Tsai, Chun-Chieh; Chiu, Ping-Fang; Chang, Chia-Chu] Chung Shan Med Univ, Sch Med, Taichung, Taiwan.
   [Wu, Chia-Lin; Tarng, Der-Cherng] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.
   [Wu, Chia-Lin; Kor, Chew-Teng; Chiu, Ping-Fang; Chang, Chia-Chu] Changhua Christian Hosp, Internal Med Res Ctr, Changhua, Taiwan.
   [Tarng, Der-Cherng] Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan.
   [Tarng, Der-Cherng] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei, Taiwan.
   [Lian, Ie-Bin] Natl Changhua Univ Educ, Grad Inst Stat & Informat Sci, Changhua, Taiwan.
   [Yang, Tao-Hsiang; Chang, Chia-Chu] Changhua Christian Hosp, Environm & Precis Med Lab, Changhua, Taiwan.
RP Chiu, PF (reprint author), Changhua Christian Hosp, Dept Internal Med, Div Nephrol, Changhua, Taiwan.; Chiu, PF (reprint author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Chiu, PF (reprint author), Changhua Christian Hosp, Internal Med Res Ctr, Changhua, Taiwan.
EM 27509@cch.org.tw; 68505@cch.org.tw
RI Wu, Chia-Lin/V-8888-2017
OI Wu, Chia-Lin/0000-0001-6045-6956; Lian, Ie-bin/0000-0003-3992-6049
FU Changhua Christian Hospital Research Foundation [103-CCH-IRP-10,
   104-CCH-IRP-012]
FX This study was funded by grants 103-CCH-IRP-10 and 104-CCH-IRP-012 from
   the Changhua Christian Hospital Research Foundation. The funder had no
   role in study design; in data collection, analysis, and interpretation;
   or in preparation of the manuscript and decision to publish.; This study
   was funded by grants 103-CCH-IRP-10 and 104-CCH-IRP-012 from the
   Changhua Christian Hospital Research Foundation. The funder had no role
   in study design; in data collection, analysis, and interpretation; or in
   preparation of the manuscript and decision to publish.
CR Air EL, 2007, DIABETES CARE, V30, P3131, DOI 10.2337/dc06-1537
   Alexandrova ML, 2005, FREE RADICAL BIO MED, V39, P297, DOI 10.1016/j.freeradbiomed.2005.04.017
   Bao YS, 2013, EUR J CLIN INVEST, V43, P829, DOI 10.1111/eci.12113
   Cao W, 2015, J AM SOC NEPHROL, V26, P1619, DOI 10.1681/ASN.2014050518
   Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087
   D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B
   DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Flex A, 2004, STROKE, V35, P2270, DOI 10.1161/01.STR.0000140740.19421.fe
   Folino AF, 2007, PROG CARDIOVASC DIS, V50, P49, DOI 10.1016/j.pcad.2007.01.001
   Grau AJ, 2001, EUR J CLIN INVEST, V31, P999, DOI 10.1046/j.1365-2362.2001.00923.x
   Ha H, 2009, NAT REV NEPHROL, V5, P203, DOI 10.1038/nrneph.2009.15
   Haapaniemi E, 2004, ACTA NEUROL SCAND, V110, P242, DOI 10.1111/j.1600-0404.2004.00304.x
   Hsieh FI, 2014, J STROKE, V16, P59, DOI 10.5853/jos.2014.16.2.59
   Hsu TW, 2014, JAMA INTERN MED, V174, P347, DOI 10.1001/jamainternmed.2013.12700
   Huang ST, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000429
   Hung PH, 2014, NEPHROL DIAL TRANSPL, V29, P873, DOI 10.1093/ndt/gft534
   Kernan WN, 2005, ARCH INTERN MED, V165, P227, DOI 10.1001/archinte.165.2.227
   Kobayashi M, 2010, AM J KIDNEY DIS, V56, P468, DOI 10.1053/j.ajkd.2010.03.018
   Kotchen TA, 2013, NEW ENGL J MED, V368, P1229, DOI 10.1056/NEJMra1212606
   Kumai Y, 2012, NEUROLOGY, V78, P1909, DOI 10.1212/WNL.0b013e318259e110
   Mogi M, 2011, CARDIOL RES PRACT, DOI 10.4061/2011/306189
   Ninomiya T, 2013, CONTRIB NEPHROL, V179, P58, DOI 10.1159/000346724
   O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65
   Ou SM, 2013, KIDNEY INT, V84, P198, DOI 10.1038/ki.2013.79
   Ovbiagele B, 2014, J STROKE CEREBROVASC, V23, P2265, DOI 10.1016/j.jstrokecerebrovasdis.2014.04.016
   Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098
   Saran R, 2015, AM J KIDNEY DIS, V66, pS1, DOI 10.1053/j.ajkd.2015.05.001
   Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80
   Strazzullo P, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4567
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   The department of information services Executive Yuan R.O.C. (Taiwan), 2014, THE REPUBLIC OF CHIN
   Toyoda K, 2014, LANCET NEUROL, V13, P823, DOI 10.1016/S1474-4422(14)70026-2
   Tsai CF, 2013, NEUROLOGY, V81, P264, DOI 10.1212/WNL.0b013e31829bfde3
   van Exel E, 2002, STROKE, V33, P1135, DOI 10.1161/01.STR.0000014206.05597.9E
   Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4
   Walberer M, 2014, BRAIN RES, V1581, P80, DOI 10.1016/j.brainres.2014.05.030
   Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110
   Yu TM, 2014, NEUROLOGY, V83, P686, DOI 10.1212/WNL.0000000000000711
   Yu YB, 2012, THROMB HAEMOSTASIS, V108, P225, DOI 10.1160/TH12-01-0010
NR 40
TC 8
Z9 8
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 29
PY 2016
VL 11
IS 6
AR e0158533
DI 10.1371/journal.pone.0158533
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DQ0AM
UT WOS:000378859400075
PM 27355475
OA DOAJ Gold, Green Published
DA 2019-06-18
ER

PT J
AU Adami, F
   Figueiredo, FWD
   Paiva, LD
   de Sa, TH
   Santos, EFD
   Martins, BL
   Valenti, VE
   de Abreu, LC
AF Adami, Fernando
   dos Santos Figueiredo, Francisco Winter
   Paiva, Laercio da Silva
   de Sa, Thiago Herick
   de Sousa Santos, Edige Felipe
   Martins, Bruno Luis
   Valenti, Vitor Engracia
   de Abreu, Luiz Carlos
TI Mortality and Incidence of Hospital Admissions for Stroke among
   Brazilians Aged 15 to 49 Years between 2008 and 2012
SO PLOS ONE
LA English
DT Article
ID CASE-FATALITY RATES; DECLINE; SYSTEM; HEALTH
AB Introduction
   The objective was to analyze rates of stroke-related mortality and incidence of hospital admissions in Brazilians aged 15 to 49 years according to region and age group between 2008 and 2012.
   Methods
   Secondary analysis was performed in 2014 using data from the Hospital and Mortality Information Systems and the Brazilian Institute of Geography and Statistics. Stroke was defined by ICD, 10th revision (I60-I64). Crude and standardized mortality (WHO reference) and incidence of hospital admissions per 100,000 inhabitants, stratified by region and age group, were estimated. Absolute and relative frequencies; and linear regression were also used. The software used was Stata 11.0.
   Results
   There were 35,005 deaths and 131,344 hospital admissions for stroke in Brazilians aged 15-49 years old between 2008 and 2012. Mortality decreased from 7.54 (95% CI 7.53; 7.54) in 2008 to 6.32 (95% CI 6.31; 6.32) in 2012 (beta = -0.27, p = 0.013, r(2) = 0.90). During the same time, incidence of hospital admissions stabilized: 24.67 (95% CI 24.66; 24.67) in 2008 and 25.11 (95% CI 25.10; 25.11) in 2012 (beta = 0.09, p = 0.692, r(2) = 0.05). There was a reduction in mortality in all Brazilian regions and in the age group between 30 and 49 years. Incidence of hospitalizations decreased in the South, but no significant decrease was observed in any age group.
   Conclusion
   We observed a decrease in stroke-related mortality, particularly in individuals over 30 years old, and stability of the incidence of hospitalizations; and also regional variation in stroke-related hospital admission incidence and mortality among Brazilian young adults.
C1 [Adami, Fernando; dos Santos Figueiredo, Francisco Winter; Paiva, Laercio da Silva; de Sousa Santos, Edige Felipe; Martins, Bruno Luis; de Abreu, Luiz Carlos] Fac Med ABC, Lab Epidemiol & Anal Dados, Dept Saude Coletividade, Santo Andre, SP, Brazil.
   [Adami, Fernando; dos Santos Figueiredo, Francisco Winter; Paiva, Laercio da Silva; de Sousa Santos, Edige Felipe; de Abreu, Luiz Carlos] Fac Med ABC, Lab Delineamento Estudos & Escrita Cient, Dept Saude Coletividade, Santo Andre, SP, Brazil.
   [de Sousa Santos, Edige Felipe] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, BR-01255 Sao Paulo, SP, Brazil.
   [de Sa, Thiago Herick] Univ Sao Paulo, Fac Saude Publ, Dept Nutr, Sao Paulo, SP, Brazil.
   [de Sousa Santos, Edige Felipe] Fac Leao Sampaio, Unidade Saude, Juazeiro De Norte, Ceara, Brazil.
   [Valenti, Vitor Engracia] Univ Estadual Paulista, Fac Filosofia & Ciencias, Dept Fonoaudiol, Marilia, SP, Brazil.
RP Adami, F (reprint author), Fac Med ABC, Lab Epidemiol & Anal Dados, Dept Saude Coletividade, Santo Andre, SP, Brazil.; Adami, F (reprint author), Fac Med ABC, Lab Delineamento Estudos & Escrita Cient, Dept Saude Coletividade, Santo Andre, SP, Brazil.
EM fernando.adami@fmabc.br
RI Figueiredo, Winter/A-7152-2015; Valenti, Vitor/C-1968-2012; Valenti,
   Vitor/Q-6355-2019; de Abreu, Luiz C/B-7873-2012; Adami,
   Fernando/D-3855-2012; Sa, Thiago Herick de/N-1952-2015
OI Figueiredo, Winter/0000-0002-9377-6443; Valenti,
   Vitor/0000-0001-7477-3805; de Abreu, Luiz C/0000-0002-7618-2109; Adami,
   Fernando/0000-0003-1918-3364; Sa, Thiago Herick de/0000-0002-9348-4483
FU Foundation for Research of the State of Sao Paulo - FAPESP
   [2013/08943-1]
FX This study was supported by the Foundation for Research of the State of
   Sao Paulo - FAPESP (reference number No: 2013/08943-1). The funders had
   the role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Andre C, 2006, STROKE, V37, P2784, DOI 10.1161/01.STR.0000244768.46566.73
   Bensenor IM, 2015, ARQ NEURO-PSIQUIAT, V73, P746, DOI 10.1590/0004-282X20150115
   Cabral NL, 2009, J NEUROL NEUROSUR PS, V80, P749, DOI 10.1136/jnnp.2008.164475
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Figueiroa BD, 2013, CAD SAUDE PUBLICA, V29, P475, DOI 10.1590/S0102-311X2013000300006
   Garritano CR, 2012, ARQ BRAS CARDIOL, V98, P519, DOI 10.1590/S0066-782X2012005000041
   George Mary G, 2011, Ann Neurol, V70, P713, DOI 10.1002/ana.22539
   Instituto de Pesquisa e Economia Aplicada-IPEA, ATL DES HUM BRAS
   Kleinbaum D, 2008, APPL REGRESSION ANAL
   Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5
   Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf
   Lotufo Paulo Andrade, 2005, Sao Paulo Med. J., V123, P3, DOI 10.1590/S1516-31802005000100001
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Minelli C, 2007, STROKE, V38, P2906, DOI 10.1161/STROKEAHA.107.484139
   Ministerio da Saude do Brasil, 2013, COORD GER INF MORT S, P0
   Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8
   Putaala J, 2012, STROKE, V43, P2624, DOI 10.1161/STROKEAHA.112.662866
   Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9
   Smajlovic D, 2015, VASC HEALTH RISK MAN, V11, P157, DOI 10.2147/VHRM.S53203
   Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X
   *WHO, 2007, INT CLASS DIS
NR 21
TC 9
Z9 9
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 22
PY 2016
VL 11
IS 6
AR e0152739
DI 10.1371/journal.pone.0152739
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DP0WX
UT WOS:000378212800002
PM 27332892
OA Other Gold, Green Published
DA 2019-06-18
ER

PT J
AU Six-Merker, J
   Meisinger, C
   Jourdan, C
   Heier, M
   Hauner, H
   Peters, A
   Linseisen, J
AF Six-Merker, Julia
   Meisinger, Christa
   Jourdan, Carolin
   Heier, Margit
   Hauner, Hans
   Peters, Annette
   Linseisen, Jakob
TI Treatment of Thyroid Dysfunctions Decreases the Risk of Cerebrovascular
   Events in Men but Not in Women: Results of the MONICA/KORA Cohort Study
SO PLOS ONE
LA English
DT Article
ID ALL-CAUSE MORTALITY; ISCHEMIC-STROKE; NATIONAL-HEALTH; SUBCLINICAL
   HYPOTHYROIDISM; CARDIOVASCULAR EVENTS; DISEASE; HYPERTHYROIDISM;
   NUTRITION; AUGSBURG; METAANALYSIS
AB Objective
   Thyroid disorders are well known to be associated with cardiovascular diseases. Some studies have shown that the negative effects of thyroid disorders are partially reversible after adequate treatment. The aim of this analysis was to assess the risk of incident ischemic cerebrovascular diseases in study participants treated for thyroid dysfunctions in a population-based cohort study.
   Methods
   For the presented analyses data from 8564 male and 8714 female individuals aged 25 to 74 years of the MONICA/KORA cohort were used (median follow-up 14.0 years). A combined binary variable "thyroid disorder" (TDC) was created utilizing data on self-reported physician-treated thyroid disorders and information about medication use. To examine the association between TDC and incident ischemic cerebrovascular events, we performed multiple adjusted Cox proportional hazard regression models and calculated hazard ratios and corresponding 95% confidence intervals (HR, 95% CI).
   Results
   During follow-up between 1984 and 2008/2009, 514 incident fatal and non-fatal ischemic cerebrovascular events occurred in men and 323 in women. At baseline, 3.5% of men and 15.6% of women reported TDC. In the fully adjusted model, males who reported TDC had a significantly reduced risk of ischemic cerebrovascular events (HR = 0.52, 95% CI = 0.29-0.92). A similar result was obtained in men, when we utilized information on thyroid hormones use only. For the total study population and for women with TDC we found no association with ischemic cerebrovascular events.
   Conclusions
   In our longitudinal analyses subjects with treated thyroid diseases had no increased risk of incident ischemic cerebrovascular events. Surprisingly in males, even a significantly reduced risk of incident ischemic cerebrovascular events was found, a result that deserves further clarification.
C1 [Six-Merker, Julia; Meisinger, Christa; Jourdan, Carolin; Heier, Margit; Peters, Annette; Linseisen, Jakob] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany.
   [Meisinger, Christa] Cent Hosp Augsburg, MONICA KORA Myocardial Infarct Registry, Augsburg, Germany.
   [Hauner, Hans] Tech Univ Munich, Klinikum Rechts Isar, Else Kroner Fresenius Ctr Nutr Med, D-80290 Munich, Germany.
   [Jourdan, Carolin] FGK Clin Res GmbH, Munich, Germany.
RP Six-Merker, J (reprint author), German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany.
EM julia.six-merker@helmholtz-muenchen.de
RI Linseisen, Jakob/B-5353-2014; Peters, Annette/A-6117-2011; Meisinger,
   Christine/B-5358-2014
OI Linseisen, Jakob/0000-0002-9386-382X; Peters,
   Annette/0000-0001-6645-0985; Meisinger, Christa/0000-0002-9026-6544
FU Helmholtz Zentrum Munchen; German Research Center for Environmental
   Health - German Federal Ministry of Education and Research; State of
   Bavaria
FX The MONICA Augsburg studies (MONitoring of Trends and Determinants in
   CArdiovascular Disease) and the KORA research platform (Cooperative
   Research in the Region of Augsburg) and were initiated and financed by
   the Helmholtz Zentrum Munchen, German Research Center for Environmental
   Health, which is funded by the German Federal Ministry of Education and
   Research and by the State of Bavaria. The funders financed the data
   collection. The funders had no role in study design, and analysis,
   decision to publish, or preparation of the manuscript.
CR Aghini-Lombardi F, 1999, J CLIN ENDOCR METAB, V84, P561, DOI 10.1210/jc.84.2.561
   Asvold BO, 2007, ARCH INTERN MED, V167, P1428, DOI 10.1001/archinte.167.13.1428
   Banks I, 2001, BRIT MED J, V323, P1058, DOI 10.1136/bmj.323.7320.1058
   Baskin H, 2002, ENDOCR PRACT, V8, P457, DOI DOI 10.4158/1934-2403-8.6.457
   Bennett DA, 2014, GLOB HEART, V9, P107, DOI 10.1016/j.gheart.2014.01.001
   Biondi B, 2004, ENDOCRINE, V24, P1, DOI 10.1385/ENDO:24:1:001
   Brix TH, 2001, THYROID, V11, P769, DOI 10.1089/10507250152484619
   Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526
   Chaker L, 2015, J CLIN ENDOCR METAB, V100, P2181, DOI 10.1210/jc.2015-1438
   Chaker L, 2014, EUR J EPIDEMIOL, V29, P791, DOI 10.1007/s10654-014-9946-8
   Coceani M, 2013, ANADOLU KARDIYOL DER, V13, P62, DOI 10.5152/akd.2013.008
   Danzi S, 2012, MED CLIN N AM, V96, P257, DOI 10.1016/j.mcna.2012.01.006
   de Carvalho GA, 2013, ARQ BRAS ENDOCRINOL, V57, P193, DOI 10.1590/S0004-27302013000300005
   Diez JJ, 2002, J GERONTOL A-BIOL, V57, pM315, DOI 10.1093/gerona/57.5.M315
   Dubow J, 2011, CURR ATHEROSCLER REP, V13, P298, DOI 10.1007/s11883-011-0187-y
   Faber J, 2014, FRONT HORM RES, V43, P45, DOI 10.1159/000360558
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Flynn RWV, 2006, J CLIN ENDOCR METAB, V91, P2159, DOI 10.1210/jc.2005-1833
   Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488
   Giri A, 2014, THYROID, V24, P1210, DOI 10.1089/thy.2014.0106
   Goldstein LB, 2006, STROKE, V37, P1583, DOI 10.1161/01.STR.0000223048.70103.F1
   Grais IM, 2014, AM J MED, V127, P691, DOI 10.1016/j.amjmed.2014.03.009
   Grobner W., 1999, HYPERURIKAMIE GICHT
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235
   Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489
   KEIL U, 1988, ACTA MED SCAND, P119
   Keil U, 1998, EUR HEART J, V19, P1197, DOI 10.1053/euhj.1998.1089
   Khalil RB, 2011, CLIN NEUROPHARMACOL, V34, P248, DOI 10.1097/WNF.0b013e31823429a7
   Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612
   Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326
   Laurberg P, 2012, EUR THYROID J, V1, P159, DOI 10.1159/000342994
   Lewington S, 2007, LANCET, V370, P1829
   Lowel H, 2005, GESUNDHEITSWESEN, V67, pS13, DOI 10.1055/s-2005-858234
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Meisinger C, 2005, GESUNDHEITSWESEN, V67, pS103, DOI 10.1055/s-2005-858251
   Meisinger C, 2012, EUR J ENDOCRINOL, V167, P363, DOI 10.1530/EJE-12-0111
   Melchert HU, 2002, SCHILDDRUSENHOMONE S
   Morris MS, 2001, ATHEROSCLEROSIS, V155, P195, DOI 10.1016/S0021-9150(00)00537-2
   Okosieme OE, 2011, QJM-INT J MED, V104, P395, DOI 10.1093/qjmed/hcq222
   Peters SAE, 2014, LANCET, V383, P1973, DOI 10.1016/S0140-6736(14)60040-4
   Peters SAE, 2013, STROKE, V44, P2821, DOI 10.1161/STROKEAHA.113.002342
   Qureshi AI, 2006, MED SCI MONITOR, V12, pCR501
   Reid JR, 2005, AM FAM PHYSICIAN, V72, P623
   Rohrig N, 2014, J CLIN EPIDEMIOL, V67, P199, DOI 10.1016/j.jclinepi.2013.08.012
   Schultz M, 2011, HORM METAB RES, V43, P653, DOI 10.1055/s-0031-1283162
   Selmer C, 2014, J CLIN ENDOCR METAB, V99, P2372, DOI 10.1210/jc.2013-4184
   Vanderpump MPJ, 2011, BRIT MED BULL, V99, P39, DOI 10.1093/bmb/ldr030
   Woeber KA, 2000, ARCH INTERN MED, V160, P1067, DOI 10.1001/archinte.160.8.1067
   Yang MH, 2015, J STROKE CEREBROVASC, V24, P912, DOI 10.1016/j.jstrokecerebrovasdis.2014.11.032
   Yonemoto K, 2011, HYPERTENS RES, V34, P274, DOI 10.1038/hr.2010.220
NR 51
TC 3
Z9 3
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 18
PY 2016
VL 11
IS 5
AR e0155499
DI 10.1371/journal.pone.0155499
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM3ZU
UT WOS:000376286100058
PM 27191851
OA Other Gold, Green Published
DA 2019-06-18
ER

PT J
AU Claassen, J
   Rahman, SA
   Huang, YX
   Frey, HP
   Schmidt, JM
   Albers, D
   Falo, CM
   Park, S
   Agarwal, S
   Connolly, ES
   Kleinberg, S
AF Claassen, Jan
   Rahman, Shah Atiqur
   Huang, Yuxiao
   Frey, Hans-Peter
   Schmidt, J. Michael
   Albers, David
   Falo, Cristina Maria
   Park, Soojin
   Agarwal, Sachin
   Connolly, E. Sander
   Kleinberg, Samantha
TI Causal Structure of Brain Physiology after Brain Injury from
   Subarachnoid Hemorrhage
SO PLOS ONE
LA English
DT Article
ID MULTIDISCIPLINARY CONSENSUS CONFERENCE; NEUROCRITICAL CARE SOCIETY;
   GLOBAL CEREBRAL EDEMA; INTRACRANIAL HYPERTENSION; NONCONVULSIVE
   SEIZURES; COMATOSE PATIENTS; MICRODIALYSIS; PROFESSIONALS; METABOLISM;
   MANAGEMENT
AB High frequency physiologic data are routinely generated for intensive care patients. While massive amounts of data make it difficult for clinicians to extract meaningful signals, these data could provide insight into the state of critically ill patients and guide interventions. We develop uniquely customized computational methods to uncover the causal structure within systemic and brain physiologic measures recorded in a neurological intensive care unit after subarachnoid hemorrhage. While the data have many missing values, poor signal-to-noise ratio, and are composed from a heterogeneous patient population, our advanced imputation and causal inference techniques enable physiologic models to be learned for individuals. Our analyses confirm that complex physiologic relationships including demand and supply of oxygen underlie brain oxygen measurements and that mechanisms for brain swelling early after injury may differ from those that develop in a delayed fashion. These inference methods will enable wider use of ICU data to understand patient physiology.
C1 [Claassen, Jan; Frey, Hans-Peter; Schmidt, J. Michael; Falo, Cristina Maria; Park, Soojin; Agarwal, Sachin] Columbia Univ, Dept Neurol, Div Crit Care Neurol, New York, NY USA.
   [Rahman, Shah Atiqur; Huang, Yuxiao; Kleinberg, Samantha] Stevens Inst Technol, Dept Comp Sci, Hoboken, NJ 07030 USA.
   [Albers, David] Columbia Univ, Dept Biomed Informat, New York, NY USA.
   [Connolly, E. Sander] Columbia Univ, Dept Neurosurg, New York, NY USA.
RP Claassen, J (reprint author), Columbia Univ, Dept Neurol, Div Crit Care Neurol, New York, NY USA.
EM jc1439@columbia.edu
OI Frey, Hans-Peter/0000-0002-1026-008X; Schmidt, J.
   Michael/0000-0001-8141-2944
FU NLM of the NIH [R01LM011826]; National Center for Advancing
   Translational Sciences, National Institutes of Health [UL1 TR000040, UL1
   RR024156]; National Library of Medicine [R01 LM006910]
FX This publication was supported by the NLM of the NIH under Award Number
   R01LM011826 (SK, YH, JC). Additional support for this work included a
   grant from the National Center for Advancing Translational Sciences,
   National Institutes of Health, through Grant Number UL1 TR000040,
   formerly the National Center for Research Resources, Grant Number UL1
   RR024156 (JC) and a grant from the National Library of Medicine under
   Award Number R01 LM006910 (DA). The content is solely the responsibility
   of the authors and does not necessarily represent the official views of
   the NIH.; We thank the nurses, attendings, fellows, and neurology and
   neurosurgery residents of the Neuroscience ICU for their overall support
   of this project. This publication was supported by the NLM of the NIH
   under Award Number R01LM011826 (SK, YH, JC). Additional support for this
   work included a grant from the National Center for Advancing
   Translational Sciences, National Institutes of Health, through Grant
   Number UL1 TR000040, formerly the National Center for Research
   Resources, Grant Number UL1 RR024156 (JC) and a grant from the National
   Library of Medicine under Award Number R01 LM006910 (DA). The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the NIH.
CR Badjatia N, 2011, STROKE, V42, P2436, DOI 10.1161/STROKEAHA.111.614685
   Baradaran H, 2015, AJNR AM J NEURORADIO
   Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395
   Bouzat P, 2015, CRIT CARE MED, V43, P445, DOI 10.1097/CCM.0000000000000720
   Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65
   Buchman TG, 2002, NATURE, V420, P246, DOI 10.1038/nature01260
   Bui N YJ, 2015, INT C SOC COMP BEH C
   Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y
   Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F
   Claassen J, 2014, ANN NEUROL, V75, P771, DOI 10.1002/ana.24166
   Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859
   Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Helbok R, 2014, NEUROCRIT CARE, V21, P85, DOI 10.1007/s12028-014-0040-6
   Helbok R, 2011, STROKE, V42, P1534, DOI 10.1161/STROKEAHA.110.604488
   Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3
   Hripcsak G, 2013, J AM MED INFORM ASSN, V20, P117, DOI 10.1136/amiajnl-2012-001145
   Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177
   Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235
   Klein AM, 2013, CLIN NEUROL NEUROSUR, V115, P2136, DOI 10.1016/j.clineuro.2013.08.004
   Kleinberg S., CAUSALITY PROBABILIT, Vvii
   Kleinberg S, 2011, P 22 INT JOINT C ART
   Kleinberg Samantha, 2013, AMIA Annu Symp Proc, V2013, P786
   Ko SB, 2012, ANN NEUROL, V72, P344, DOI 10.1002/ana.23619
   Komotar RJ, 2009, NEUROSURGERY, V64, P397, DOI 10.1227/01.NEU.0000338946.42939.C7
   Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5
   Miller C, 2014, NEUROCRIT CARE, V21, P121, DOI 10.1007/s12028-014-0021-9
   Mocco J, 2007, Neurosurg Focus, V22, pE7
   OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241
   Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6
   Provencio JJ, 2014, NEUROCRIT CARE, V21, P177, DOI 10.1007/s12028-014-0038-0
   Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0
   Rahman SA, 2015, J BIOMEDICAL INFORM
   Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490
   Sedigh-Sarvestani M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002788
   Taccone FS, 2014, NEUROCRIT CARE, V21, P38, DOI 10.1007/s12028-014-0033-5
   Ullah G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000776
   Wibral M, 2014, TRANSFER ENTROPY NEU
NR 38
TC 3
Z9 3
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 28
PY 2016
VL 11
IS 4
AR e0149878
DI 10.1371/journal.pone.0149878
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DK8XE
UT WOS:000375211700002
PM 27123582
OA DOAJ Gold, Green Published
DA 2019-06-18
ER

PT J
AU Radisauskas, R
   Malinauskiene, V
   Milinaviciene, E
   Kranciukaite-Butylkiniene, D
   Tamosiunas, A
   Bernotiene, G
   Luksiene, D
   Milasauskiene, Z
   Sopagiene, D
   Rastenyte, D
AF Radisauskas, Ricardas
   Malinauskiene, Vilija
   Milinaviciene, Egle
   Kranciukaite-Butylkiniene, Daina
   Tamosiunas, Abdonas
   Bernotiene, Gailute
   Luksiene, Dalia
   Milasauskiene, Zemyna
   Sopagiene, Diana
   Rastenyte, Daiva
TI Trends in the Attack Rates, Incidence, and Mortality of Stroke during
   1986-2012: Data of Kaunas (Lithuania) Stroke Registry
SO PLOS ONE
LA English
DT Article
ID RISK-FACTORS; CASE-FATALITY; GLOBAL BURDEN; UNITED-STATES; SURVIVAL;
   POPULATION; PREVENTION; COUNTRIES; DECLINE; DISEASE
AB Background
   There is a lack of reliable epidemiological data on longitudinal trends in stroke attack rates, incidence, and mortality in the countries of the Baltic region.
   Aims
   The aim of the present study was to explore the longitudinal trends of stroke in middle-aged urban population of Lithuania during the period of 1986 through 2012.
   Methods
   All stroke events in the studied population were ascertained and validated according to the standardized criteria outlined by the WHO MONICA Project. The study included all patients in Kaunas (Lithuania) city aged 25 to 64 years who experienced a stroke between 1986 and 2012. Estimates of time-trends of the annual percentage change in stroke attack rates, incidence of stroke, and mortality from this condition were made by applying the Joinpoint regression analysis.
   Results
   During the study period, 9,992 stroke events were registered. The overall proportion of recurrent events was 25.7%. Overall, 18.9% of the events (20.0% in men, and 17.4% in women) were fatal within 28 days. During the period of 1986 to 2012, a flat trend in the incidence of stroke was observed among both male and female middle-aged inhabitants of Kaunas city, while attack rates were increasing due to the increase in recurrent strokes. Both mortality and 28-day case fatality of stroke declined significantly over the study period in both sexes.
   Conclusions An increase both in the incidence and recurrence of stroke among middle-aged men residing in Kaunas city and in the recurrence of stroke among women denotes the inefficiency of measures applied both for primary and secondary prevention of stroke in Lithuania. The revision of current prevention strategies and the introduction of new ones are of paramount importance in order to fight the epidemic of stroke.
C1 [Radisauskas, Ricardas; Malinauskiene, Vilija; Milinaviciene, Egle; Kranciukaite-Butylkiniene, Daina; Tamosiunas, Abdonas; Bernotiene, Gailute; Luksiene, Dalia] Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania.
   [Radisauskas, Ricardas; Malinauskiene, Vilija; Luksiene, Dalia] Lithuanian Univ Hlth Sci, Dept Environm & Occupat Med, Kaunas, Lithuania.
   [Milinaviciene, Egle] Lithuanian Univ Hlth Sci, Dept Rehabil, Kaunas, Lithuania.
   [Kranciukaite-Butylkiniene, Daina] Lithuanian Univ Hlth Sci, Dept Family Med, Kaunas, Lithuania.
   [Tamosiunas, Abdonas; Milasauskiene, Zemyna] Lithuanian Univ Hlth Sci, Dept Prevent Med, Kaunas, Lithuania.
   [Sopagiene, Diana] Klaipeda Univ, Dept Publ Hlth, Klaipeda, Lithuania.
   [Rastenyte, Daiva] Lithuanian Univ Hlth Sci, Dept Neurol, Kaunas, Lithuania.
RP Radisauskas, R (reprint author), Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania.; Radisauskas, R (reprint author), Lithuanian Univ Hlth Sci, Dept Environm & Occupat Med, Kaunas, Lithuania.
EM ricardas.radisauskas@lsmuni.lt
CR Aiyagari V, 2015, J STROKE CEREBROVASC, V24, P290, DOI 10.1016/j.jstrokecerebrovasdis.2014.08.002
   Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa
   Arboix A, 2008, CEREBROVASC DIS, V26, P509, DOI 10.1159/000155989
   Ayis SA, 2013, J NEUROL NEUROSUR PS, V84, P604, DOI 10.1136/jnnp-2012-303525
   Bejot Y, 2008, REV NEUROL-FRANCE, V164, P138, DOI 10.1016/j.neurol.2007.06.003
   Fang MC, 2014, AM J MED, V127, P608, DOI 10.1016/j.amjmed.2014.03.017
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0
   Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80
   Goldacre MJ, 2008, STROKE, V39, P2197, DOI 10.1161/STROKEAHA.107.509695
   Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238
   Hallstrom B, 2008, STROKE, V39, P10, DOI 10.1161/STROKEAHA.107.491779
   Harmsen P, 2009, STROKE, V40, P2691, DOI 10.1161/STROKEAHA.109.550814
   Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7
   Khellaf M, 2010, STROKE, V41, P2762, DOI 10.1161/STROKEAHA.110.592147
   Krishnamurthi R.V., 2013, LANCET GLOB HEALTH, V1, pe259, DOI DOI 10.1016/S2214-109X(13)70089-5
   Kunst AE, 2011, STROKE, V42, P2126, DOI 10.1161/STROKEAHA.110.599712
   Lakshminarayan K, 2014, STROKE, V45, P2575, DOI 10.1161/STROKEAHA.114.005512
   Lakshminarayan K, 2009, AM J EPIDEMIOL, V169, P1070, DOI 10.1093/aje/kwp029
   Lee S, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000269
   Lewsey JD, 2009, CIRC-CARDIOVASC QUAL, V2, P475, DOI 10.1161/CIRCOUTCOMES.108.825968
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Luger S, 2014, INT J STROKE, V9, P569, DOI 10.1111/ijs.12289
   Modig K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064928
   Norrving B, 2013, NEUROLOGY, V80, pS5, DOI 10.1212/WNL.0b013e3182762397
   O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3
   Ovbiagele B, 2010, STROKE, V41, P1748, DOI 10.1161/STROKEAHA.110.585455
   Peeters A, 2011, EUR J EPIDEMIOL, V26, P369, DOI 10.1007/s10654-011-9546-9
   Putaala J, 2012, STROKE, V43, P2624, DOI 10.1161/STROKEAHA.112.662866
   Radisauskas R, 2014, MEDICINA-LITHUANIA, V50, P182, DOI 10.1016/j.medici.2014.08.003
   Rastenyte D, 2006, SCAND J PUBLIC HEALT, V34, P488, DOI 10.1080/14034940600551640
   Reklaitiene R, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-68
   Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2
   Sutton CJ, 2010, J EPIDEMIOL COMMUN H, V64, P523, DOI 10.1136/jech.2008.086785
   Tamosiunas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114283
   Tolonen H, 2000, RUOKOKOSKI E WHO MON
   Tunstall-Pedoe H, 2003, MONICA MONOGRAPH MUL
   Vibo R, 2005, STROKE, V36, P2544, DOI 10.1161/01.STR.0000189633.33623.69
   Waterhouse JAH, 1976, IARC SCI PUBLICATION, V15
   WHO MONICA Project, 1990, WHO MONICA PROJECT 5
   Wieberdink RG, 2012, EUR J EPIDEMIOL, V27, P287, DOI 10.1007/s10654-012-9673-y
   Yang QH, 2006, CIRCULATION, V113, P1335, DOI 10.1161/CIRCULATIONAHA.105.570846
NR 42
TC 0
Z9 1
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 28
PY 2016
VL 11
IS 4
AR e0153942
DI 10.1371/journal.pone.0153942
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DK8XE
UT WOS:000375211700038
PM 27124412
OA DOAJ Gold, Green Published
DA 2019-06-18
ER

PT J
AU Zhang, YF
   Jin, M
   Du, B
   Lin, H
   Xu, CY
   Jiang, WJ
   Jia, JP
AF Zhang, Yunfeng
   Jin, Min
   Du, Bin
   Lin, Hao
   Xu, Chengyong
   Jiang, Weijian
   Jia, Jianping
TI A Novel Canine Model of Acute Vertebral Artery Occlusion
SO PLoS One
LA English
DT Article
ID ISCHEMIC-STROKE; MECHANICAL THROMBECTOMY; THROMBOEMBOLIC STROKE;
   ANIMAL-MODEL; SWINE MODEL; RECANALIZATION; DEVICE; REVASCULARIZATION;
   REPERFUSION; EFFICACY
AB Background
   The extended time window and theoretic reduction in hemorrhage make mechanical strategies an attractive approach for the treatment of patients with ischemic stroke. However, a limited availability of suitable animal models of cerebrovascular thrombosis has hampered the study of novel endovascular interventions. The aim of the present study was to develop a new technique for site-specific placement of a thrombus in a canine model that would allow for the evaluation of mechanical thrombectomy and clot retrieval methods and the visualization of thrombus dislocation or fragmentation during angiographic manipulation.
   Methods
   Angiography and embolization with a preformed thrombus were performed in 12 canines. Under fluoroscopic guidance, an embolism protection device (EPD) was anchored to the middle segment of the left vertebral artery (VA) via the left femoral arterial sheath. A preformed radiopaque clot was injected through the guide catheter into the left VA, via the contralateral femoral artery, proximal to the EPD. After 15 min of occlusion, the EPD was removed and persistent occlusion of the VA was documented angiographically.
   Results
   Angiography performed during the observation period confirmed the persistence of VA occlusion in each case, and displacement of the radiopaque clots did not occur during the 3-hour observation period. The technique allowed selective embolization of targeted vessels without thrombus fragmentation.
   Conclusion
   This study demonstrates, for the first time, a canine model of post-circulation embolism induced by autologous blood clot placement. This model can be rapidly formed and easily operated, and the site of thrombosis can be readily controlled.
C1 [Zhang, Yunfeng; Jia, Jianping] Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China.
   [Jin, Min; Du, Bin; Lin, Hao; Xu, Chengyong; Jiang, Weijian] Chinese Peoples Liberat Army, Artillery Gen Hosp 2, Beijing, Peoples R China.
   [Zhang, Yunfeng] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong, Peoples R China.
RP Jia, JP (reprint author), Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China.
EM jiajp@vip.126.com
OI Jia, Jianping/0000-0003-4624-0336
CR Amiridze N, 2009, J STROKE CEREBROVASC, V18, P281, DOI 10.1016/j.jstrokecerebrovasdis.2008.11.013
   Boltze J, 2008, J CEREBR BLOOD F MET, V28, P1951, DOI 10.1038/jcbfm.2008.89
   Boulos AS, 2011, J NEUROSURG, V114, P1117, DOI 10.3171/2010.8.JNS09352
   Busch E, 1997, BRAIN RES, V778, P16, DOI 10.1016/S0006-8993(97)01008-1
   Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792
   Castano C, 2010, STROKE, V41, P1836, DOI 10.1161/STROKEAHA.110.584904
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Feng L, 2013, EXP THER MED, V6, P947, DOI 10.3892/etm.2013.1248
   Gory B, 2013, INTERV NEURORADIOL, V19, P147, DOI 10.1177/159101991301900201
   Gounis MJ, 2013, STROKE, V44, pS7, DOI 10.1161/STROKEAHA.111.000692
   Gounis MJ, 2013, J NEUROINTERV SURG, V5, P85, DOI 10.1136/neurintsurg-2012-010435
   Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905
   Gralla J, 2006, AM J NEURORADIOL, V27, P1357
   Gravanis I, 2008, EXPERT OPIN THER TAR, V12, P159, DOI 10.1517/14728222.12.2.159 
   Jahan R, 2010, AM J NEURORADIOL, V31, P1938, DOI 10.3174/ajnr.A2169
   Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780
   Khatri P, 2009, NEUROLOGY, V73, P1066, DOI 10.1212/WNL.0b013e3181b9c847
   Levy EI, 2006, AM J NEURORADIOL, V27, P2069
   Levy EI, 2011, NEUROSURGERY, V69, P915, DOI 10.1227/NEU.0b013e318222afd1
   Levy EI, 2009, STROKE, V40, P3552, DOI 10.1161/STROKEAHA.109.561274
   Mehra M, 2012, J NEUROINTERV SURG, V4, P307, DOI 10.1136/neurintsurg-2011-010101
   Nogueira RG, 2012, J NEUROINTERV SURG, V4, P295, DOI 10.1136/neurintsurg-2011-010053
   Orset C, 2007, STROKE, V38, P2771, DOI 10.1161/STROKEAHA.107.487520
   Pereira VM, 2015, J NEURORADIOLOGY, V42, P12, DOI 10.1016/j.neurad.2014.11.002
   Przybylowski Colin J, 2014, World J Clin Cases, V2, P614, DOI 10.12998/wjcc.v2.i11.614
   Ren M, 2012, J NEUROSCI METH, V211, P296, DOI 10.1016/j.jneumeth.2012.09.006
   Rha JH, 2007, STROKE, V38, P967, DOI 10.1161/01.STR.0000258112.14918.24
   Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061
   Suh SH, 2010, AM J NEURORADIOL, V31, P459, DOI 10.3174/ajnr.A1865
   Sun L, 2011, BRAIN RES, V1368, P346, DOI 10.1016/j.brainres.2010.10.067
   TIMI Study Group, 1985, NEW ENGL J MED, V312, P932, DOI DOI 10.1056/NEJM198504043121435]
   Wardlaw JM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub3
   Yuki I, 2013, AM J NEURORADIOL, V34, pE87, DOI 10.3174/ajnr.A3221
NR 33
TC 2
Z9 2
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 6
PY 2015
VL 10
IS 11
AR e0142251
DI 10.1371/journal.pone.0142251
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CV6RT
UT WOS:000364398700100
PM 26545253
OA Other Gold, Green Published
DA 2019-06-18
ER

PT J
AU Zhao, J
   Mou, YS
   Bernstock, JD
   Klimanis, D
   Wang, SX
   Spatz, M
   Maric, D
   Johnson, K
   Klinman, DM
   Li, XH
   Li, XH
   Hallenbeck, JM
AF Zhao, Jing
   Mou, Yongshan
   Bernstock, Joshua D.
   Klimanis, Dace
   Wang, Sixian
   Spatz, Maria
   Maric, Dragan
   Johnson, Kory
   Klinman, Dennis M.
   Li, Xiaohong
   Li, Xinhui
   Hallenbeck, John M.
TI Synthetic Oligodeoxynucleotides Containing Multiple Telemeric TTAGGG
   Motifs Suppress Inflammasome Activity in Macrophages Subjected to Oxygen
   and Glucose Deprivation and Reduce Ischemic Brain Injury in Stroke-Prone
   Spontaneously Hypertensive Rats
SO PLOS ONE
LA English
DT Article
ID FOCAL CEREBRAL-ISCHEMIA; REGULATORY T-CELLS; NLRP3 INFLAMMASOME; TISSUE
   DISTRIBUTION; IMMUNE-SYSTEM; MOUSE LUNG; IN-VIVO; ACTIVATION; MICE;
   DEATH
AB The immune system plays a fundamental role in both the development and pathobiology of stroke. Inflammasomes are multiprotein complexes that have come to be recognized as critical players in the inflammation that ultimately contributes to stroke severity. Inflammasomes recognize microbial and host-derived danger signals and activate caspase-1, which in turn controls the production of the pro-inflammatory cytokine IL-1 beta. We have shown that A151, a synthetic oligodeoxynucleotide containing multiple telemeric TTAGGG motifs, reduces IL-1 beta production by activated bone marrow derived macrophages that have been subjected to oxygen-glucose deprivation and LPS stimulation. Further, we demonstrate that A151 reduces the maturation of caspase-1 and IL-1 beta, the levels of both the iNOS and NLRP3 proteins, and the depolarization of mitochondrial membrane potential within such cells. In addition, we have demonstrated that A151 reduces ischemic brain damage and NLRP3 mRNA levels in SHR-SP rats that have undergone permanent middle cerebral artery occlusion. These findings clearly suggest that the modulation of inflammasome activity via A151 may contribute to a reduction in pro-inflammatory cytokine production by macrophages subjected to conditions that model brain ischemia and modulate ischemic brain damage in an animal model of stroke. Therefore, modulation of ischemic pathobiology by A151 may have a role in the development of novel stroke prevention and therapeutic strategies.
C1 [Zhao, Jing; Li, Xiaohong] Shandong Univ, Jinan Cent Hosp, Dept Neurol, Jinan 250013, Shandong, Peoples R China.
   [Zhao, Jing; Mou, Yongshan; Bernstock, Joshua D.; Klimanis, Dace; Spatz, Maria; Li, Xinhui; Hallenbeck, John M.] NINDS, Stroke Branch, NIH, Bethesda, MD 20892 USA.
   [Wang, Sixian] Cornell Univ, Coll Arts & Sci, Ithaca, NY USA.
   [Maric, Dragan] NINDS, Flow Cytometry Core Facil, Bethesda, MD 20892 USA.
   [Johnson, Kory] NINDS, Informat Technol & Bioinformat Program, NIH, Bethesda, MD 20892 USA.
   [Klinman, Dennis M.] NCI, Canc & Inflammat Program, NIH, Bethesda, MD 20892 USA.
RP Li, XH (reprint author), Shandong Univ, Jinan Cent Hosp, Dept Neurol, 105 Jiefang Rd, Jinan 250013, Shandong, Peoples R China.
EM xiaohong-li@sdu.edu.cn; lixinh@mail.nih.gov; hallenbj@ninds.nih.gov
RI zhao, jing/B-3868-2019
OI Bernstock, Joshua/0000-0002-7814-3867
FU Intramural Research Program of the National Institute of Neurological
   Disorders and Stroke/National Institutes of Health
FX This research was supported by the Intramural Research Program of the
   National Institute of Neurological Disorders and Stroke/National
   Institutes of Health.
CR Abulafia DP, 2009, J CEREBR BLOOD F MET, V29, P534, DOI 10.1038/jcbfm.2008.143
   Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0
   Bahjat FR, 2011, J CEREBR BLOOD F MET, V31, P1229, DOI 10.1038/jcbfm.2011.6
   Bedikian AY, 2014, MELANOMA RES, V24, P237, DOI 10.1097/CMR.0000000000000056
   Benchoua A, 2004, J CEREBR BLOOD F MET, V24, P1272, DOI 10.1097/01.WCB.0000140272.54583.FB
   Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070
   Bijsterbosch MK, 1997, NUCLEIC ACIDS RES, V25, P3290, DOI 10.1093/nar/25.16.3290
   Bode C, 2014, INT IMMUNOPHARMACOL, V23, P516, DOI 10.1016/j.intimp.2014.09.027
   Bode C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067991
   Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007
   Chang YP, 2015, J CELL PHYSIOL, V230, P1567, DOI 10.1002/jcp.24903
   Chen Y, 2003, P NATL ACAD SCI USA, V100, P15107, DOI 10.1073/pnas.2436538100
   Cheng X, 2008, J MOL CELL CARDIOL, V45, P168, DOI 10.1016/j.yjmcc.2008.04.003
   Chiba T, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/759103
   Courties G, 2014, JAMA NEUROL, V71, P233, DOI 10.1001/jamaneurol.2013.5026
   Davis Beckley K, 2013, Methods Mol Biol, V1031, P27, DOI 10.1007/978-1-62703-481-4_3
   Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405
   Denes A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.86
   Denes A, 2015, P NATL ACAD SCI USA, V112, P4050, DOI 10.1073/pnas.1419090112
   Deroide N, 2013, J CLIN INVEST, V123, P1176, DOI 10.1172/JCI65167
   Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550
   Dong L, 2005, ARTHRITIS RHEUM-US, V52, P651, DOI 10.1002/art.20810
   Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286
   Emsley HCA, 2002, J CEREBR BLOOD F MET, V22, P1399, DOI 10.1097/01.WCB.0000037880.62590.28
   Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9
   Fang H, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-27
   Fann DYW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.326
   Fann DYW, 2014, EXP NEUROL, V257, P114, DOI 10.1016/j.expneurol.2014.04.017
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Fugate JE, 2014, LANCET INFECT DIS, V14, P869, DOI 10.1016/S1473-3099(14)70755-8
   Fujimoto C, 2009, CLIN EXP IMMUNOL, V156, P528, DOI 10.1111/j.1365-2249.2009.03918.x
   Guo YT, 2012, J AM COLL CARDIOL, V60, P2263, DOI 10.1016/j.jacc.2012.04.063
   Gursel I, 2003, J IMMUNOL, V171, P1393, DOI 10.4049/jimmunol.171.3.1393
   Gurung P, 2015, TRENDS MOL MED, V21, P193, DOI 10.1016/j.molmed.2014.11.008
   Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001
   Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490
   Henao-Mejia J, 2012, NAT IMMUNOL, V13, P321, DOI 10.1038/ni.2257
   Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2
   Iadecola C, 1996, STROKE, V27, P1373, DOI 10.1161/01.STR.27.8.1373
   Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399
   Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106
   Jahrsdorfer Bernd, 2008, Update Cancer Ther, V3, P27, DOI 10.1016/j.uct.2007.11.003
   Kaminski JJ, 2013, J IMMUNOL, V191, P3876, DOI 10.4049/jimmunol.1300530
   Kastbom A, 2015, J RHEUMATOL
   Kim YJ, 2006, J NEUROSCI RES, V84, P1037, DOI 10.1002/jnr.21011
   Klinman DM, 2015, MOL THER, V23, P222, DOI 10.1038/mt.2014.251
   Klinman DM, 2009, ANN NY ACAD SCI, V1175, P80, DOI 10.1111/j.1749-6632.2009.04970.x
   Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329
   Koo T, 2013, HUM GENE THER, V24, P479, DOI 10.1089/hum.2012.234
   Lambertsen KL, 2012, J CEREBR BLOOD F MET, V32, P1677, DOI 10.1038/jcbfm.2012.88
   Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452
   Li N, 2013, IMMUNOL LETT, V151, P54, DOI 10.1016/j.imlet.2013.02.004
   Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927
   Lim SY, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00027
   Mazzone P, 2010, INT J ENV RES PUB HE, V7, P4111, DOI 10.3390/ijerph7124111
   Mazzotta G, 2004, EUR J NEUROL, V11, P377, DOI 10.1111/j.1468-1331.2004.00798.x
   McColl BW, 2009, NEUROSCIENCE, V158, P1049, DOI 10.1016/j.neuroscience.2008.08.019
   MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049
   O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741
   Peng B, 2001, ANTISENSE NUCLEIC A, V11, P15, DOI 10.1089/108729001750072092
   Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37
   SAIJO Y, 1994, ONCOL RES, V6, P243
   Sato T, 2008, J IMMUNOL, V180, P7648, DOI 10.4049/jimmunol.180.11.7648
   Satoh T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.169
   Saver JL, 2011, J THROMB HAEMOST, V9, P333, DOI 10.1111/j.1538-7836.2011.04371.x
   Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040
   Seijkens T, 2014, DIABETES, V63, P3982, DOI 10.2337/db14-0272
   SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0
   Shirota H, 2005, J IMMUNOL, V174, P4579, DOI 10.4049/jimmunol.174.8.4579
   Shirota H, 2004, J IMMUNOL, V173, P5002, DOI 10.4049/jimmunol.173.8.5002
   Shirota H, 2014, EXPERT REV VACCINES, V13, P299, DOI 10.1586/14760584.2014.863715
   Sotgiu S, 2006, EUR J NEUROL, V13, P505, DOI 10.1111/j.1468-1331.2006.01280.x
   Stevens SL, 2008, J CEREBR BLOOD F MET, V28, P1040, DOI 10.1038/sj.jcbfm.9600606
   Takahashi M, 2011, TRENDS CARDIOVAS MED, V21, P37, DOI 10.1016/j.tcm.2012.02.002
   Tannahill GM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00106
   TARKOWSKI E, 1995, STROKE, V26, P1393, DOI 10.1161/01.STR.26.8.1393
   Trott DW, 2014, ADV PHYSIOL EDUC, V38, P20, DOI 10.1152/advan.00063.2013
   Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638
   Westwell-Roper Clara, 2013, Methods Mol Biol, V1040, P9, DOI 10.1007/978-1-62703-523-1_2
   Wilson A, 2005, MOL THER, V12, P510, DOI 10.1016/j.ymthe.2005.04.005
   Yamada H, 2004, CRIT CARE MED, V32, P2045, DOI 10.1097/01.CCM.0000142397.38134.EF
   Zeuner RA, 2003, ARTHRITIS RHEUM, V48, P1701, DOI 10.1002/art.11035
   Zhang N, 2014, MEDIAT INFLAMM, DOI 10.1155/2014/370530
   ZHANG RW, 1995, BIOCHEM PHARMACOL, V49, P929, DOI 10.1016/0006-2952(95)00010-W
   Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663
NR 85
TC 6
Z9 7
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 16
PY 2015
VL 10
IS 10
AR e0140772
DI 10.1371/journal.pone.0140772
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CU0DF
UT WOS:000363185500107
PM 26473731
OA Other Gold, Green Published
DA 2019-06-18
ER

PT J
AU Feigin, VL
   Krishnamurthi, RV
   Barker-Collo, S
   McPherson, KM
   Barber, PA
   Parag, V
   Arroll, B
   Bennett, DA
   Tobias, M
   Jones, A
   Witt, E
   Brown, P
   Abbott, M
   Bhattacharjee, R
   Rush, E
   Suh, FM
   Theadom, A
   Rathnasabapathy, Y
   Ao, BT
   Parmar, PG
   Anderson, C
   Bonita, R
AF Feigin, Valery L.
   Krishnamurthi, Rita V.
   Barker-Collo, Suzanne
   McPherson, Kathryn M.
   Barber, P. Alan
   Parag, Varsha
   Arroll, Bruce
   Bennett, Derrick A.
   Tobias, Martin
   Jones, Amy
   Witt, Emma
   Brown, Paul
   Abbott, Max
   Bhattacharjee, Rohit
   Rush, Elaine
   Suh, Flora Minsun
   Theadom, Alice
   Rathnasabapathy, Yogini
   Ao, Braden Te
   Parmar, Priya G.
   Anderson, Craig
   Bonita, Ruth
CA ARCOS IV Grp
TI 30-Year Trends in Stroke Rates and Outcome in Auckland, New Zealand
   (1981-2012): A Multi-Ethnic Population-Based Series of Studies
SO PLOS ONE
LA English
DT Article
ID NORTHERN MANHATTAN STROKE; CASE-FATALITY RATES; REGIONAL COMMUNITY
   STROKE; RISK-FACTORS; SUBARACHNOID HEMORRHAGE; ETHNIC DISPARITIES;
   GLOBAL BURDEN; ATRIAL-FIBRILLATION; CEREBROVASCULAR-DISEASE;
   CARDIOVASCULAR-DISEASE
AB Background Insufficient data exist on population-based trends in morbidity and mortality to determine the success of prevention strategies and improvements in health care delivery in stroke. The aim of this study was to determine trends in incidence and outcome (1-year mortality, 28-day case-fatality) in relation to management and risk factors for stroke in the multi-ethnic population of Auckland, New Zealand (NZ) over 30-years.
   Methods Four stroke incidence population-based register studies were undertaken in adult residents (aged >= 15 years) of Auckland NZ in 1981-1982, 1991-1992, 2002-2003 and 2011-2012. All used standard World Health Organization (WHO) diagnostic criteria and multiple overlapping sources of case-ascertainment for hospitalised and non-hospitalised, fatal and non-fatal, new stroke events. Ethnicity was consistently self-identified into four major groups. Crude and age-adjusted (WHO world population standard) annual incidence and mortality with corresponding 95% confidence intervals (CI) were calculated per 100,000 people, assuming a Poisson distribution.
   Results 5400 new stroke patients were registered in four 12 month recruitment phases over the 30-year study period; 79% were NZ/European, 6% Maori, 8% Pacific people, and 7% were of Asian or other origin. Overall stroke incidence and 1-year mortality decreased by 23% (95% CI 5%-31%) and 62% (95% CI 36%-86%), respectively, from 1981 to 2012. Whilst stroke incidence and mortality declined across all groups in NZ from 1991, Maori and Pacific groups had the slowest rate of decline and continue to experience stroke at a significantly younger age (mean ages 60 and 62 years, respectively) compared with NZ/Europeans (mean age 75 years). There was also a decline in 28-day stroke case fatality (overall by 14%, 95% CI 11%-17%) across all ethnic groups from 1981 to 2012. However, there were significant increases in the frequencies of pre-morbid hypertension, myocardial infarction, and diabetes mellitus, but a reduction in frequency of current smoking among stroke patients.
   Conclusions In this unique temporal series of studies spanning 30 years, stroke incidence, early case-fatality and 1-year mortality have declined, but ethnic disparities in risk and outcome for stroke persisted suggesting that primary stroke prevention remains crucial to reducing the burden of this disease.
C1 [Feigin, Valery L.; Krishnamurthi, Rita V.; Jones, Amy; Witt, Emma; Brown, Paul; Abbott, Max; Bhattacharjee, Rohit; Rush, Elaine; Theadom, Alice; Ao, Braden Te; Parmar, Priya G.] Auckland Univ Technol, Auckland, New Zealand.
   [Barker-Collo, Suzanne; Barber, P. Alan; Parag, Varsha; Arroll, Bruce; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand.
   [McPherson, Kathryn M.] Hlth Res Council New Zealand, Auckland, New Zealand.
   [Bennett, Derrick A.] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England.
   [Tobias, Martin] Minist Hlth, Publ Hlth Intelligence, Wellington, New Zealand.
   [Brown, Paul] Univ Calif Merced, Merced, CA USA.
   [Suh, Flora Minsun] Univ Queensland, Brisbane, Qld, Australia.
   [Rathnasabapathy, Yogini] North Shore Hosp, Waitemata Dist Hlth Board, Auckland, New Zealand.
   [Anderson, Craig] Univ Sydney, Camperdown, NSW, Australia.
RP Feigin, VL (reprint author), Auckland Univ Technol, Auckland, New Zealand.
EM valery.feigin@aut.ac.nz
RI Bennett, Derrick/O-7998-2019
OI Barber, P Alan/0000-0003-2469-9023; McPherson,
   Kathryn/0000-0003-1240-8882; Anderson, Craig/0000-0002-7248-4863;
   Feigin, Valery L./0000-0002-6372-1740; Parmar, Priya/0000-0001-6001-9326
FU Health Research Council of New Zealand [10/458]
FX Support was provided by grant number 10/458 from the Health Research
   Council of New Zealand [http://www.hrc.govt.nz]. The funder had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR AHMAD OB, 2000, GPE DISCUSSION PAPER, V31
   AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113
   Albers GW, 2011, STROKE, V42, P2645, DOI 10.1161/STROKEAHA.111.618850
   Alberti KGMM, 2013, NAT REV ENDOCRINOL, V9, P258, DOI 10.1038/nrendo.2013.54
   Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2
   Anderson CS, 2005, STROKE, V36, P2087, DOI 10.1161/01.STR.0000181079.426900.bf
   [Anonymous], 2007, LANCET, V369, P247
   Bell C, 1996, NEW ZEAL MED J, V109, P66
   Benatru I, 2006, STROKE, V37, P1674, DOI 10.1161/01.STR.0000226979.56456.a8
   Blakely T, 2005, SOC SCI MED, V61, P2233, DOI 10.1016/j.socscimed.2005.02.011
   BONITA R, 1983, STROKE, V14, P342, DOI 10.1161/01.STR.14.3.342
   Bonita R, 1997, STROKE, V28, P758, DOI 10.1161/01.STR.28.4.758
   BONITA R, 1993, LANCET, V342, P1470, DOI 10.1016/0140-6736(93)92938-P
   BONITA R, 1995, INT J EPIDEMIOL, V24, P535, DOI 10.1093/ije/24.3.535
   BONITA R, 1984, AM J EPIDEMIOL, V120, P236, DOI 10.1093/oxfordjournals.aje.a113885
   BONITA R, 1995, STROKE, V26, P541, DOI 10.1161/01.STR.26.4.541
   Briggs A, 2013, BMJ-BRIT MED J, V347
   Carter K, 2006, STROKE, V37, P56, DOI 10.1161/01.STR.0000195131.23077.85
   CASPER M, 1992, AM J PUBLIC HEALTH, V82, P1600, DOI 10.2105/AJPH.82.12.1600
   Chroinin DN, 2011, STROKE, V42, P1021, DOI 10.1161/STROKEAHA.110.596734
   Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119
   Corbin DOC, 2004, STROKE, V35, P1254, DOI 10.1161/01.STR.0000127371.24658.df
   Corso G, 2009, NEUROEPIDEMIOLOGY, V32, P186, DOI 10.1159/000195688
   de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655
   Diaz KM, 2014, HYPERTENSION, V64, P465, DOI 10.1161/HYPERTENSIONAHA.114.03565
   Dundas R, 2001, ETHNIC HEALTH, V6, P95, DOI 10.1080/13557850120068423
   Dyall L, 2006, N Z MED J, V119
   Dyall L, 2008, SOC POLICY J NZ, P178
   Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5
   Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528
   Feigin V, 2006, LANCET NEUROL, V5, P130, DOI 10.1016/S1474-4422(05)70325-2
   Feigin V, 2005, STROKE, V36, P1360, DOI 10.1161/01.STR.0000170710.95689.41
   Feigin VL, 2007, INT J STROKE, V2, P208, DOI 10.1111/j.1747-4949.2007.00140.x
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Feigin VL, 2014, INT J STROKE, V9, P61, DOI 10.1111/ijs.12117
   Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0
   Fink J, 2006, N Z MED J, V119, P1
   Fisher A, 2014, J STROKE CEREBROVASC, V23, P759, DOI 10.1016/j.jstrokecerebrovasdis.2013.06.035
   FRASER GE, 1978, INT J EPIDEMIOL, V7, P277, DOI 10.1093/ije/7.3.277
   Friberg L, 2014, STROKE
   Gulliford MC, 2010, J NEUROL NEUROSUR PS, V81, P416, DOI 10.1136/jnnp.2009.193136
   Gunarathne A, 2008, J HUM HYPERTENS, V22, P18, DOI 10.1038/sj.jhh.1002265
   Hajat C, 2001, STROKE, V32, P37, DOI 10.1161/01.STR.32.1.37
   Hallstrom B, 2008, STROKE, V39, P10, DOI 10.1161/STROKEAHA.107.491779
   Hannon N, 2011, STROKE, V42, P2503, DOI 10.1161/STROKEAHA.110.602235
   Harris R, 2006, LANCET, V367, P2005, DOI 10.1016/S0140-6736(06)68890-9
   Harwood M, 2000, STROKE, V31, P2517, DOI 10.1161/01.STR.31.10.2517
   Health Mo, 2012, HLTH NZ AD 2011 12 K
   Health Mo, 2013, MORTALITY DEMOGRAPHI
   Health Mo, 2013, HLTH LOSS NZ REP NZ
   Heuschmann PU, 2008, STROKE, V39, P2204, DOI 10.1161/STROKEAHA.107.507285
   Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192
   Howard G, 2013, STROKE, V44, P1282, DOI 10.1161/STROKEAHA.111.000529
   Howard G, 2011, STROKE, V42, P3369, DOI 10.1161/STROKEAHA.111.625277
   Inagawa T, 2001, STROKE, V32, P1499, DOI 10.1161/01.STR.32.7.1499
   Islam SM, 2008, STROKE, V39, P776, DOI 10.1161/STROKEAHA.107.493643
   KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973
   Kawachi I, 2005, HEALTH AFFAIR, V24, P343, DOI 10.1377/hlthaff.24.2.343
   Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d
   Kita Y, 2009, INT J STROKE, V4, P241, DOI 10.1111/j.1747-4949.2009.00293.x
   Kleindorfer DO, 2010, STROKE, V41, P1326, DOI 10.1161/STROKEAHA.109.575043
   Koton S, 2014, JAMA-J AM MED ASSOC, V312, P259, DOI 10.1001/jama.2014.7692
   Krishnamurthi R, 2014, INT J STROKE, V9, P140, DOI 10.1111/ijs.12108
   Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5
   Kwon JW, 2013, WORLD NEUROSURG, V79, P499, DOI 10.1016/j.wneu.2012.07.032
   Leyden JM, 2013, STROKE, V44, P1226, DOI 10.1161/STROKEAHA.113.675140
   Macpherson KJ, 2011, BMC NEUROLOGY, V11
   Manobianca G, 2010, EUR J NEUROL, V17, P1148, DOI 10.1111/j.1468-1331.2010.02983.x
   McGruder HF, 2004, STROKE, V35, P1557, DOI 10.1161/01.STR.0000130427.84114.50
   McLean RM, 2013, NZ MED J, V126
   McPherson KM, 2003, BRIT MED J, V327, P443, DOI 10.1136/bmj.327.7412.443
   Ministry of Health, 2004, ETHN DAT PROT HLTH D
   Mo Health, 2010, TAT KAH MAOR HLTH CH
   Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   Napier AD, 2014, LANCET, V384, P1607, DOI 10.1016/S0140-6736(14)61603-2
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Palm F, 2010, STROKE, V41, P1865, DOI 10.1161/STROKEAHA.110.592642
   Rastenyte D, 2006, SCAND J PUBLIC HEALT, V34, P488, DOI 10.1080/14034940600551640
   Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1
   Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2
   Sacco RL, 2001, STROKE, V32, P1725, DOI 10.1161/01.STR.32.8.1725
   SACCO RL, 1995, NEUROLOGY, V45, P659, DOI 10.1212/WNL.45.4.659
   Sacco RL, 1998, AM J EPIDEMIOL, V147, P259
   SAKURAI Y, 1995, TOHOKU J EXP MED, V177, P89, DOI 10.1620/tjem.177.89
   SPRAFKA JM, 1994, DIABETIC MED, V11, P678, DOI 10.1111/j.1464-5491.1994.tb00332.x
   Statistics New Zealand, 2014, NZ CENS 2013
   Stroke Foundation of New Zealand and New Zealand Guidelines Group, 2010, NZ CLIN GUID STROK M
   Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5
   Sudlow CLM, 1996, STROKE, V27, P550, DOI 10.1161/01.STR.27.3.550
   Syme PD, 2005, STROKE, V36, P1837, DOI 10.1161/01.STR.0000177873.82478.1c
   Talelli Penelope, 2008, Ther Adv Cardiovasc Dis, V2, P387, DOI 10.1177/1753944708093411
   Tilling K, 2001, INT J EPIDEMIOL, V30, P1351, DOI 10.1093/ije/30.6.1351
   Tobias M, 2007, AUST NZ J PUBL HEAL, V31, P520, DOI 10.1111/j.1753-6405.2007.00136.x
   Vaartjes IP, STROKE
   Vibo R, 2005, STROKE, V36, P2544, DOI 10.1161/01.STR.0000189633.33623.69
   Waxman A., 2004, Development (London), V47, P75, DOI 10.1057/palgrave.development.1100032
   Wieberdink RG, 2012, EUR J EPIDEMIOL, V27, P287, DOI 10.1007/s10654-012-9673-y
   Ziegler PD, 2012, AM J CARDIOL, V110, P1309, DOI 10.1016/j.amjcard.2012.06.034
NR 99
TC 30
Z9 31
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 20
PY 2015
VL 10
IS 8
AR e0134609
DI 10.1371/journal.pone.0134609
PG 28
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CP5KH
UT WOS:000359919900009
PM 26291829
OA Other Gold, Green Published
DA 2019-06-18
ER

PT J
AU Helbig, AK
   Stockl, D
   Heier, M
   Ladwig, KH
   Meisinger, C
AF Helbig, A. Katharina
   Stoeckl, Doris
   Heier, Margit
   Ladwig, Karl-Heinz
   Meisinger, Christa
TI Symptoms of Insomnia and Sleep Duration and Their Association with
   Incident Strokes: Findings from the Population-Based MONICA/KORA
   Augsburg Cohort Study
SO PLOS ONE
LA English
DT Article
ID TYPE-2 DIABETES-MELLITUS; CAUSE-SPECIFIC MORTALITY; GERMAN HEALTH
   INTERVIEW; CARDIOVASCULAR-DISEASE; ISCHEMIC-STROKE; RISK-FACTOR;
   GENERAL-POPULATION; SEVERITY INDEX; QUALITY INDEX; HEART-DISEASE
AB Objective
   To examine the relationship between symptoms of insomnia and sleep duration and incident total (non-fatal plus fatal) strokes, non-fatal strokes, and fatal strokes in a large cohort of men and women from the general population in Germany.
   Methods
   In four population-based MONICA (monitoring trends and determinants in cardiovascular disease)/KORA (Cooperative Health Research in the Region of Augsburg) surveys conducted between 1984 and 2001, 17,604 men and women (aged 25 to 74 years) were asked about issues like sleep, health behavior, and medical history. In subsequent surveys and mortality follow-ups, incident stroke cases (cerebral hemorrhage, ischemic stroke, transient ischemic attack, unknown stroke type) were gathered prospectively until 2009. Sex-specific hazard ratios (HR) and their 95% confidence intervals (CI) were estimated using sequential Cox proportional hazards regression models.
   Results
   During a mean follow-up of 14 years, 917 strokes (710 non-fatal strokes and 207 fatal strokes) were observed. Trouble falling asleep and difficulty staying asleep were not significantly related to any incident stroke outcome in either sex in the multivariable models. Among men, the HR for the association between short (<= 5 hours) and long (>= 10 hours) daily sleep duration and total strokes were 1.44 (95% CI: 1.01-2.06) and 1.63 (95% CI: 1.16-2.29), after adjustment for basic confounding variables. As for non-fatal strokes and fatal strokes, in the analyses adjusted for age, survey, education, physical activity, alcohol consumption, smoking habits, body mass index, hypertension, diabetes, and dyslipidemia, the increased risks persisted, albeit somewhat attenuated, but no longer remained significant. Among women, in the multivariable analyses the quantity of sleep was also not related to any stroke outcome.
   Conclusion
   In the present study, symptoms of insomnia and exceptional sleep duration were not significantly predictive of incident total strokes, non-fatal strokes, and fatal strokes in either sex.
C1 [Helbig, A. Katharina; Stoeckl, Doris; Heier, Margit; Ladwig, Karl-Heinz; Meisinger, Christa] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany.
   [Ladwig, Karl-Heinz] Tech Univ Munich, Klinikum Rechts Isar, Dept Psychosomat Med & Psychotherapy, D-80290 Munich, Germany.
RP Helbig, AK (reprint author), German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany.
EM Katharina.Helbig@helmholtz-muenchen.de
RI Ladwig, Karl-Heinz/B-5351-2014; Meisinger, Christine/B-5358-2014
OI Ladwig, Karl-Heinz/0000-0003-0710-1720; Meisinger,
   Christa/0000-0002-9026-6544
FU Helmholtz Zentrum Munchen, German Research Center for Environmental
   Health; German Federal Ministry of Education, Science, Research, and
   Technology; state of Bavaria
FX The KORA (Cooperative Research in the Region of Augsburg) research
   platform is financed by the Helmholtz Zentrum Munchen, German Research
   Center for Environmental Health, which is funded by the German Federal
   Ministry of Education, Science, Research, and Technology and by the
   state of Bavaria.
CR Aggarwal S, 2013, CLIN CARDIOL, V36, P671, DOI 10.1002/clc.22160
   Aldabal Laila, 2011, Open Respir Med J, V5, P31, DOI 10.2174/1874306401105010031
   Allison P, 2010, SURVIVAL ANAL USING
   Altman NG, 2012, SLEEP MED, V13, P1261, DOI 10.1016/j.sleep.2012.08.005
   Amagai Y, 2004, J EPIDEMIOL, V14, P124, DOI 10.2188/jea.14.124
   Amagai Y, 2010, J EPIDEMIOL, V20, P106, DOI 10.2188/jea.JE20090053
   [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105
   Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6
   Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4
   Birbaumer N, 2010, BIOL PSYCHOL
   BLIWISE DL, 1994, J CLIN EPIDEMIOL, V47, P35, DOI 10.1016/0895-4356(94)90031-0
   Blomstrand A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005173
   Budhiraja R, 2011, SLEEP, V34, P859, DOI 10.5665/SLEEP.1114
   Busch MA, 2013, BUNDESGESUNDHEITSBLA, V56, P656, DOI 10.1007/s00103-012-1659-0
   BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4
   Cai H, 2015, SLEEP, V38, P529, DOI 10.5665/sleep.4564
   Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585
   Chalmers J, 1999, J HYPERTENS, V17, P151
   Chang JJ, 2012, J RURAL HEALTH, V28, P268, DOI 10.1111/j.1748-0361.2011.00398.x
   Chaput JP, 2014, PHYSIOL BEHAV, V134, P86, DOI 10.1016/j.physbeh.2013.09.006
   Chen JC, 2008, STROKE, V39, P3185, DOI 10.1161/STROKEAHA.108.521773
   COX DR, 1972, J R STAT SOC B, V34, P187
   Ellis JG, 2014, SLEEP, V37, P97, DOI 10.5665/sleep.3316
   Elwood P, 2006, J EPIDEMIOL COMMUN H, V60, P69, DOI 10.1136/jech.2005.039057
   Epstein JF, 2001, PUBLIC OPIN QUART, V65, P529, DOI 10.1086/323577
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0
   German Society for General Medicine and Family Medicine (DEGAM), 2012, STROK DEGAM GUID NUM
   Gillum RF, 2001, INT J OBESITY, V25, P628, DOI 10.1038/sj.ijo.0801590
   Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238
   Grandner MA, 2007, SLEEP MED REV, V11, P341, DOI 10.1016/j.smrv.2007.03.010
   Grandner MA, 2012, J SLEEP RES, V21, P427, DOI 10.1111/j.1365-2869.2011.00990.x
   Green MJ, 2012, SLEEP, V35, P815, DOI 10.5665/sleep.1882
   Hamazaki Y, 2011, SCAND J WORK ENV HEA, V37, P411, DOI 10.5271/sjweh.3168
   Hankerson SH, 2011, J NATL MED ASSOC, V103, P576, DOI 10.1016/S0027-9684(15)30383-7
   Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382
   Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235
   Huang WS, 2013, SLEEP MED, V14, P1341, DOI 10.1016/j.sleep.2013.07.017
   Icks A, 2009, DIABETOLOGIA, V52, P1836, DOI 10.1007/s00125-009-1434-4
   Ikehara S, 2009, SLEEP, V32, P295, DOI 10.1093/sleep/32.3.295
   Jackowska M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047292
   Kakizaki M, 2013, J SLEEP RES, V22, P209, DOI 10.1111/j.1365-2869.2012.01053.x
   Kim Y, 2013, PREV MED, V57, P377, DOI 10.1016/j.ypmed.2013.06.017
   Kolominsky-Rabas PL, 2006, STROKE, V37, P1179, DOI 10.1161/01.STR.0000217450.21310.90
   Kronholm E, 2011, SLEEP MED, V12, P215, DOI 10.1016/j.sleep.2010.07.021
   Ladwig KH, 2004, ANN EPIDEMIOL, V14, P332, DOI 10.1016/j.annepidem.2003.09.003
   Larsson SC, 2015, NEUROLOGY
   Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0
   Leng Y, 2015, NEUROLOGY, V84, P1072, DOI 10.1212/WNL.0000000000001371
   Lowel H, 2005, GESUNDHEITSWESEN, V67, pS13, DOI 10.1055/s-2005-858234
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Magee CA, 2012, J SLEEP RES, V21, P441, DOI 10.1111/j.1365-2869.2011.00993.x
   Mallampalli MP, 2014, J WOMENS HEALTH, V23, P553, DOI 10.1089/jwh.2014.4816
   Meisinger C, 2006, DIABETOLOGIA, V49, P1770, DOI 10.1007/s00125-006-0298-0
   Meisinger C, 2006, J HYPERTENS, V24, P293, DOI 10.1097/01.hjh.0000200508.10324.8e
   Meisinger C, 2005, DIABETOLOGIA, V48, P235, DOI 10.1007/s00125-004-1634-x
   Meisinger C, 2002, ARCH INTERN MED, V162, P82, DOI 10.1001/archinte.162.1.82
   Mezick EJ, 2011, SLEEP MED REV, V15, P51, DOI 10.1016/j.smrv.2010.03.001
   Michal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104324
   Morin CM, 2014, SLEEP, V37, P319, DOI 10.5665/sleep.3406
   Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601
   Morin CM, 1993, INSOMNIA PSYCHOL ASS
   Morphy H, 2007, SLEEP, V30, P274
   Palma JA, 2013, SLEEP MED, V14, P229, DOI 10.1016/j.sleep.2012.11.019
   Pan A, 2014, STROKE
   Patel SR, 2006, SLEEP, V29, P881, DOI 10.1093/sleep/29.7.881
   Patyar S, 2015, J STROKE CEREBROVASC, V24, P905, DOI 10.1016/j.jstrokecerebrovasdis.2014.12.038
   Phillips CL, 2013, NAT SCI SLEEP, V5, P43, DOI 10.2147/NSS.S34841
   Prasanna SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009016, 10.1371/journal.pone.0014189]
   Qureshi AI, 1997, NEUROLOGY, V48, P904, DOI 10.1212/WNL.48.4.904
   Rehm J, 2003, EUR ADDICT RES, V9, P157, DOI 10.1159/000072222
   Robert Koch-Institut, 2005, USITC PUBL, V27
   Rod NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091965
   Rod NH, 2011, AM J EPIDEMIOL, V173, P300, DOI 10.1093/aje/kwq371
   ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645
   Sabanayagam C, 2010, SLEEP, V33, P1037, DOI 10.1093/sleep/33.8.1037
   Sattar N, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000099
   Scherbakov N, 2013, INT J CARDIOL, V170, P89, DOI 10.1016/j.ijcard.2013.10.031
   Schlack R, 2013, BUNDESGESUNDHEITSBLA, V56, P740, DOI 10.1007/s00103-013-1689-2
   Sivertsen B, 2014, J SLEEP RES, V23, P124, DOI 10.1111/jsr.12102
   Sofi F, 2014, EUR J PREV CARDIOL, V21, P57, DOI 10.1177/2047487312460020
   Stone KL, 2009, J AM GERIATR SOC, V57, P604, DOI 10.1111/j.1532-5415.2008.02171.x
   Tikk K, 2014, STROKE, V45, P2041, DOI 10.1161/STROKEAHA.114.005025
   Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859
   United Nations, 2013, WORLD POP AG 2013
   Valipour A, 2012, Pneumologie, V66, P584, DOI 10.1055/s-0032-1325664
   Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723
   Vgontzas AN, 2013, SLEEP MED REV, V17, P241, DOI 10.1016/j.smrv.2012.09.005
   von dem Knesebeck O, 1998, SUBJECTIVE HLTH ELDE
   von Ruesten A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030972
   von Zerssen D, 1976, PSYCHOMANUAL MAIN PA
   Westerlund A, 2013, EUR J EPIDEMIOL, V28, P463, DOI 10.1007/s10654-013-9802-2
   WRIGHT BM, 1970, LANCET, V1, P337
   Wu MP, 2014, STROKE, V45, P1349, DOI 10.1161/STROKEAHA.113.003675
NR 94
TC 15
Z9 16
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 31
PY 2015
VL 10
IS 7
AR e0134480
DI 10.1371/journal.pone.0134480
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO0JY
UT WOS:000358838400125
PM 26230576
OA Green Published, Other Gold
DA 2019-06-18
ER

PT J
AU Tang, WJ
   Dong, WW
   Xie, P
   Cheng, PF
   Bai, SJ
   Ren, YF
   Wang, G
   Chen, XY
   Cui, C
   Zhuang, YX
   Huang, W
AF Tang, Weiju
   Dong, Weiwei
   Xie, Peng
   Cheng, Pengfei
   Bai, Shunjie
   Ren, Yifei
   Wang, Gong
   Chen, Xiuying
   Cui, Chun
   Zhuang, Yuxiang
   Huang, Wen
TI The Effect of Pre-Condition Cerebella Fastigial Nucleus Electrical
   Stimulation within and beyond the Time Window of Thrombolytic on
   Ischemic Stroke in the Rats
SO PLOS ONE
LA English
DT Article
ID ACTIVATED-RECEPTOR-GAMMA; CEREBRAL-ISCHEMIA; NEUROGENIC NEUROPROTECTION;
   HIPPOCAMPAL-NEURONS; BRAIN-INJURY; ROSIGLITAZONE; REPERFUSION;
   MECHANISM; ALTEPLASE
AB Objective
   To investigate the effect of neurogenic neuroprotection conferred by cerebellar fastigial nucleus stimulation (FNS) and the role of PPAR gamma-mediated inflammation in a rat model of cerebral ischemia reperfusion.
   Methods
   After a continuous 1 hour fastigial nucleus electric stimulation, the male Sprague Dawley (SD) rats were given middle cerebral artery occlusion (MCAO) for 1, 3, 6, 9, 12 and 15 hours undergoing reperfusion with intravenous recombinant tissue plasminogen activator (rt-PA), while the control group received without FNS. After 72h of reperfusion, the neurological deficits, infarct volume and brain edema were evaluated. The brain tissue in ischemic penumbra was determined the myeloperoxidase (MPO) activity by a spectrophotometer and expression of PPAR. was measured by Rt-PCR and Western blotting.
   Results
   Our findings showed that FNS group had significantly reduced infarct volume and brain edema, and improved neurological deficits compared with the control group, especially in 6h and 9h reperfusion subgroups(p<0.05). The expression levels of PPAR. increased gradually and the peak may be before and after 9h reperfusion, the 3h, 6h, 9h, 12h and 15h reperfusion subgroups were higher than each control group(p<0.05). The MPO activity of 6h, 12h and 15h reperfusion subgroups were higher than each control group(p<0.05).
   Conclusions
   The neuroprotective effects of FNS have been shown to prolong the therapeutic window in cerebral ischemia/reperfusion, which might be related to the PPAR gamma mediated-inflammation in penumbral region.
C1 [Tang, Weiju; Wang, Gong; Chen, Xiuying; Huang, Wen] Third Mil Med Univ, Xinqiao Hosp, Dept Neurol, Chongqing, Peoples R China.
   [Dong, Weiwei; Xie, Peng; Cheng, Pengfei; Bai, Shunjie; Ren, Yifei] Third Mil Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.
   [Cui, Chun; Zhuang, Yuxiang] Third Mil Med Univ, Xinqiao Hosp, Dept Radiol, Chongqing, Peoples R China.
RP Huang, W (reprint author), Third Mil Med Univ, Xinqiao Hosp, Dept Neurol, Chongqing, Peoples R China.
EM bosshuangwen@126.com
FU National Natural Science Foundation of China [81171113]; Natural Science
   Foundation of Chongqing, China [CSTC 2011BA5012]
FX This work was supported by research grants from the National Natural
   Science Foundation of China (Grant # 81171113), the Natural Science
   Foundation of Chongqing, China (Grant # CSTC 2011BA5012). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Barreto GE, 2012, EXP NEUROL, V238, P284, DOI 10.1016/j.expneurol.2012.08.015
   Busch E, 1997, BRAIN RES, V778, P16, DOI 10.1016/S0006-8993(97)01008-1
   Chen JG, 2007, J PHARMACOL SCI, V103, P317, DOI 10.1254/jphs.FP0061235
   Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015
   Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7
   Golanov EV, 2003, CELL MOL NEUROBIOL, V23, P651, DOI 10.1023/A:1025088516742
   Golanov EV, 1998, NEUROREPORT, V9, P819, DOI 10.1097/00001756-199803300-00010
   Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656
   Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032
   Kinouchi T, 2012, STROKE, V43, P478, DOI 10.1161/STROKEAHA.111.618926
   Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97
   Lee CH, 2014, ANAT CELL BIOL, V47, P111, DOI 10.5115/acb.2014.47.2.111
   Liu JL, 2014, NEURAL REGEN RES, V9, P727, DOI 10.4103/1673-5374.131577
   LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84
   Luo YM, 2006, J NEUROCHEM, V97, P435, DOI 10.1011/j.1471-4159.2006.03758.x
   Majid Arshad, 2014, ISRN Neurol, V2014, P515716, DOI 10.1155/2014/515716
   MATSUO Y, 1994, STROKE, V25, P1469, DOI 10.1161/01.STR.25.7.1469
   Mohammadi A, 2014, IRAN J BASIC MED SCI, V17, P263
   Nour M, 2012, INTERV NEUROL, V1, P185, DOI 10.1159/000353125
   Okami N, 2013, J CEREBR BLOOD F MET, V33, P106, DOI 10.1038/jcbfm.2012.138
   Owens B, 2014, NATURE, V510, pS1, DOI 10.1038/510S1a
   Reis DJ, 1990, STROKE, V21, P172
   Rupadevi M, 2011, J PHARMACOL PHARMACO, V2, P36, DOI 10.4103/0976-500X.77113
   Sun H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041716
   Sundararajan S, 2005, NEUROSCIENCE, V130, P685, DOI 10.1016/j.neuroscience.2004.10.021
   Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4
   Wang QA, 2011, STROKE, V42, P389, DOI 10.1161/STROKEAHA.110.597336
   Zhao XR, 2009, J NEUROSCI, V29, P6186, DOI 10.1523/JNEUROSCI.5857-08.2009
   Zhou P, 2005, J NEUROCHEM, V95, P221, DOI 10.1111/j.1471-4159.2005.03358.x
   夏一鲁, 1999, [中风与神经疾病杂志, Journal of Apoplexy and Nervous Diseases], V16, P3
NR 32
TC 7
Z9 8
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 27
PY 2015
VL 10
IS 5
AR e0128447
DI 10.1371/journal.pone.0128447
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CJ0RO
UT WOS:000355185600118
PM 26016630
OA Green Published, Other Gold
DA 2019-06-18
ER

PT J
AU Wang, AX
   Li, ZX
   Luo, YX
   Liu, XX
   Guo, XH
   Wu, SL
   Zhao, XQ
   Jonas, JB
AF Wang, Anxin
   Li, Zhaoxia
   Luo, Yanxia
   Liu, Xiaoxue
   Guo, Xiuhua
   Wu, Shouling
   Zhao, Xingquan
   Jonas, Jost B.
TI Asymptomatic Intracranial Arterial Stenosis and Metabolic Syndrome: The
   APAC Study
SO PLOS ONE
LA English
DT Article
ID SYSTEMATIC ANALYSIS; GLOBAL BURDEN; RISK-FACTORS; ATHEROSCLEROSIS;
   PREVALENCE; DISEASE; INJURIES; COUNTY; STROKE
AB Purpose: The metabolic syndrome (MetS) is a major risk factor for cardiovascular diseases. We investigated potential associations between MetS and asymptomatic intracranial arterial stenosis (ICAS) in a general population.
   Methods: The community-based "Asymptomatic Polyvascular Abnormalities in Community Study'' examined asymptomatic polyvascular abnormalities in a Chinese population aged 40+ years without history of stroke and coronary heart disease. MetS was defined by the International Diabetes Federation criteria. Asymptomatic ICAS was diagnosed by transcranial color-coded Doppler sonography.
   Results: Out of 5393 study participants, asymptomatic ICAS was detected in 713 (13.2%) participants, and MetS in 1323 (24.5%) individuals. Prevalence of asymptomatic ICAS increased significantly from 7.5% to 24.2% with increasing number of MetS components. After adjusting for age, gender, physical activity, body mass index, low-density lipoprotein cholesterol and high-sensitivity C-reactive protein, MetS was significantly associated with asymptomatic ICAS (OR: 1.50; 95% CI: 1.23,1.83). Compared with the subgroup without MetS, the ORs for asymptomatic ICAS increased (P<0.0001) for each of 5 components of MetS from 1.71 (95% CI: 1.27,2.30), to 2.20 (95% CI: 1.63,2.98), 2.79 (95CI: 2.01,3.88), 3.08 (95% CI: 2.11,4.51) and 4.27 (95% CI: 2.22,8.20).
   Conclusions: In multivariate analysis, MetS was an independent and additional factor associated with asymptomatic ICAS. Study participants with 5 MetS components had a 4 times higher risk of asymptomatic ICAS than participants with no MetS component.
C1 [Wang, Anxin; Li, Zhaoxia; Zhao, Xingquan] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.
   [Wang, Anxin; Luo, Yanxia; Guo, Xiuhua] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China.
   [Wang, Anxin; Luo, Yanxia; Guo, Xiuhua] Capital Med Univ, Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China.
   [Liu, Xiaoxue] Tangshan Peoples Hosp, Dept Cardiol, Tangshan, Peoples R China.
   [Wu, Shouling] Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China.
   [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Seegartenklin Heidelberg, D-69115 Heidelberg, Germany.
RP Guo, XH (reprint author), Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China.
EM guoxiuh@ccmu.edu.cn; drwusl@163.com; zxq@vip.163.com
FU National Natural Science Foundation of China [81202279]; advanced health
   care professional development project of Beijing Municipal Health Bureau
   [2009-3-32]
FX This research was supported by a grant from the National Natural Science
   Foundation of China (Grant No. 81202279), and by a grant from advanced
   health care professional development project of Beijing Municipal Health
   Bureau (Grant No. 2009-3-32). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript. Disclosure/Conflict of Interest: None.
CR Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   Bang Oh Young, 2005, J Clin Neurol, V1, P69, DOI 10.3988/jcn.2005.1.1.69
   Bang OY, 2005, NEUROLOGY, V65, P296, DOI 10.1212/01.wnl.0000168862.09764.9f
   Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X
   Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3
   De Silva DA, 2009, J STROKE CEREBROVASC, V18, P424, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.010
   Ding X, 2014, INT J NEUROSCI, V124, P834, DOI 10.3109/00207454.2013.879580
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Feldmann E, 2007, NEUROLOGY, V68, P2099, DOI 10.1212/01.wnl.0000261488.05906.c1
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5
   Huang HW, 2007, CEREBROVASC DIS, V24, P111, DOI 10.1159/000103125
   Jeng JS, 2010, EXPERT REV CARDIOVAS, V8, P1423, DOI 10.1586/ERC.10.129
   Lopez-Cancio E, 2012, ATHEROSCLEROSIS, V221, P221, DOI 10.1016/j.atherosclerosis.2011.12.020
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Mi DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051421
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Park JH, 2007, EUR J NEUROL, V14, P379, DOI 10.1111/j.1468-1331.2006.01682.x
   Park JH, 2011, STROKE, V42, P3040, DOI 10.1161/STROKEAHA.111.620104
   Park Kwang-Yeol, 2006, J Clin Neurol, V2, P29, DOI 10.3988/jcn.2006.2.1.29
   SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14
   Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2
   Wang AX, 2014, J HYPERTENS, V32, P1600, DOI 10.1097/HJH.0000000000000230
   Wang AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061665
   Wong KS, 2007, NEUROLOGY, V68, P2035, DOI 10.1212/01.wnl.0000264427.09191.89
   Wong KS, 2007, NEUROLOGY, V68, P2031, DOI 10.1212/01.wnl.0000264426.63544.ee
   Zhang S, 2013, EUR J NEUROL, V20, P1479, DOI 10.1111/ene.12210
   Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084685
NR 29
TC 6
Z9 6
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 2
PY 2014
VL 9
IS 12
AR e113205
DI 10.1371/journal.pone.0113205
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AU8TQ
UT WOS:000345869700030
PM 25463628
OA Other Gold, Green Published
DA 2019-06-18
ER

PT J
AU Zhong, CK
   Lv, LY
   Liu, CJ
   Zhao, L
   Zhou, M
   Sun, WJ
   Xu, T
   Tong, WJ
AF Zhong, Chongke
   Lv, Liying
   Liu, Changjiang
   Zhao, Liang
   Zhou, Mo
   Sun, Wenjie
   Xu, Tan
   Tong, Weijun
TI High Homocysteine and Blood Pressure Related to Poor Outcome of Acute
   Ischemia Stroke in Chinese Population
SO PLOS ONE
LA English
DT Article
ID VASCULAR ENDOTHELIAL-CELLS; C-REACTIVE PROTEIN; PLASMA HOMOCYSTEINE;
   CARDIOVASCULAR-DISEASE; GLOBAL BURDEN; RISK; SEVERITY; METAANALYSIS;
   ASSOCIATION; PREVENTION
AB Objectives: To assess the association between plasma homocysteine (Hcy), blood pressure (BP) and poor outcome at hospital discharge among acute ischemic stroke patients, and if high Hcy increases the risk of poor outcome based on high BP status in a northern Chinese population.
   Methods: Between June 1, 2009 and May 31, 2013, a total of 3695 acute ischemic stroke patients were recruited from three hospitals in northern Chinese cities. Demographic characteristics, lifestyle risk factors, medical history, and other clinical characteristics were recorded for all subjects. Poor outcome was defined as a discharge modified Rankin Scale (mRS) score >= 3 or death. The association between homocysteine concentration, admission blood pressure, and risk of poor outcome following acute ischemic stroke was analyzed by using multivariate non-conditional logistic regression models.
   Results: Compared with those in the lowest quartile of Hcy concentration in a multivariate-adjusted model, those in the highest quartile of Hcy concentration had increased risk of poor outcome after acute ischemic stroke, (OR = 1.33, P<0.05). The dose-response relationship between Hcy concentration and risk of poor outcome was statistically significant (p-value for trend = 0.027). High BP was significantly associated with poor outcome following acute ischemic stroke (adjusted OR = 1.44, 95% CI, 1.19-1.74). Compared with non-high BP with nhHcy, in a multivariate-adjusted model, the ORs (95% CI) of non-high BP with hHcy, high BP with nhHcy, and high BP with hHcy to poor outcome were 1.14 (0.85-1.53), 1.37 (1.03-1.84) and 1.70 (1.29-2.34), respectively.
   Conclusion: The present study suggested that high plasma Hcy and blood pressure were independent risk factors for prognosis of acute ischemic stroke, and hHcy may further increase the risk of poor outcome among patients with high blood pressure. Additionally, the results indicate that high Hcy with high BP may cause increased susceptibility to poor outcome among acute ischemic stroke patients in a northern Chinese population.
C1 [Zhong, Chongke; Zhou, Mo; Xu, Tan; Tong, Weijun] Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Jiangsu, Peoples R China.
   [Lv, Liying] Xinganmeng Peoples Hosp, Dept Neurol, Xinganmeng, Inner Mongolia, Peoples R China.
   [Liu, Changjiang] Fuxin Ctr Hosp, Dept Neurol, Fuxing, Liaoning, Peoples R China.
   [Zhao, Liang] Chengde Med Univ, Affiliated Hosp, Dept Neurol, Chengde, Hebei, Peoples R China.
   [Sun, Wenjie] Guangdong Pharmaceut Univ, Sch Food Sci, Zhongshan, Peoples R China.
   [Sun, Wenjie] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA.
   [Xu, Tan] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA.
RP Xu, T (reprint author), Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Jiangsu, Peoples R China.
EM xutan@suda.edu.cn; tongweijun@suda.edu.cn
RI Sun, Wenjie/I-7692-2013
FU National Natural Science Foundation of China [81172760]
FX This study was supported by National Natural Science Foundation of China
   (Grant No. 81172760). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ALLAIN CC, 1974, CLIN CHEM, V20, P470
   Alvarez FJ, 2004, J CEREBR BLOOD F MET, V24, P1267, DOI 10.1097/01.WCB.0000139370.93203.4A
   BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497
   Bonita R, 2004, LANCET NEUROL, V3, P391, DOI 10.1016/S1474-4422(04)00800-2
   Eastern S, 1998, LANCET, V352, P1801
   Faraci FM, 2004, STROKE, V35, P345, DOI 10.1161/01.STR.0000115161.10646.67
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001/jama.277.22.1775
   He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467
   Iso H, 2004, CIRCULATION, V109, P2766, DOI 10.1161/01.CIR.0000131942.77635.2D
   Kalita J, 2009, CLIN NEUROL NEUROSUR, V111, P364, DOI 10.1016/j.clineuro.2008.12.010
   Khan U, 2008, STROKE, V39, P2943, DOI 10.1161/STROKEAHA.107.513416
   Leonardi-Bee J, 2002, STROKE, V33, P1315, DOI 10.1161/01.STR.0000014509.11540.66
   LLOYD B, 1978, CLIN CHEM, V24, P1724
   MCCULLY KS, 1969, AM J PATHOL, V56, P111
   Meairs S, 2006, CEREBROVASC DIS, V22, P75, DOI 10.1159/000093098
   Mizrahi EH, 2005, ARCH PHYS MED REHAB, V86, P60, DOI 10.1016/j.apmr.2004.01.031
   Naess H, 2013, J STROKE CEREBROVASC, V22, pE435, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.031
   Perini F, 2005, NEUROL SCI, V26, P310, DOI 10.1007/s10072-005-0505-7
   Pniewski Ja, 2002, ACTA NEUROBIOLOGIAE, V63, P127
   Qizilbash N, 1995, NASLOV CHOLESTEROL D
   Refsum H, 1997, J INHERIT METAB DIS, V20, P286, DOI 10.1023/A:1005321225893
   Refsum H, 2004, CLIN CHEM, V50, P3, DOI 10.1373/clinchem.2003.021634
   Ridker PM, 1999, JAMA-J AM MED ASSOC, V281, P1817, DOI 10.1001/jama.281.19.1817
   Song IU, 2009, J NEUROL SCI, V278, P60, DOI 10.1016/j.jns.2008.11.011
   Stead LG, 2006, NEUROLOGY, V66, P1878, DOI 10.1212/01.wnl.0000219628.78513.b5
   Tofler GH, 2002, THROMB HAEMOSTASIS, V88, P799
   Towfighi A, 2010, J NEUROL SCI, V298, P153, DOI 10.1016/j.jns.2010.07.013
   Tu WJ, 2013, NEUROL RES, V35, P912, DOI 10.1179/1743132813Y.0000000228
   Tuttolomondo A, 2011, INT J CARDIOL, V151, P318, DOI 10.1016/j.ijcard.2010.06.005
   Wald DS, 2002, BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202
   Wang H, 1997, J BIOL CHEM, V272, P25380, DOI 10.1074/jbc.272.40.25380
   Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X
   Wang YZ, 2013, STROKE, V44, P3298, DOI 10.1161/STROKEAHA.113.002604
   Wu XQ, 2013, EUR J INTERN MED, V24, P362, DOI 10.1016/j.ejim.2013.01.015
   Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488
   Zhang C, 2001, J BIOL CHEM, V276, P35867, DOI 10.1074/jbc.M100747200
NR 37
TC 24
Z9 32
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 29
PY 2014
VL 9
IS 9
AR e107498
DI 10.1371/journal.pone.0107498
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AU6XR
UT WOS:000345745400024
PM 25265507
OA Green Published, Other Gold
DA 2019-06-18
ER

PT J
AU Adeloye, D
AF Adeloye, Davies
TI An Estimate of the Incidence and Prevalence of Stroke in Africa: A
   Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID SUB-SAHARAN AFRICA; NEUROLOGICAL DISORDERS; CASE-FATALITY; REGIONAL
   BURDEN; RISK-FACTORS; COMMUNITY; EPIDEMIOLOGY; POPULATION; DISEASE;
   NIGERIA
AB Background: Stroke is increasingly becoming a challenging public health issue in Africa, and the non-availability of data has limited research output and consequently the response to this burden. This study aimed to estimate the incidence and prevalence of stroke in Africa in 2009 towards improved policy response and management of the disease in the region.
   Methods: A systematic search of Medline, EMBASE and Global Health for original population-based or hospital-based studies on stroke was conducted. A random effect meta-analysis was conducted on crude stroke incidence and prevalence rates, and a meta-regression-like epidemiological model was applied on all data points. The fitted curve generated from the model was used to estimate incident cases of stroke and number of stroke survivors in Africa at midpoints of the United Nation population 5-year age groups for the year 2009.
   Results: The literature search yielded a total of 1227 studies. 19 studies from 10 African countries were selected. 483 thousand new stroke cases among people aged 15 years or more were estimated in Africa in 2009, equivalent to 81.2 (13.2-94.9)/100,000 person years. A total of 1.89 million stroke survivors among people aged 15 years or more were estimated in Africa in 2009, with a prevalence of 317.3 (314.0-748.2)/100000 population. Comparable figures for the year 2013 based on the same rates would amount to 535 thousand (87.0-625.3) new stroke cases and 2.09 million (2.06-4.93) stroke survivors, suggesting an increase of 10.8% and 9.6% of incident stroke cases and stroke survivors respectively, attributable to population growth and ageing between 2009 and 2013.
   Conclusion: The findings of this review suggest the burden of stroke in Africa is high and still increasing. There is need for more research on stroke and other vascular risk factors towards instituting appropriate policy, and effective preventive and management measures.
C1 Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.
RP Adeloye, D (reprint author), Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.
EM Davies.Adeloye@ed.ac.uk
CR Adoukonou TA, 2010, REV NEUROL-FRANCE, V166, P882, DOI [10.1016/j.neuro1.2010.06.004, 10.1016/j.neurol.2010.06.004]
   AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113
   ASHOK PP, 1986, J NEUROL NEUROSUR PS, V49, P519, DOI 10.1136/jnnp.49.5.519
   Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9
   Bennett DA, 2012, NEUROEPIDEMIOLOGY, V38, P30, DOI 10.1159/000334744
   Bonita R, 2003, LANCET NEUROL, V2, P592, DOI 10.1016/S1474-4422(03)00524-6
   Chan Kit Yee, 2012, J Glob Health, V2, P020101, DOI 10.7189/jogh.02.020101
   Chin JH, 2012, NEUROLOGY, V78, P1007, DOI 10.1212/WNL.0b013e318248df95
   Connor MD, 2004, STROKE, V35, P627, DOI 10.1161/01.STR.0000117096.61838.C7
   Connor MD, 2007, LANCET NEUROL, V6, P269, DOI 10.1016/S1474-4422(07)70002-9
   Cossi MJ, 2012, CEREBROVASC DIS, V33, P166, DOI 10.1159/000334195
   Damasceno A, 2010, STROKE, V41, P2463, DOI 10.1161/STROKEAHA.110.594275
   Danesi M, 2007, NEUROEPIDEMIOLOGY, V28, P216, DOI 10.1159/000108114
   Danesi MA, 2013, J NEUROL SCI, V331, P43, DOI 10.1016/j.jns.2013.04.026
   Dewhurst F, 2013, ACTA NEUROL SCAND, V127, P198, DOI 10.1111/j.1600-0404.2012.01709.x
   El Tallawy HNA, 2013, NEUROPSYCH DIS TREAT, V9, P767, DOI 10.2147/NDT.S36956
   ELZUNNI S, 1995, ANN SAUDI MED, V15, P367, DOI 10.5144/0256-4947.1995.367
   Farghaly WMA, 2013, NEUROPSYCH DIS TREAT, V9, P1785, DOI 10.2147/NDT.S48322
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0
   Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7
   HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541
   Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7
   JOUBERT J, 1991, S AFR MED J, V80, P567
   Kandil MR, 2006, EGYPT J NEUROL PSYCH, V43, P593
   Kengne AP, 2006, INT J STROKE, V1, P180, DOI 10.1111/j.1747-4949.2006.00064.x
   Khedr EM, 2013, NEUROEPIDEMIOLOGY, V40, P288, DOI 10.1159/000346270
   Kolapo KO, 2011, TROP MED INT HEALTH, V16, P707, DOI 10.1111/j.1365-3156.2011.02759.x
   Lemogoum D, 2005, AM J PREV MED, V29, P95, DOI 10.1016/j.amepre.2005.07.025
   Matenga J, 1997, S AFR MED J, V87, P606
   Mathers CD, 2005, UNCERTAINTY DATA AVA
   Matuja W, 2004, TROP DOCT, V34, P144, DOI 10.1177/004947550403400305
   Mensah GA, 2008, HEART, V94, P697, DOI 10.1136/hrt.2007.127753
   Mensah George A, 2003, Ethn Dis, V13, pS4
   Nyame P K, 1994, West Afr J Med, V13, P183
   O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3
   Olubunmi O, 2007, BENIN J POSTGRADUATE, V9
   OSUNTOKUN BO, 1987, ACTA NEUROL SCAND, V75, P13, DOI 10.1111/j.1600-0404.1987.tb07883.x
   OSUNTOKUN BO, 1979, STROKE, V10, P205, DOI 10.1161/01.STR.10.2.205
   Owolabi M, 2012, NEUR C 64 AM AC NEUR
   ROMDHANE NA, 1993, NEUROEPIDEMIOLOGY, V12, P285, DOI 10.1159/000110330
   ROSMAN KD, 1986, STROKE, V17, P667, DOI 10.1161/01.STR.17.4.667
   Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5
   Sudlow CLM, 1996, STROKE, V27, P550, DOI 10.1161/01.STR.27.3.550
   TEKLEHAIMANOT R, 1990, NEUROEPIDEMIOLOGY, V9, P263, DOI 10.1159/000110783
   The World Bank, 2014, POV EQ DAT
   Truelsen T., 2006, GLOBAL BURDEN CEREBR
   Truelsen T, 2010, LANCET NEUROL, V9, P755, DOI 10.1016/S1474-4422(10)70161-7
   UN (United Nations), 2013, WORLD POP PROSP 2012
   Wahab KW, 2008, INT J STROKE, V3, P290, DOI 10.1111/j.1747-4949.2008.00217.x
   WALKER R, 1994, T ROY SOC TROP MED H, V88, P609, DOI 10.1016/0035-9203(94)90193-7
   Walker RW, 2013, SAMJ S AFR MED J, V103, P107, DOI [10.7196/SAMJ.5793, 10.7196/samj.5793]
   Walker R, 2010, LANCET NEUROL, V9, P786, DOI 10.1016/S1474-4422(10)70144-7
   Walker RW, 2000, LANCET, V355, P1684, DOI 10.1016/S0140-6736(00)02240-6
   *WHO, 2002, WORLD HLTH REP 2002
   World Bank, 2012, WORLD BANK LIST EC
   World Health Organization, 1990, STROK EV REG DAT C 4
   World Health Organization, 2004, GLOB BURD DIS GBD 20
   1988, J CLIN EPIDEMIOL, V41, P105
NR 59
TC 39
Z9 39
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 26
PY 2014
VL 9
IS 6
AR e100724
DI 10.1371/journal.pone.0100724
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AK2WP
UT WOS:000338280800058
PM 24967899
OA Green Published, Other Gold
DA 2019-06-18
ER

EF